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Summary 
Legionella pneumophila is a gram-negative, opportunistic pathogen that naturally parasitizes 
environmental amoeba, but can also infect human alveolar macrophages, thus causing a severe 
and potentially lethal pneumonia called “Legionnaires’ disease”. L. pneumophila is an obligate 
aerobe organism that prefers amino acids as main source of carbon and energy. Nevertheless, the 
genome of Legionella encodes complete pathways that are needed for carbohydrate catabolism, 
making it possible that more substrates besides amino acids are used for nutrition by the bacteria. 
In this study a novel growth medium was designed and used to investigate the metabolism of 
glycerol and inositol by L. pneumophila. Previous studies of the transcriptome of L. pneumophila 
growing inside macrophages revealed that the expression of glycerol kinase (lpg1414) and 
glycerol-3-phosphate dehydrogenase (glpD) was highly upregulated compared to extracellular 
growing bacteria (Faucher et al., 2011). In line with this study, we found that glycerol did not 
enhance extracellular growth of L. pneumophila. However, glycerol did promote intracellular 
growth in Acanthamoeba castellanii and macrophages in a glpD-dependent manner, and a glpD 
deletion mutant had a severe growth disadvantage compared to wild-type bacteria. Isotopologue 
profiling experiments with [U-13C3]glycerol, [U-
13C6]glucose or [U-
13C3]serine as precursors 
revealed that all three carbon sources were metabolized by L. pneumophila. Glycerol and glucose 
were mainly used to synthesize mannose and histidine, which proved that gluconeogenesis and 
the PPP are active in L. pneumophila, while serine was mainly used in the glycolytic pathway and 
the TCA cycle for energy generation. This work revealed that L. pneumophila employs a bipartite 
metabolism, where serine is used for energy generation, while glucose and glycerol are 
exclusively used for anabolic purposes. This metabolic concept seems also to apply for 
intracellularly growing L. pneumophila and other intracellular pathogens.  
Furthermore, the genome of L. pneumophila harbors a cluster of genes with homologies to genes 
implicated in inositol metabolism in other prokaryotes. These genes were also shown to be 
upregulated upon infection of macrophages (Faucher et al., 2011). In this work, the first protein 
of this cluster, Lpg1653, was identified as inositol transporter, as it enabled L. pneumophila to 
transport 14C-inositol. The transporter was termed IolT, according to inositol transporters in other 
bacteria. Similar to glycerol, inositol did not enhance extracellular growth in different media, but 
promoted intracellular growth of L. pneumophila in A. castellanii and murine macrophages, and 
therefore might also be used as an intracellular carbon source. Interestingly, the expression of 
 
xv 
 
iolT was regulated by RpoS, a central regulator of differentiation and virulence genes of 
L. pneumophila. 
Taken together, the work outlined in this thesis expanded the understanding of L. pneumophila 
metabolism and proved that the bacteria can metabolize glycerol and inositol. The concept of a 
bipartite metabolism that was shown here might be important to understand the intimate relations 
and interactions between intracellular pathogens and their host cells. These insights might in 
consequence help to find new therapies for L. pneumophila and other intracellular pathogens. 
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Zusammenfassung 
Legionella pneumophila ist ein Gram-negatives, opportunistisches Pathogen, welches 
natürlicherweise Amöben in der freien Natur parasitiert, aber auch in der Lage ist, 
Alveolarmakrophagen zu infizieren und dadurch eine schwere und potentiell tödliche Pneumonie, 
die sogenannte Legionärskrankheit, auslösen kann. L. pneumophila ist ein obligat aerobes 
Bakterium, das Aminosäuren als bevorzugte Kohlenstoff- und Energiequelle nutzt. Es ist 
allerdings möglich, dass weitere Substrate neben Aminosäuren den Bakterien als 
Nahrungsgrundlage dienen, da im Genom der Legionellen offenbar komplette Stoffwechselwege 
für den Kohlenhydratmetabolismus kodiert sind. 
In dieser Arbeit wurde ein neuartiges Wachstumsmedium für Legionellen entwickelt und dazu 
benutzt, den Glyzerin- und Inositolstoffwechsel von L. pneumophila zu untersuchen. Vorgängige 
Transkriptomstudien von Legionellen, die intrazellulär in Makrophagen wuchsen, zeigten, dass 
verglichen mit extrazellulär wachsenden Bakterien, die Expression der Glyzerinkinase (lpg1414) 
und der Glyzerin-3-Phosphat Dehydrogenase (glpD), stark hochreguliert war (Faucher et al., 
2011). Damit übereinstimmend zeigten wir in der vorliegenden Studie, dass Glyzerin keinen 
Einfluss auf das extrazelluläre Wachstum von L. pneumophila hat, jedoch das intrazelluläre 
Wachstum in Acanthamoeba castellanii und Makrophagen fördert. Dies war abhängig von GlpD, 
und eine glpD Deletionsmutante hatte einen schweren Wachstumsnachteil im direkten Vergleich 
mit Wildtypbakterien. Isotopologisches Profiling mit [U-13C3]Glyzerin, [U-
13C6]Glukose oder 
[U-13C3]Serin als Ausgangssubstanzen zeigte, dass L. pneumophila alle drei Substrate 
verstoffwechseln kann. Glyzerin und Glukose wurden dazu benutzt, Mannose und Histidin zu 
synthetisieren, wodurch bewiesen wurde, dass die Glukoneogenese und der Pentosephosphatweg 
in L. pneumophila ablaufen. Serin anderseits wurde in der Glykolyse und im TCA-Zyklus 
verwendet, um Energie zu gewinnen. Es konnte dadurch gezeigt werden, dass Legionellen einen 
zweigeteilten Stoffwechsel betreiben, in dem Serin zur Energiegewinnung und Glukose sowie 
Glyzerin ausschließlich zu anabolen Zwecken verwendet werden. Dieses Stoffwechselkonzept 
scheint auch auf intrazellulär wachsende Legionellen und andere intrazelluläre Pathogene 
anwendbar zu sein. 
Das Genom von Legionellen enthält eine Gruppe an Genen, die große Homologien zu Genen 
zeigen, welche in anderen Prokaryoten mit dem Stoffwechsel von Inositol assoziiert sind. 
Transkriptomstudien zeigten, dass die Expression dieses Clusters in Makrophagen hochreguliert 
war (Faucher et al., 2011). In der vorliegenden Arbeit wurde das erste Protein dieses Clusters, 
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Lpg1653, als Inositoltransporter identifiziert, da es L. pneumophila erlaubte 14C-Inositol zu 
transportieren. In Anlehnung an die Namensgebung in anderen Bakterien wurde das Protein IolT 
genannt. Ähnlich wie Glyzerin, hatte Inositol keinen Einfluss auf das extrazelluläre Wachstum 
von L. pneumophila, verbesserte aber wiederum das intrazelluläre Wachstum in A. castellanii und 
Makrophagen. Inositol könnte deshalb als intrazelluläre Kohlenstoff- und Energiequelle 
verwendet werden. Interessanterweise wurde die Expression von iolT durch RpoS gesteuert, 
einem der zentralen Regulatoren der Genexpression in L. pneumophila. 
Zusammenfassend lässt sich sagen, dass die vorliegende Arbeit das Verständnis des 
Stoffwechsels von L. pneumophila erweitert und nachweist, dass die Bakterien Glyzerin und 
Inositol verstoffwechseln können. Das Konzept eines zweigeteilten Metabolismus trägt zu einem 
verbesserten Verständnis der Beziehungen zwischen intrazellulären Pathogenen und ihren 
Wirtszellen bei. Diese Einsichten könnten nützlich sein, um neue Therapien gegen 
L. pneumophila und andere intrazelluläre Pathogene zu finden. 
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1. Introduction 
 
1.1 Legionella pneumophila 
1.1.1 Discovery, Epidemiology and Ecology 
Legionella pneumophila is a flagellated, rod-shaped obligate aerobe bacterium belonging to the 
family of Legionellaceae within the γ-proteobacteria (Brenner et al., 1979). L. pneumophila is 
furthermore the causative agent of Legionnaires’ disease, a severe and atypical pneumonia with a 
relatively high mortality rate of 15%. L. pneumophila was first isolated in 1943 from guinea pigs 
and described as “Rickettsia-like” (Tatlock, 1944). Another strain was isolated in 1953 from soil 
samples, showing the ability to infect free-living amoeba (Drozanski, 1956). These strains were 
subsequently classified as members of the genus Legionella in 1996 (Hookey et al., 1996). The 
bacterium gained first attention as a human pathogen at a convention of the American Legion in 
1976, where over 180 people were infected and developed symptoms of pneumonia. 29 people 
died in consequence of the infection. The disease was termed Legionnaires’ disease in 
accordance to this outbreak, and the soon identified bacterium causing the outbreak was named 
Legionella pneumophila (Fraser et al., 1977; McDade et al., 1977). Following the identification 
of the bacterium, also other unsolved outbreaks of respiratory illness could be traced back to 
L. pneumophila showing the epidemiological relevance of this bacterium (Thacker et al., 1978). 
Patients infected with L. pneumophila do not necessarily develop pneumonia but might only 
suffer from the milder flu-like form of Legionnaires’ disease termed Pontiac fever (Glick et al., 
1978) or might not show any symptoms at all (Boshuizen et al., 2001). There are more than 50 
Legionella species described today.  L. pneumophila and L. longbeachae are responsible for most 
of the clinical cases, although more than half of all described species can be associated with 
human disease (Newton et al., 2010; Hilbi et al., 2011a). Several genome sequences are available 
including the sequences of L. pneumophila and L. longbeachae (Chien et al., 2004; Cazalet et al., 
2010).  
Infection with Legionella spp. normally occurs via the inhalation of contaminated aerosols. Man-
made artificial water sources like household water systems, water towers, air conditioners and 
also whirlpools are common reservoirs for the bacteria (Fields, 1996; Nguyen et al., 2006). Of 
special interest in the epidemiology of L. pneumophila are nosocomial infections. The main 
problem here is that the bacteria impact high risk groups – elderly, ill or immunocompromised 
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persons – and are frequently underdiagnosed, as manifestations are often non-specific and require 
specialized testing (Sabria and Yu, 2002). With further urbanization, demographic changes and 
the rising number of people suffering from autoimmune disorders or immune deficiencies, the 
impact of Legionellosis on the population will further rise. 
The bacteria are naturally found as parasites in free-living protozoa (Rowbotham, 1980) and 
associated with complex aquatic biofilms formed by species such as Pseudomonas aeruginosa or 
Klebsiella pneumoniae (Murga et al., 2001; Mampel et al., 2006; Abdel-Nour et al., 2013). 
Protozoan predators like amoeba are also part of these communities and feed on bacteria residing 
within these biofilms (Abdel-Nour et al., 2013) (Figure 1.1 A). L. pneumophila is able to infect 
and replicate within a broad range of natural occurring hosts including Acanthamoeba castellanii 
(Holden et al., 1984), Hartmannella vermiformis (Fields et al., 1993) or Dictyostelium 
discoideum (Hägele et al., 2000; Solomon and Isberg, 2000). Furthermore, L. pneumophila can 
infect and replicate in human epithelial cells and alveolar macrophages, which were identified as 
the bacterial targets in human disease (Nash et al., 1984). Notably, there is no indication that 
L. pneumophila can be transmitted from person to person, showing that humans are an 
evolutionary dead end for the pathogen (Ensminger et al., 2012).  
The processes involved in bacterial survival within naturally occurring protozoa or macrophages 
are very similar and seem to be evolutionarily conserved as a result of the selection for virulence 
factors that support growth within a wide range of host cells (Brüggemann et al., 2006; Hoffmann 
et al., 2014b). Although it is believed that L. pneumophila is not able to replicate independently 
of a host cell in natural water sources (Declerck, 2010), the bacteria can persist in many 
extracellular niches. The optimal conditions for L. pneumophila are at 35°C with neutral or 
slightly acidic pH (Fields et al., 2002). Nevertheless, Legionellaceae have been isolated from 
physically challenging habitats such as extremely acidic environments (Sheehan et al., 2005; Hao 
et al., 2010), Antarctic freshwater lakes (Carvalho et al., 2008) and from water sources with 
temperatures over 60°C. Although, under such high temperatures the bacteria are only able to 
survive in association with thermotolerant amoeba (Taylor et al., 2009). 
 
1.1.2 Life Cycle and Developmental Forms of Legionella pneumophila 
As described earlier, L. pneumophila can exist in extracellular niches as part of biofilm 
communities but can also replicate intracellularly within a great number of eukaryotic hosts. 
Early studies showed that L. pneumophila bacteria do alternate between at least two 
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morphologically distinct forms, differing in motility, shape and energy-rich polymers 
(Rowbotham, 1986). Based on these observations a model for the L. pneumophila life cycle was 
proposed that consists of two phases: replication and transmission. The bacteria do alternate 
between a transmissive and a replicative form in response to environmental and metabolic stimuli 
(Molofsky and Swanson, 2004). While the transmissive form is motile, resistant to environmental 
stresses like UV light, heat, osmotic pressure, nutrient limitation and is also infectious, the 
replicative form lacks all these traits, but is able to replicate intracellularly (Rowbotham, 1986; 
Molofsky and Swanson, 2004; Brüggemann et al., 2006). In its simplest form the life cycle is 
therefore biphasic (Figure 1.1 A): transmissive bacteria are taken up by a host cell and establish 
an intracellular niche that provides protection from lysosomal degradation (see section 1.1.3 for 
details). Availability of nutrients and other favourable factors then lead to the repression of 
transmissive traits and activate replicative traits that allow the bacteria to multiply intracellularly. 
When nutrients become limiting, a regulatory cascade leads to the downregulation of replicative 
traits and the bacteria switch back to the transmissive form (Molofsky and Swanson, 2004). At 
this point the bacteria also exhibit pore-forming activity that allows lysis and escape from the 
spent host cell (Alli et al., 2000). As the developmental state of L. pneumophila determines 
successful intracellular replication, the switch between transmission and replication has to be 
strictly regulated. Key players to facilitate this switch are, among others, the global regulator 
CsrA (Molofsky and Swanson, 2003), the second messenger guanosine 3´,5´-bispyrophosphate 
(ppGpp) (Dalebroux et al., 2010), the stringent response enzymes RelA and SpoT (Dalebroux et 
al., 2009), the alternative sigma factor RpoS (Hales and Shuman, 1999b) and several two 
component systems, all of which will be described in detail in section 1.2.4. 
Favourable for in vitro studies is the fact that the biphasic life cycle of L. pneumophila can be 
modelled in broth cultures, where the bacteria switch between an exponential phase form (EPF), 
resembling the replicative form in vivo, and a stationary phase form (SPF), resembling the 
transmissive form in vivo, which is motile and virulent (Molofsky and Swanson, 2004; Robertson 
et al., 2014). Indeed, many features of L. pneumophila, like regulation through nutrients, 
virulence and motility, are mimicked in the broth model (Molofsky and Swanson, 2004) (Figure 
1.1 B), while others, like the requirement of an acidic pH for successful intracellular replication 
in macrophages (Sturgill-Koszycki and Swanson, 2000), are not. This cycle presumably not only 
happens in artificial culture media, but allegedly resembles growth in biofilm communities, 
where L. pneumophila could feed on dead microorganisms (Temmerman et al., 2006) or 
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metabolise nutrients released by other bacteria (Wadowsky and Yee, 1985; Tison, 1987) (Figure 
1.1 A). 
 
Figure 1.1: The life cycle and developmental forms of L. pneumophila. Infectious L. pneumphila (MIF) are taken 
up by amoeba or other phagocytes and establish a replication-permissive compartment. Availability of nutrients 
triggers the switch to the replicative phase form (RPF) and bacteria divide intracellularly. When nutrients become 
limiting, the bacteria switch back to the transmissive form, and virulent and motile bacteria leave the spent host cell. 
L. pneumophila also colonizes multispecies biofilms, where the bacteria alter between an exponential phase form 
(EPF) and a stationary phase form (SPF) that is infective. When contaminated aerosols are inhaled by humans, the 
bacteria can infect human alveolar macrophages, causing a severe pneumonia (A) (adapted from (Molofsky and 
Swanson, 2004)). The switch between replicative and transmissive form in response to nutrients can be modelled in 
broth, which is believed to resemble growth in biofilms in nature (B). The developmental forms of L. pneumophila 
are interconnected by a complex network. In addition to forms that resemble in vivo phenomena (RPF, MIF) and 
forms that resemble in vitro phenomena (EPF, SPF), bacteria can develop into a filamentous form (FF), especially 
in response to stress and into a spore like form (VBNCC) that can persist in water environments, both of which are 
virulent against eukaryotic cells (C) (adapted from (Robertson et al., 2014)). 
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Besides the two previously described EPFs and SPFs, more developmental forms of 
L. pneumophila have been found to date, all of which might be interconnected by a complex 
network (Al-Bana et al., 2014; Robertson et al., 2014). These other forms include mature 
infectious forms (MIFs), replicative phase forms (RPFs), filamentous forms (FFs), viable but not 
culturable cells (VBNCCs) and many intermediate forms (Figure 1.1 C). MIFs and RPFs are the 
in vivo counterparts of exponential phase (EPFs) and stationary phase (SPFs) bacteria, 
respectively, in broth. While EPFs and RPFs are at least morphologically indifferent from one 
another (Faulkner and Garduno, 2002), MIFs differ from SPFs in the regard that MIFs are 
metabolically inert and loaded with inclusions of poly-3-hydroxybutyrate, more resistant to 
antibiotics and in general more infectious than SPFs (Garduno et al., 2002). MIFs represent the 
transmissive form of L. pneumophila that exits a spent host cell after intracellular growth, while 
SPFs are most likely produced within biofilms in nature (Robertson et al., 2014) (Figure 1.1 A). 
The filamentous form of L. pneumophila is believed to develop in response to stress, like nutrient 
limitation (Warren and Miller, 1979), high temperature (Piao et al., 2006) or UV light 
(Charpentier et al., 2011). FFs are found in broth, in water environments and infected lung tissue 
(Prashar et al., 2012) and are known to be infectious to macrophages (Prashar et al., 2013). 
Interestingly, as a consequence of FF uptake by macrophages, the filamentous cells undergo 
fragmentation and differentiate into RPFs (Prashar et al., 2013), a process also occurring in vitro 
in broth cultures where they differentiate into EPFs (Piao et al., 2006). At last, L. pneumophila 
exhibits a VBNCC state that is developed extracellularly in response to stress (Al-Bana et al., 
2014) and can be produced from EPFs, SPFs and MIFs (Ohno et al., 2003; Al-Bana et al., 2014). 
VBNCCs can persist in water environments for extended periods of time, until they receive a 
signal to wake up (Robertson et al., 2014). That signal can be the uptake of VBNCCs by amoeba, 
upon which the bacteria differentiate into replicating cells and grow inside the host cell (Al-Bana 
et al., 2014). The fact that these different forms of L. pneumophila can develop from each other 
and also the observation that L. pneumophila reaches different developmental endpoints in 
different host cells (Garduno et al., 2002; Abdelhady and Garduno, 2013), shows that the 
Legionella life cycle could indeed be more complex than the biphasic model would suggest 
(Figure 1.1 C). 
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1.1.3 Virulence and Intracellular Replication 
The key component for L. pneumophila virulence and successful intracellular replication is the 
Icm/Dot (intracellular multiplication/defective organelle trafficking) type IV secretion system 
(T4SS) consisting of 27 proteins forming two subcomplexes that span the inner and outer 
bacterial membrane (Burns, 2003; Segal et al., 2005; Vincent et al., 2006). The main function of 
the Icm/Dot T4SS is the delivery of a vast number of effector proteins into the host cell, of which 
currently over 300 have been identified. The high number of these effectors often results in 
functional redundancy and is considered to be due to host diversity (O'Connor et al., 2011). Many 
of these effectors target central cell processes, which ultimately leads to the formation of an 
ER-derived compartment called the Legionella-containing vacuole (LCV) that enables 
L. pneumophila to replicate intracellularly (Shin and Roy, 2008). Eukaryotic pathways targeted 
by these effectors include endocytic, secretory or retrograde trafficking, and the bacteria exploit 
small GTPases, phosphoinositide lipids as well as ubiquitinylation and apoptosis factors to form 
the LCV (Hubber and Roy, 2010; Rolando and Buchrieser, 2012; Haneburger and Hilbi, 2013; 
Hoffmann et al., 2014a; Horenkamp et al., 2014; Finsel and Hilbi, 2015). The importance of the 
Icm/Dot secretion system is reflected by the fact that mutants lacking the T4SS are not able to 
replicate intracellularly, but are rapidly degraded in the lysosomal pathway upon uptake by the 
host cell (Roy and Isberg, 1997; Zink et al., 2002).  
In addition to the Icm/Dot T4SS L. pneumophila also possesses the Lvh T4SS, a type V secretion 
system, an Lss type I secretion system and an Lsp type II secretion system (T2SS). The T2SS was 
shown to be essential for intracellular growth of L. pneumophila in amoeba and macrophages 
(Hales and Shuman, 1999a; Liles et al., 1999). Interestingly, the possibility that the Lvh T4SS 
protein VirD4 is able to complement the virulence defect of a dotA mutant was reported 
(Bandyopadhyay et al., 2007; Bandyopadhyay et al., 2013), indicating a role of this additional 
T4SS for the virulence of L. pneumophila. Functionality of the Lss type I secretion system was 
also recently shown, since an lssBD mutant, lacking the inner membrane transporter LssB and the 
periplasmic membrane fusion protein LssD, showed strongly attenuated virulence (Fuche et al., 
2015). 
The intracellular replication cycle of L. pneumophila basically consists of four phases: adhesion 
and uptake, formation of the LCV, replication and finally exit from the spent host cell (Figure 
1.2). The Icm/Dot T4SS is important for bacterial uptake as L. pneumophila can actively 
stimulate macropinocytotic internalisation, and Icm/Dot mutants are less efficiently taken up by 
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amoeba and HL-60 cells (Hilbi et al., 2001; Watarai et al., 2001; Lu and Clarke, 2005). 
L. pneumophila RtxA is a homologue of LapA of Pseudomonas putita, which was shown to act 
as adhesin involved in cell-cell interactions (Cirillo et al., 2001). RtxA is also a substrate of the 
L. pneumophila Lss T1SS, and mutants lacking RtxA or the T1SS were defective for entry into 
host cells (Cirillo et al., 2001; Fuche et al., 2015).  
 
 
Figure 1.2: Intracellular infection and replication cycle of L. pneumophila. The bacteria bind to host cell 
receptors and promote their uptake by type-I and type-IV secreted effectors (I). After uptake, fusion with lysosomes 
is blocked (II), the LCV merges with ER exit site vesicles, and mitochondria associate with the LCV (III). 
Ribosomes and membranes derived from the rough ER fuse with the LCV and PtdIns(4)P specifically accumulates 
in the LCV membrane (IV). The bacteria switch to their replicative form (green) and replicate in a compartment 
resembling the ER (V). At the end of their replication cycle the bacteria switch back to the transmissive form (red) 
and escape from their spent host cell (VI). L. pneumophila virulence factors and effector proteins are shown in red, 
see text for details. 
 
Other factors relevant for effective adhesion of L. pneumophila to host cells include the integrin 
analogue LaiA (Chang et al., 2005), the collagen-like protein Lcl binding to the extracellular 
matrix of host cells and supporting infection in A. castellanii (Duncan et al., 2011; Abdel-Nour et 
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al., 2014) and the major outer membrane proteins (MOMPs) that are targets of the complement 
system of the innate immune system, facilitating binding to macrophage complement receptors 
(Bellinger-Kawahara and Horwitz, 1990). 
Host cell factors and effector proteins involved in formation of the LCV are numerous and will 
not all be discussed in detail here (for a review refer to Finsel and Hilbi, 2015). Interference with 
the endocytic pathway and therefore evasion of phagolysosome fusion is the essential first step 
after uptake. The effector protein VipA was found to directly bind actin and polymerize 
microfilaments, thus altering organelle trafficking in the host cell (Franco et al., 2012). VipD is a 
phospholipase that binds the activated GTPase Rab5 on endosomes eventually blocking their 
fusion with the LCV (Gaspar and Machner, 2014). Also, acidification of the phagosome is 
inhibited by L. pneumophila. The Icm/Dot substrate SidK prevents acidification of the LCV by 
targeting the host cell V-ATPase subunit VatA and therefore inhibiting ATP hydrolysis, proton 
translocation and ultimately vacuole acidification (Xu et al., 2010). Communication with the 
endocytic pathway is not completely inhibited as marker of late endosomes/lysosomes were 
found to be present on the LCV (Urwyler et al., 2009).  
Simultaneously with the avoidance of lysosomal degradation, L. pneumophila modifies the LCV 
to a compartment that resembles the endoplasmic reticulum (ER) and allows replication of the 
bacteria (Tilney et al., 2001). As an initial step, mitochondria and smooth ER exit site vesicles 
associate with the LCV shortly after uptake into the host cell (Horwitz, 1983; Kagan and Roy, 
2002). However, the frequency of mitochondria and smooth vesicles decreases again after a few 
hours and ribosomes associate with the LCV (Horwitz, 1983; Swanson and Isberg, 1995). Also, 
ER-specific enzymes, like glucose-6-phosphatase, or the chaperone calnexin (Kagan and Roy, 
2002; Robinson and Roy, 2006) localize with the LCV, suggesting that the ribosomes do not 
originate from the cytoplasm but rather from the fusion of rough ER membranes with the LCV 
(Robinson and Roy, 2006). 
 An important factor for LCV formation is the exploitation of the host cell phosphoinositide (PI) 
metabolism. PI lipids control the identity of organelles and vesicle trafficking pathways by 
providing binding sites for host regulatory proteins (Di Paolo and De Camilli, 2006). 
L. pneumophila perturbs and exploits the PI pattern of the LCV to anchor Icm/Dot substrates to 
the vacuole (Hilbi et al., 2011b). Several Icm/Dot effectors might actively enrich the levels of 
PtdIns(4)P in the LCV membrane, including LpnE, which is associated with the PtdIns(4,5)P2-5-
phosphatase OCRL and the PtdIns-4-kinase-IIIβ (PI4KIIIβ) of the host cell (Weber et al., 2009). 
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The effectors LecE and LpdA recruit protein kinases to the LCV, which subsequently might bind 
PI4KIIIβ (Viner et al., 2012). Finally, the effector SidF, a phosphatidylinositol polyphosphate-3-
phosphatase might directly enrich PtdIns(4)P in the LCV membrane (Hsu et al., 2012). Another 
effector, LppA, was shown to hydrolyse phosphorylated PIs in vitro, although it did not affect the 
PI pattern of LCVs in vivo. LppA acts as a hexakisphosphate inositol (phytate) phosphatase and 
might promote intracellular replication by removing the iron chelator phytate from the 
intracellular milieu (Weber et al., 2014a). Overall, PtdIns(4)P represents an LCV lipid marker 
that steadily accumulates on the membrane of the pathogen compartment in the course of 2 h post 
infection  (Weber et al., 2014b), acts as binding target for several Icm/Dot effectors and may also 
contribute to the acquisition of ER vesicles (Weber et al., 2006). 
GTPases are key regulators of vesicle transport that interact with downstream proteins and can 
switch between an inactive, GDP-bound, and an active, GTP-bound, conformation (Stenmark, 
2009). L. pneumophila also exploits small GTPases; an especially well-studied example is Rab1. 
Rab1 is localized to the LCV by several Icm/Dot substrates (Kagan et al., 2004). The effector 
protein SidM, also known as DrrA, binds to PtdIns(4)P and acts as a guanine nucleotide 
exchange factor that activates Rab1 (Brombacher et al., 2009; Schoebel et al., 2009). LidA 
interacts with activated Rab1, keeping the GTPase in its active state (Neunuebel et al., 2012). 
Another Icm/Dot substrate, AnkX, was also shown to interact with Rab1. The effector can 
modify inactive Rab1 by phosphocholination, which leads to the incorporation of Rab1 into the 
LCV membrane, where it is dephosphocholinated by Lem3 (Mukherjee et al., 2011; Goody et al., 
2012). Activated Rab1 ultimately leads to the recruitment of ER exit site vesicles (Kagan et al., 
2004; Arasaki et al., 2012). Besides Rab1 also other small GTPases of the Rab family have been 
found in the proteome of purified LCVs from macrophages and also seem to be involved in 
formation of the replication-permissive compartment (Hoffmann et al., 2014a). Interaction with 
ER exit site vesicles is believed to prepare the LCV for interaction with rough ER vesicles, 
converting the LCV from a plasma membrane-derived vacuole to a compartment resembling the 
host ER, where the bacteria will replicate with a doubling time of about 2 h (Tilney et al., 2001). 
Other studies report that ER recruitment is not essential to trigger replication of L. pneumophila, 
as mutants defective for the acquisition of ER membranes were not impaired in initial replication 
(Weber et al., 2014b). 
For replication, the bacteria undergo a major transcriptional switch that alters the expression of 
almost half the genome, representing the replicative phase (Brüggemann et al., 2006; Faucher et 
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al., 2011). Nutrients are the key factor for this switch. Especially, genes involved in amino acid 
synthesis as well as uptake (Wieland et al., 2005; Faucher et al., 2011) and iron uptake systems 
(Cianciotto, 2007) are upregulated and important to initiate replication. Also, the availability and 
uptake of nucleosides was shown to be important for intracellular replication (Fonseca et al., 
2014).  
The limitation of nutrients is also a key factor for switching back to the transmissive phase at the 
end of the intracellular replication cycle of L. pneumophila, where virulence traits such as the 
flagellar machinery and Icm/Dot substrates are upregulated (Brüggemann et al., 2006). The 
intracellular replication cycle is closed by lysis of the host and the release of flagellated, virulent 
L. pneumophila cells to the environment. Several processes have been described that might 
facilitate host cell lysis. Haemolytic proteins such as legiolysin (Rdest et al., 1991) and Msp 
(Szeto and Shuman, 1990; Poras et al., 2012) as well as several phospholipases (Bender et al., 
2009; Lang et al., 2012; Aurass et al., 2013) might actively lyse the host cell. The effector 
proteins LepA and LepB have been shown to promote the nonlytic egress from protozoa (Chen et 
al., 2004), and also induction of apoptosis in macrophages (Müller et al., 1996) has been 
discussed as possible exit strategy of L. pneumophila.  
  
1. Introduction 
 
29 
 
1.2 Metabolism of Legionella pneumophila 
1.2.1 Amino Acid Metabolism 
L. pneumphila is an obligate aerobe organism (Warren and Miller, 1979). Early studies of the 
metabolism of L. pneumophila showed the preference for amino acids as main source of carbon 
and energy (Pine et al., 1979; George et al., 1980; Ristroph et al., 1981; Tesh and Miller, 1981; 
Tesh et al., 1983). Cell growth in chemically defined media revealed auxotrophies for the amino 
acids arginine, cysteine, isoleucine, leucine, methionine, threonine and valine (George et al., 
1980; Tesh and Miller, 1981). Serine as well as threonine were discussed as major carbon sources 
for L. pneumophila (George et al., 1980). This need for amino acids is reflected in the genome of 
L. pneumophila, where around 12 classes of ATP binding cassette transporters, amino acid 
permeases and proteases are found, which are likely implicated in amino acid uptake (Cazalet et 
al., 2004; Chien et al., 2004). The absence of biosynthetic pathways for certain amino acids in the 
genomes of several L. pneumophila strains (Cazalet et al., 2004; Chien et al., 2004; Steinert et 
al., 2007; D'Auria et al., 2010; Schroeder et al., 2010) and L. longbeachae (Cazalet et al., 2010; 
Kozak et al., 2010) corresponds to amino acid auxotrophies that were investigated and confirmed 
in defined media. L. pneumophila employs several well-studied systems to cope with these 
auxotrophies, some of which will be described below. 
L. pneumphila lacks enzymes that allow the synthesis of arginine from glutamate, as the 
conversion of glutamate to N-acetylglutamate did not occur in chemically defined medium and 
activity of the N-acetylglutamate synthetase was not measurable in bacterial cell extracts (Tesh 
and Miller, 1983). Supplementation of the medium with arginine or ornithine and citrulline, 
which are precursors of arginine emerging in later steps of the synthesis from glutamate, restored 
growth (Tesh and Miller, 1983). Availability of arginine might also function as a regulatory 
switch during intracellular growth, as mutants lacking the arginine repressor ArgR were unable to 
replicate inside host cells (Hovel-Miner et al., 2010). Several genes, including parts of the 
Icm/Dot T4SS and translocated effector proteins, were differentially expressed in argR deletion 
mutants compared to wild-type bacteria (Hovel-Miner et al., 2010). In addition, the eukaryotic 
arginine transporter SLC7A2 was upregulated in infected macrophages (Portier et al., 2015) and 
is supposedly incorporated in the membrane of LCVs (Hoffmann et al., 2014a), which might 
facilitate the uptake of arginine into the LCV. 
The common solid growth medium for L. pneumophila is buffered charcoal yeast extract (BCYE) 
agar, supplemented with L-cysteine and ferric pyrophosphate (Feeley et al., 1979). 
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L. pneumophila lacks the key cysteine biosynthetic enzymes serine acetyltransferase and cysteine 
synthase, and no activity of these enzymes was detected in cell extracts (Chien et al., 2004; 
Ewann and Hoffman, 2006). L. pneumophila is therefore auxotroph for cysteine and employs at 
least two energy-dependent cysteine transporters. Interestingly, the amount of cysteine in BCYE 
agar is much higher than what is required for bacterial growth, as the main part of cysteine is 
rapidly oxidized to cystine within the medium, which L. pneumophila cannot utilize (Ewann and 
Hoffman, 2006).  
The phagosomal transporter A (PhtA) was identified as an important factor for replication and 
differentiation in macrophages (Sauer et al., 2005) (Figure 1.3). PhtA is a threonine transporter, 
and mutants lacking phtA did not grow in chemically defined medium, but were rescued by 
excess tryptone or dipeptides containing threonine, indicating that PhtA is not the only threonine 
uptake system in L. pneumophila (Sauer et al., 2005). Like ArgR mutants (Hovel-Miner et al., 
2010), bacteria lacking the PhtA transporter were not able to replicate inside macrophages, due to 
their inability to differentiate from the transmissive to the replicative state. Also PhtJ, a valine 
transporter, was needed for successful differentiation and replication within macrophages (Sauer 
et al., 2005; Chen et al., 2008), proving the importance of these transporters and the availability 
of certain amino acids as key regulators for L. pneumphila differentiation. The Pht-family also 
includes the phtC-phtD locus (Chen et al., 2008). Expression of phtC in E. coli strains, lacking all 
known nucleoside transporters, allowed these strains to transport pyrimidines. PhtC and PhtD 
function as thymidine transporters required for replication in macrophages and survival of 
thymidine deprivation (Fonseca et al., 2014). A recent study also demonstrated the importance of 
the shikimate pathway for intracellular replication in macrophages. The aromatic amino acids 
phenylalanine, tryptophan and tyrosine are synthesized by this pathway, and mutants lacking key 
enzymes were not able to replicate within macrophages, which are auxotrophic for tryptophan 
and phenylalanine. The mutant bacteria were still able to replicate normally in Acanthamoeba 
spp., which synthesize aromatic amino acids, indicating that aromatic amino acids can also be 
taken up from the host cell (Jones et al., 2015). 
Already in early studies, serine was discussed as a major carbon source for L. pneumophila 
(George et al., 1980). Using the method of isotopologue profiling, which is based on the 
incorporation of precursors labelled with stable isotopes into key metabolites such as protein-
derived amino acids or storage compounds (Zamboni et al., 2009), it was shown that serine is 
indeed taken up in large amounts by L. pneumophila growing in broth (Eylert et al., 2010). Serine 
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was incorporated directly into proteins, but also used to synthesize other amino acids and poly-3-
hydroxybutyrate (Eylert et al., 2010), proving its role as an effective and important carbon and 
energy source for L. pneumophila. 
 
 
Figure 1.3: Intracellular metabolism of L. pneumophila. Several host cell glucose transporters (green) and amino 
acid transporters (orange) are presumably located in the LCV membrane and facilitate nutrient uptake. The genome 
of L. pneumophila encodes several ABC transporters, permeases and transporters belonging to the phagosomal 
transporter (Pht) family (violet), which are used to take up amino acids. Iron reducing factors (HGA-melanin) and 
the siderophore legiobactin, together with iron transporters like FeoAB, are used to take up iron. Several type-II 
secreted effector proteins, like the chitinase ChiA, the endoglucanase CelA or the glycoamylase GamA, degrade 
polysaccharides. Finally, Icm/Dot effector proteins are used to interfere with host protein synthesis (Lgt1, Lgt2, 
Lgt3), build up a pool of free amino acids by employing the host proteasome (AnkB), act as a phytase (LppA) or 
function as an iron transporter in the LCV membrane (MavN). L. pneumophila effector proteins are shown in red. 
Abbreviations: Lpn, Legionella pneumophila; LCV, Legionella-containing vacuole; eEF1A, eukaryotic elongation 
factor 1A; SCF1, ubiquitin ligase complex. 
 
To take up and utilize amino acids, L. pneumophila also relies on and exploits host metabolic 
functions. The eukaryotic neutral amino acid transporter SLC1A5 is upregulated in macrophages 
infected with L. pneumophila, and depletion of this transporter by RNA interference or 
competitive pharmacological inhibition abolishes intracellular growth of the bacteria (Wieland et 
al., 2005). Proteomic analysis of LCVs isolated from infected macrophages suggested that 
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SLC1A5, together with other amino acid transporters (SLC7A5, SLC3A2) and glucose 
transporters (SLC2A1, SLC2A6), is located in the LCV membrane and might facilitate uptake of 
nutrients into the LCV lumen (Hoffmann et al., 2014a) (Figure 1.3). 
Also, Icm/Dot-translocated effector proteins are used to modulate host cell metabolic functions 
(Figure 1.3). Several effectors were identified that directly block host protein translation. Among 
them are the glycosyltransferases Lgt1, Lgt2 and Lgt3, that modify eukaryotic elongation factor 
eEF1A, which leads to the inhibition of protein synthesis and ultimately to the death of the host 
cell (Belyi et al., 2011). Another effector, AnkB, leads to increased levels of free amino acids in 
the host cell by utilizing the host cell proteasome (Price et al., 2011). AnkB can interact with the 
host SCF1 ubiquitin ligase complex via an F-box domain, harbours two ANK domains, which 
mediate protein-protein interactions in eukaryotes, and a CaaX motive that is modified by 
farnesylation (Price et al., 2009; Ensminger and Isberg, 2010; Lomma et al., 2010; Price et al., 
2010; Price and Kwaik, 2010). AnkB is farnesylated inside the host cell and thus anchored to the 
LCV membrane. Polyubiquitinated proteins generated by AnkB are then degraded by the host 
proteasome generating a pool of free amino acids (Price et al., 2011). 
 
1.2.2 Carbohydrate Metabolism 
The genomes of L. pneumophila (Cazalet et al., 2004; Chien et al., 2004; Steinert et al., 2007; 
D'Auria et al., 2010; Schroeder et al., 2010) and L. longbeachae (Cazalet et al., 2010; Kozak et 
al., 2010) encode a complete glycolytic pathway, the Entner-Doudoroff (ED) pathway, as well as 
an incomplete pentose phosphate pathway (PPP), suggesting the capacity of carbohydrate 
catabolism. Indeed, studies with 14C-radio-labelled substrates indicated that glucose, pyruvate, 
glycerol and acetate are metabolized by L. pneumophila (Pine et al., 1979; Weiss et al., 1980; 
Tesh et al., 1983). Glucose was not rapidly metabolized upon growth in a chemically defined 
medium, and the catabolic route of glucose metabolism remained unclear, although it was 
suggested that glucose metabolism occurs via the pentose phosphate pathway and the ED 
pathway, rather than by the glycolytic pathway (Weiss et al., 1980; Tesh et al., 1983). Consistent 
with the notion that glycerol might be metabolized by L. pneumophila, it was observed that genes 
required for glycerol catabolism were highly upregulated during infection of macrophages, 
compared to growth in broth (Faucher et al., 2011). Also, genes associated with the ED pathway, 
as well as a glucokinase and a glucoamylase were upregulated upon growth in A. castellanii 
(Brüggemann et al., 2006). The ED pathway was meanwhile identified as the route of glucose 
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catabolism in L. pneumophila. Isotopologue profiling revealed the uptake of 13C-labelled glucose 
by L. pneumophila growing in broth, and carbon flow from glucose into downstream metabolites 
was dependent on the zwf gene encoding the glucose-6-phosphate dehydrogenase (Eylert et al., 
2010). Mutants lacking other genes of the ED pathway were also not able to metabolize glucose 
anymore and were defective for intracellular growth in Acanthamoeba culbertsoni and 
mammalian cells (Harada et al., 2010). Besides the simple sugar glucose, also polysaccharides 
are metabolized by L. pneumophila, and several T2SS substrates involved in the degradation of 
complex carbohydrates have been described. The bacteria secrete a chitinase (ChiA), an 
endoglucanase (CelA) that was indeed found to degrade cellulose, as well as a glucoamylase 
(GamA) that degraded carboxymethyl cellulose, glycogen and starch (DebRoy et al., 2006; 
Pearce and Cianciotto, 2009; Herrmann et al., 2011) (Figure 1.3). The T2SS is essential for 
intracellular growth of L. pneumophila in amoebae and macrophages (Hales and Shuman, 1999a; 
Liles et al., 1999) and although neither ChiA, CelA nor GamA were required for successful 
intracellular growth, complex carbohydrates might well be used as a source of carbon and energy 
inside a host. At last, the polyamine spermidine moderately favoured intracellular replication of 
L. pneumophila (Nasrallah et al., 2011) and mutants lacking PotD, a spermidine-binding protein, 
were not able to initiate intracellular replication (Nasrallah et al., 2014), suggesting the 
possibility of polyamines as carbon source or regulatory components. 
 
1.2.3 Micronutrient Requirements 
Microorganisms require metals as cofactors for many enzymes. L. pneumophila is no exception, 
especially as it is an intracellular pathogen and limitation of certain metal ions is a key 
component of host immunity against pathogens. Iron, calcium, magnesium and zinc were shown 
to stimulate extracellular growth of L. pneumophila in chemically defined medium (Reeves et al., 
1981), and accordingly, iron is an essential component of L. pneumophila standard growth media 
(Feeley et al., 1979) and chemically defined media (Reeves et al., 1981; Ristroph et al., 1981). 
Calcium and magnesium might also be important for biofilm formation, as they were shown to 
enhance the adherence of L. pneumophila to surfaces (Koubar et al., 2013). 
Iron is essential for most, if not all bacteria, as it is cofactor for many enzymes within prosthetic 
groups like heme or iron-sulfur clusters (Ratledge and Dover, 2000; Andreini et al., 2008). Iron 
exists in two forms, ferrous (Fe2+) and ferric (Fe3+) iron, the latter of which is insoluble. The form 
predominantly present is mostly dependent on the pH and availability of oxygen (Williams, 2012; 
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Becker and Skaar, 2014). Iron limitation is also an important factor of immunity against 
pathogens, and reduction of available ferric iron is important to restrict bacterial growth. In 
eukaryotic cells, iron is either bound in prosthetic groups or complexed in the storage protein 
ferritin to make it unavailable for intracellular pathogens and to prevent iron toxicity (Recalcati et 
al., 2008).  
L. pneumophila grown under iron-limiting conditions showed reduced virulence and was unable 
to survive within host cells (James et al., 1995). Also, host cells treated with iron chelators did 
not support growth of L. pneumophila anymore (Gebran et al., 1994; Byrd and Horwitz, 2000), 
highlighting the importance of iron availability for L. pneumophila in vivo. Not surprisingly, the 
bacteria therefore employ many systems for iron reduction, complexation and transport. 
L. pneumophila has at least two ferric reductases devoted to the assimilation of iron within the 
bacterial cell (Johnson et al., 1991; Poch and Johnson, 1993) and at least one secreted factor 
necessary for iron reduction, called homogentisic acid (HGA) (Chatfield and Cianciotto, 2007). 
HGA is produced in the course of phenylalanine and tyrosine metabolism of L. pneumophila and 
can be polymerized to HGA-melanin (Flydal et al., 2012). HGA and HGA-melanin can restore 
bacterial growth under iron-limiting conditions, enhance the uptake of iron and release ferrous 
iron from transferrin and ferritin, two major iron chelators of mammalian cells (Zheng et al., 
2013). Also Icm/Dot substrates might facilitate the acquisition of iron (Figure 1.3). LppA is a 
type IV-secreted phytase of L. pneumophila that might help to counteract iron-limiting conditions 
within natural hosts of L. pneumophila, such as D. discoideum and A. castellanii. Phytate is not 
only an abundant phosphor storage compound ,but also a strong iron chelator that could be used 
to limit intracellular iron for pathogens (Weber et al., 2014a). Another type IV-secreted effector 
protein, called MavN, was identified as a mediator of iron acquisition in L. pneumophila. MavN 
is inserted into the LCV membrane, binds iron and presumably is an iron transporter, facilitating 
the uptake of iron into the LCV (Isaac et al., 2015). MavN, also known as IroT, was found to be 
highly induced under iron-limiting conditions and mutants lacking the transporter were highly 
impaired for growth in A. castellanii and human macrophages (Portier et al., 2015). (Figure 1.3). 
L. pneumophila produces the high-affinity iron siderophore legiobactin, used to chelate and 
transport iron (Liles et al., 2000; Starkenburg et al., 2004). Important for synthesis and function 
of legiobactin are at least four proteins: The cytoplasmic LbtA, which is a siderophore synthetase, 
LbtB the inner-membrane efflux transporter of legiobactin, LbtU located in the outer-membrane 
and acting as receptor of ferrilegiobactin and finally LbtC which is predicted to be the transporter 
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of ferrilegiobactin located in the inner membrane (Allard et al., 2006; Chatfield et al., 2011; 
Chatfield et al., 2012). The structure of legiobactin was recently elucidated and constitutes a 
polycarboxylate identical in structure to rhizoferrin, a siderophore made by funghi (Burnside et 
al., 2015). Legiobactin is also very important in vivo, as lbtA mutant strains of L. pneumophila 
showed reduced ability to infect lungs of A/J mice (Allard et al., 2009). Other iron transporters 
have also been identified in L. pneumophila, including the FeoAB system, a homologue of the 
well-characterized E. coli system, which is also important for in vivo growth (Robey and 
Cianciotto, 2002) (Figure 1.3). 
 
1.2.4 Regulation of Differentiation and Virulence by Metabolism 
The availability of certain nutrients is essential for the switch between transmission and 
replication, as seen for example for L. pneumophila mutants lacking the arginine transcriptional 
regulator ArgR or the threonine transporter PhtA, which are no longer able to switch from the 
transmissive to the replicative form inside host cells (see section 1.2.1). As amino acids represent 
the main carbon and energy source for L. pneumophila, it is not surprising that they are also main 
regulatory factors for the phenotypic switch (Byrne and Swanson, 1998; Sauer et al., 2005). The 
network of factors that mediate this switch is complex and will be dissected in the following 
paragraphs (Figure 1.4). 
The second messenger guanosine-3`,5`-bispyrophosphate (ppGpp) is central for the switch 
between the replicative/non-motile to the virulent/motile form of L. pneumophila in response to 
amino acid or nutrient limitation (Hammer and Swanson, 1999; Dalebroux et al., 2010). ppGpp is 
the trigger of the so-called stringent response and alters the preference of RNA polymerase for 
certain sigma factors, thus facilitating changes in gene expression profiles (Dalebroux et al., 
2010). The alarmone ppGpp is synthesized by two enzymes in L. pneumophila, RelA and SpoT. 
RelA is a ribosome-associated enzyme that is activated when uncharged tRNAs accumulate at the 
ribosome as a consequence of low amino acid levels in the cell (Dalebroux et al., 2009). SpoT 
interacts with the acyl-carrier protein ACP and is activated by the reduction in the rate of fatty 
acid biosynthesis or increased levels of short chain fatty acids (Edwards et al., 2009). The 
enzyme therefore synthesizes ppGpp, not in response to low amino acid levels but by monitoring 
fatty acid biosynthesis. Furthermore, during exponential growth SpoT acts as a ppGpp-hydrolase, 
which keeps the concentration of the alarmone within the cell low to assure that transmissive 
traits are not expressed during replication (Dalebroux et al., 2009). 
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Figure 1.4: Regulation of replicative and transmissive traits by L. pneumophila. As long as nutrients are 
available, the global regulator CsrA prevents the expression of virulence traits and promotes expression of replicative 
traits. Also, SpoT hydrolases ppGpp, blocking the downstream regulatory cascade. When nutrients become limiting, 
ppGpp is synthesized by RelA and SpoT, leading to production of the alternative sigma factor RpoS, which in turn 
regulates the two component systems CpxRA, PmrAB, LetAS, the integration host factor IHF and the Legionella 
quorum sensing system Lqs. CsrA is silenced by the two regulatory RNAs RsmY and RsmZ, which leads to the 
swtich from replicative to transmissive phase and to the expression of virulence traits, motility and Icm/Dot effector 
proteins (model adapted from (Manske and Hilbi, 2014)). 
 
High levels of ppGpp lead to an increase in stability and activity of RpoS, the alternative sigma 
factor σ38/σS that acts as the central regulator of differentiation in the L. pneumophila life-cycle 
(Bachman and Swanson, 2001; Zusman et al., 2002). RpoS regulates 208 genes in exponential 
and 571 genes in stationary growth phase including genes required for central metabolism 
(Hovel-Miner et al., 2009), small regulatory RNAs, two component systems, ArgR and the 
quorum sensing regulator LqsR (see below). An rpoS mutant of L. pneumophila does grow 
normally in broth, but is not able to replicate intracellularly in amoeba (Hales and Shuman, 
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1999b), highlighting its role as a central regulator of the L. pneumophila life-cycle. Another 
factor that might be important for activation of RpoS is the ribosome-binding protein DksA. 
Deletion mutants lacking dksA still produce ppGpp but are defective for flagellar gene expression 
and macrophage cytotoxicity, and DksA is believed to cooperate with ppGpp (Dalebroux et al., 
2010). However, it is not known whether DksA also influences the expression of RpoS as shown 
for E. coli, where deletion of dksA results in significantly lower levels of RpoS, even when 
ppGpp is produced (Brown et al., 2002). Furthermore, there also exists a regulatory feedback 
loop between RpoS and SpoT that negatively regulates expression of spoT to prevent hydrolytic 
degradation of ppGpp. Mutants of rpoS showed decreased levels of ppGpp and failed to induce 
the stringent response upon growth in water (Trigui et al., 2015). 
Downstream of RpoS are at least three two component systems and one quorum sensing system 
influencing the virulence of L. pneumophila. The CpxRA system, consisting of the response 
regulator CpxR and the cognate sensor kinase CpxA, was the first two component system in 
L. pneumophila that was shown to regulate an icm/dot virulence gene (Gal-Mor and Segal, 
2003a). Until now several other icm/dot genes and several Icm/Dot-translocated substrates have 
been found to be regulated by CpxR, establishing CpxRA as an important regulator of the 
Icm/Dot T4SS (Altman and Segal, 2008). Also, the PmrAB two component system is known to 
be regulated by RpoS (Hovel-Miner et al., 2009) and acts itself as a regulator of several Icm/Dot 
substrates (Zusman et al., 2007). Mutants lacking pmrAB are severely attenuated for intracellular 
growth and differentially express a large number of genes, including metabolic genes and the 
flagellar machine (Al-Khodor et al., 2009). Furthermore, pmrAB mutants exhibit significantly 
lower levels of another important regulatory protein, the “carbon storage regulator” CsrA (Al-
Khodor et al., 2009), and the two component system is therefore integral part of the link between 
metabolism and virulence (see below). The third two component system is the LetAS system that 
acts as an inducer of transmissive traits (Hammer et al., 2002). In mutants lacking the response 
regulator LetA several icm/dot genes were differentially expressed (Gal-Mor and Segal, 2003b), 
and also expression of rpoS was reduced, demonstrating that RpoS is also influenced by 
downstream two component systems (Lynch et al., 2003). The induction of transmissive traits is 
facilitated in an indirect fashion, as LetAS acts as a repressor of CsrA (Sahr et al., 2009) by 
inducing the expression of two small RNAs, rsmY and rsmZ (Rasis and Segal, 2009). CsrA is a 
RNA-binding protein that blocks translation of transcripts encoding stationary phase and 
transmissive trait proteins in exponentially growing cells, and therefore, acts as an antagonist for 
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the stringent response. When rsmY and rsmZ are expressed, they bind to CsrA, allowing 
translation of previously blocked transmissive traits, promoting the switch from replicative to 
transmissive phase (Rasis and Segal, 2009). At last, the Legionella quorum sensing (lqs) cluster is 
also involved in this regulatory cascade. The Lqs system consists of the autoinducer synthase 
LqsA producing the α-hydroxyketone signaling molecule LAI-1 (Spirig et al., 2008), the sensor 
kinases LqsS (Tiaden et al., 2010) and LqsT (Kessler et al., 2013) and the response regulator 
LqsR (Tiaden et al., 2007). Expression of lqsR is growth-phase dependent and regulated by RpoS 
and to a lesser extent by LetA (Tiaden et al., 2007). In a mutant lacking the whole lqs cluster, 
genes involved in protein production, amino acid and carbohydrate metabolism and other 
replicative traits were upregulated, whereas genes associated with transmissive traits were 
downregulated, suggesting that also Lqs acts as a regulator of the life-style switch (Tiaden et al., 
2008). Finally, the integration host factor (IHF) is a DNA-binding protein that is important for the 
differentiation of replicative L. pneumophila to transmissive bacteria (Morash et al., 2009). 
Expression of IHF is positively regulated by RpoS, and IHF itself also auto-regulates its own 
expression (Zhao et al., 2007). Regulation through IHF and the LetAS two component system is 
intertwined, as LetA negatively regulates IHF expression but IHF also cooperates with LetA to 
induce transcription of rsmY and rsmZ (Zhao et al., 2007). 
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1.3 Central Carbon Metabolism, Amino Acid Biosynthesis and Inositol 
Metabolism 
1.3.1 Central Carbon Metabolism and Amino Acid Biosynthesis 
Central carbon metabolism describes the enzymatic reactions that degrade different nutrients to 
produce precursor molecules for biosynthesis pathways as well as for energy storage (Csete and 
Doyle, 2004). Central metabolism includes several metabolic pathways like the glycolytic 
pathway, the PPP and the tricarbolic acid (TCA) cycle (Donachie and Begg, 1970; Konopka, 
1984). The glycolytic pathway converts glucose to two molecules pyruvate and delivers two 
molecules ATP; pyruvate then being fed into the TCA cycle, which again delivers ATP as well as 
NAD(P)H/H+ and precursors for several biosynthesis pathways, including fatty acid biosynthesis. 
The PPP is central for the interconversion of glucose or fructose into C4-, C5- and C7-sugars, 
which are important for many biosynthesis pathways like cell wall synthesis or purine 
metabolism. The pathway consists of an oxidative part that delivers NADPH/H+ and a non-
oxidative part that catalyzes the interconversion of carbohydrates, resulting in fructose-6-
phosphate and glyceraldehyde-3-phosphate as intermediates of the glycolytic pathway. Some 
bacteria have an additional pathway, the ED pathway that can be used to metabolize glucose. 
Here, glucose is catabolized to the specific intermediate of the ED pathway, 2-keto-3-deoxy-6-
phosphogluconate (KDPG) that is then cleaved to form glyceraldehyde-3-phosphate and pyruvate 
(Entner and Doudoroff, 1952). In absence of usable sugars, intermediates of the glycolytic 
pathway as well as glucose can be made in the gluconeogenic pathway that is closely related to 
the glycolytic pathway, but not its exact reversion (Anderson and Cooper, 1969). Another reason 
why these pathways are so central for metabolism is the fact that many nutrients besides glucose, 
enter these central pathways at some point of their catabolism, as for example seen for inositol 
(Kröger and Fuchs, 2009) or glycerol (Joseph et al., 2008). L. pneumophila also possesses these 
central metabolic pathways, including the ED pathway, the glycolytic pathway, the TCA cycle 
and a PPP which, however, lacks the transaldolase as well as the 6-phosphogluconate 
dehydrogenase (Chien et al., 2004). 
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Figure 1.5: Central carbon metabolism and amino acid synthesis by L. pneumophila. The central carbon 
metabolism of L. pneumophila consists of the Entner-Doudoroff (ED) pathway, the glycolytic pathway, the citric 
acid cycle (TCA) and the pentose phosphate pathway (PPP) that delivers intermediates and precursors for 
biosynthesis of e.g. fatty acids or storage compounds (3-HBA, PHB). Amino acids are also synthesized from 
intermediates of this central metabolism and are grouped into five biosynthesis families: 3-phosphoglycerate group 
(blue), pyruvate group (green), α-ketoglutarate group (orange), oxaloacetate group (yellow) and aromatic group 
(purple). Histidin is derived from intermediates of the PPP (red). Amino acids are shown in 3-letter code and 
essential amino acids for L. pneumophila are shown in red. 
Abbreviations: 6-PG, 6-phosphogluconate; KDPG, 2-keto-3-desoxy-phosphogluconate; Shi, shikimate; Cho, 
chorismate; DAP, diaminopimelic acid; α-KGA, α-Ketoglutarate; 3-HBA, 3-hydroxybutyrate; PHB, 
polyhydroxybutyrate. 
 
Amino acids are the building blocks of proteins and can be synthesized in several fundamentally 
different biosynthesis pathways, which will not be described in detail here. Nevertheless, all 
amino acids share one common feature. The backbone of amino acids is derived from different 
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intermediates of central carbon metabolism, and amino acids can be, depending on their initial 
precursor, grouped into five biosynthetic families: the 3-phsophoglycerate group comprising Ser, 
Cys and Gly; the pyruvate group containing Ala, Val and Leu; the α-ketoglutarate group with 
Glu, Gln, Pro and Ala; the oxaloacetate group comprising Asp, Asn, Thr, Ile, Met and Lys (as 
intermediate between pyruvate and oxaloacetate group) and finally the group of aromatic amino 
acids with Phe, Tyr and Trp that are derived from the shikimate pathway. Histidine is a special 
case, as it is standing aside of the other amino acids and is being derived from the PPP with 
ribose-5-phosphate as precursor (Figure 1.5). Not all organisms can synthesize all amino acids 
themselves, which defines the term essential amino acid. This means that these amino acids have 
to be taken up from the environment, making the organism auxotrophic for a given amino acid. 
L. pneumophila is auxotrophic for several amino acids, including Cys, Val, Leu, Met, Thr, Ile and 
Arg (see section 1.2.1) (Figure 1.5). 
 
1.3.2 Inositol Metabolism 
Inositol is a polyol, a sugar alcohol, which exists in nine stereoisomeric forms, with myo-inositol 
(MI) being the most abundant stereoisomer (Turner et al., 2002). MI is abundant in soil and 
aquatic environments and normally exists in various states of phosphorylation with between one 
and six phosphate groups (Turner et al., 2002; Mao et al., 2009). The most common form of 
inositol in soil is the six-fold phosphorylated inositol hexakisphosphate, also known as phytic 
acid or phytate, which serves as a major phosphorus storage compound in plants and seeds (Sakai 
et al., 2015) and makes up for more than 80% of organic phosphate in soil (Turner et al., 2002). 
Phytate is highly negatively charged and can complex a variety of ions, including iron, and is also 
highly resistant to enzymatic hydrolysis, which might account for its accumulation in the ground 
(Turner et al., 2002). A special group of enzymes, so-called phytases, are used to catalyze the 
stepwise removal of phosphate from phytate (Lei et al., 2013), a crucial step for recycling organic 
phosphate. MI is furthermore the key component of phosphoinositide lipids that are important for 
the definition of subcellular compartments and membrane dynamics in eukaryotic cells 
(Haneburger and Hilbi, 2013). The biosynthesis of inositol proceeds through a conserved 
metabolic pathway in eukaryotes and archaea that consists of two steps, the isomerization of 
glucose-6-phosphate to inositol-3-phosphate by inositol synthase enzymes, followed by the 
dephosphorylation to inositol by inositol monophosphatases (Fischbach et al., 2006). Moreover, 
environmental inositol or inositol-3-phosphate can be used directly for the synthesis of phytate or 
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its differentially phosphorylated intermediates, e.g. by D. discoideum (Stephens and Irvine, 
1990). 
As MI is naturally occurring in many ecosystems, it is not surprising that also a large number of  
microorganisms can grow on MI as sole source of carbon and energy, including Bacillus subtilis 
(Yoshida et al., 2008), Lactobacillus casei (Yebra et al., 2007) or Salmonella enterica (Kröger 
and Fuchs, 2009). The molecular genetics of bacterial MI catabolism have been best described in 
B. subtilis, where two operons, iolABCDEFGHIJ and iolRS as well as the gene iolT, are 
responsible for MI degradation (Yoshida et al., 2008). IolT and IolF have been identified as 
inositol transporters belonging to the major facilitator superfamily, but only IolT is essential, as 
mutants lacking iolT did show major growth defects (Yoshida et al., 2002). Another central 
component of inositol catabolism is the regulator protein IolR that, in the absence of inositol, 
binds to the operator sites within the iol operon (Yoshida et al., 1999). In the presence of MI, 
2-deoxy-5-keto-D-gluconic-acid-6-phosphate, a central intermediate of MI catabolism, 
antagonizes the repressor IolR and allows expression of the iol operon (Yoshida et al., 1997). The 
degradation of MI then finally results in dihydroxyacetone phosphate, acetyl-CoA and CO2 as 
end products (Kröger and Fuchs, 2009) (Figure 1.6). Although the genetic organization of iol 
genes can differ from organism to organism and must not necessarily consist of all genes found in 
the genome of B. subtilis, the principal reactions seem to be conserved and consist of seven 
stepwise reactions (Yoshida et al., 2008; Kröger and Fuchs, 2009). 
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Figure 1.6: Schematic pathway of myo-inositol catabolism. Myo-inositol is transported across the cell membrane 
by IolT and then degraded in several enzymatic steps to dihydroxyacetone phosphate and acetyl-CoA which then 
enter the central carbon metabolism (model adapted from (Yoshida et al., 2008; Kröger and Fuchs, 2009)). 
 
After import of MI by IolT, the first reaction is the dehydrogenation of MI to 2-keto-myo-inositol 
catalyzed by IolG, followed by dehydration to 3,5/4-trihydroxycyclohexane, catalyzed by IolE. 
The next reaction, catalyzed by the hydrolase IolD, breaks the hexane ring, yielding 5-deoxy-
glucuronic acid, which is then isomerized by IolB to 2-deoxy-5-keto-D-gluconic acid. The next 
step is the ATP-dependent phosphorylation of the compound, catalyzed by IolC, which yields the 
central intermediate 2-deoxy-5-keto-D-gluconic-acid-6-phosphate, subsequently cleaved by the 
bisphosphate aldolase IolJ into dihydroxyacetone phosphate and malonate semialdehyde. The 
latter is then finally converted into acetyl-CoA in a dehydrogenase reaction catalyzed by IolA, 
which releases CO2. The endproducts dihydroxyacetone phosphate and acetyl-CoA can then be 
channeled into the central metabolism (Figure 1.6). 
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1.4 Aims of the Thesis 
L. pneumophila colonizes a variety of extra- and intracellular niches and is therefore exposed to a 
plethora of different possible carbon and energy sources. Nevertheless, not much is known about 
the nutrition of L. pneumophila. The bacteria are auxotrophic for different amino acids, and 
serine is believed to be the major carbon substrate of L. pneumophila (George et al., 1980). Yet, 
the genome of L. pneumophila reveals the possibility of other nutrients as carbon sources, and 
complete pathways for carbohydrate metabolism are encoded (Chien et al., 2004). Indeed, 
glucose was found to be metabolized by L. pneumophila (Eylert et al., 2010), but the full 
metabolic capacities of L. pneumophila are still not explored. 
The aim of this thesis was the investigation of the glycerol and inositol metabolism of 
L. pneumophila and its relevance for extra- and intracellular growth of the bacteria. This was 
done by constructing defined deletion mutants lacking the glycerol-3-phosphate dehydrogenase 
GlpD, the putative inositol transporter Lpg1653 or the putative inositol dehydrogenase IolG and 
by performing different extra- and intracellular growth assays with these mutants. To this end, a 
newly developed Legionella minimal growth medium was employed. Using the technique of 
isotopologue profiling the metabolism of glycerol was investigated in detail and also compared 
with the catabolism of the known carbon substrates glucose and serine. The putative inositol 
degradation cluster lpg1653-lpg1649 of L. pneumophila was identified by sequence homology, 
and the function of Lpg1653 as inositol transporter was tested using radioactive 14C-inositol. The 
expression of iolT and the whole inositol degradation cluster was to be tested with an unstable 
GFP variant in different L. pneumophila deletion mutants. Finally, the accessibility of the LCV 
for carbon substrates was investigated using a fluorescent glucose analogue. 
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2.  Materials and Methods 
2.1 Materials 
2.1.1 Laboratory Equipment 
Item Model Manufacturer 
Amix-Viewer software v 3.9.22 Bruker Biospin (Rheinstetten) 
Autoclave Sterimaquet Maquet (Rastatt) 
Autoclave  Varioklav classic  H+P (Oberschleissheim) 
Cell homogenizer  Isobiotec (Heidelberg) 
Benchtop centrifuge  5417R  Eppendorf (Hamburg) 
Centrifuge  3-30K  Sigma-Aldrich (St. Louis) 
Centrifuge  5810 Eppendorf (Hamburg) 
Centrifuge  Heraeus Megafuge 40R  Thermo Fisher Scientific 
(Waltham) 
CO2 incubator  Heraeus HeraCell 240  Thermo Fisher Scientific 
(Waltham) 
Colony counter  Countermat flash IUL (Barcelona) 
Confocal microscope TCS SP5  Leica (Mannheim) 
Cryogenic freezer box Mr. FrostyTm  freezing 
container 
Thermo Fisher Scientific 
(Waltham) 
Culture microscope  Axiovert 25  Zeiss (Oberkochen) 
Diaphragm vacuum pump  MZ 2C Vacuubrand (Wertheim) 
Electrophoresis chamber  Mini-Subcell GT Bio-Rad (Munich) 
Electroporation device  GenePulser Xcell Bio-Rad (Munich) 
Freeze-dryer Alpha 2-4 LD plus Christ (Osterrode) 
Gas chromatograph / Mass 
spectrometer 
QP2010 Plus Shimadzu (Kyoto) 
GC / MS analysis software Lab Solution Software Shimadzu (Kyoto) 
Gel imaging system  GelDoc EQ Bio-Rad (Munich) 
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Hot plate magnetic stirrer  RCT basic  IKA (Staufen) 
Ice machine  AF30  Scotsman (Vernon Hills) 
Incubation cabinet  Multitron Pro Infors HT (Sulzemoos) 
Incubation cabinet  Forma Orbital Shaker  Thermo Fisher Scientific 
(Waltham) 
Incubator BF 400 Binder (Tuttlingen) 
Incubator  Heraeus BR6000 Thermo Fisher Scientific 
(Waltham) 
Incubator  Heraeus Function Line  Thermo Fisher Scientific 
(Waltham) 
Incubator IPP400 Memmert (Schwabach) 
Incubator IPP500  Memmert (Schwabach) 
Liquid scintilation and 
luminescence counter 
Trilux 1450 Micro Beta Perkin Elmer (Waltham) 
Microplate reader Fluostar Optima BMG Labtech (Ortenberg) 
Mixer  Vortex-Genie 2  IKA (Staufen) 
NMR spectrometer AVANCE-II 600 Bruker Biospin (Rheinstetten) 
PCR cycler T3  Biometra (Goettingen) 
pH meter  Level 1 inoLab (Weilheim) 
Pipettes  Pipetman Gilson (Middleton) 
Pipettor  Pipetus  Hirschmann (Eberstadt) 
Power supply  PAC100  Bio-Rad (Munich) 
Precision balance  BP61-S  Sartorius (Goettingen) 
Precision balance  PG2002-S  Mettler-Toledo (Greifensee) 
Ribolyser  Hybaid (Cambridge) 
Spectrophotometer  Helios Epsilon  Thermo (Waltham) 
Spectrophotometer  NanoDrop ND-1000  PeqLab (Erlangen) 
Suspension mixer CMV  Fröbel (Lindau) 
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Thermal mixer  Thermomixer comfort  Eppendorf (Hamburg) 
UV-transilluminator   Bachofer (Reutlingen) 
Water bath  Wasserbad 1005  GFL (Burgwedel) 
Standard laboratory equipment was used in addition to the listed items. 
 
2.1.2 Chemicals and Consumables 
Item Supplier 
1 kb plus DNA ladder  Life Technologies (Grand Island) 
1.5 mL reaction tubes Eppendorf (Hamburg) 
2-NBDG Sigma-Aldrich (St. Louis) 
4 mL scintillation vials Perkin Elmer (Waltham) 
5 mm glass tubes ST-500 Norell (Marion) 
13 mL plastic tubes Sarstedt (Nürnbrecht) 
15 mL reaction tubes Greiner (Frickenhausen) 
50 mL reaction tubes Greiner (Frickenhausen) 
6-well plates TPP (Trasadingen) 
24-well plates TPP (Trasadingen) 
96-well plates TPP (Trasadingen) 
96-well plates black, clear bottom Perkin Elmer (Waltham) 
ACES  AppliChem (Darmstadt) 
Acetonitrile Sigma-Aldrich (St. Louis) 
Activated charcoal powder  Fluka (Buchs) 
Agar BD Biosciences (Franklin Lakes) 
Agarose  Biozym (Hessisch Oldendorf) 
Amiloride hydrochloride hydrate Sigma-Aldrich (St. Louis) 
Bacteriological peptone  Oxoid (Wesel) 
Bacto proteose peptone  BD Biosciences (Franklin Lakes) 
Bacto yeast extract  BD Biosciences (Franklin Lakes) 
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BBL yeast extract  BD Biosciences (Franklin Lakes) 
CaCl2 x 2 H20 Roth (Karlsruhe) 
Cell culture flasks TPP (Trasadingen) 
Cellulose acetate membrane filter disks (pore 
size 0.2 µm) 
Roth (Karlsruhe) 
Cellulose nitrate membrane filter disks (pore 
size 0.45 µm) 
Roth (Karlsruhe 
Chloroquine diphosphate Sigma-Aldrich (St. Louis) 
Cryogenic freezing tubes Thermo (Waltham) 
Cuvettes Brand GmbH (Wertheim) 
Cytochalasin B Sigma-Aldrich (St. Louis) 
D2O Euriso-Top (St-Aubin) 
D(+)-glucose monohydrate  Fluka (Buchs) 
D(+)-glucose-6-phosphate sodium salt Sigma Aldrich (St. Louis) 
DMSO Merck (Darmstadt) 
DNA purification kit  Macherey-Nagel (Dueren) 
dNTP mix Thermo Fisher Scientific (Waltham) 
DreamTaq green PCR master mix (2x)  Thermo Fisher Scientific (Waltham) 
EcoLume scintillation cocktail MP Biomedicals (Santa Ana) 
EDTA (disodium salt) Sigma-Aldrich (St. Louis) 
EGTA Roth (Karlsruhe) 
Electroporation cuvette (2 – 4 mm gap) Bio-Rad (Munich) 
Ethanol Roth (Karlsruhe) 
FCS  Life Technologies (Grand Island) 
Filtropur 0.2 µm filter units Sarstedt (Nürnbrecht) 
FeN3O9 x 9 H2O  Sigma-Aldrich (St. Louis) 
Fe-pyrophosphate hydrate (Fe4O21P6) Sigma-Aldrich (St. Louis) 
Glycerol Roth (Karlsruhe) 
Glycine  MP Biomedicals (Eschwege) 
HCl Roth (Karlsruhe) 
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HEPES Roth (Karlsruhe) 
Inositol Roth (Karlsruhe) 
KH2PO4 Fluka (Buchs) 
L-arginine Merck (Darmstadt) 
L-aspartate Sigma-Aldrich (St. Louis) 
LB agar Lennox Invitrogen (Carlsbad) 
LB broth base Lennox Invitrogen (Carlsbad) 
L-cysteine  Sigma-Aldrich (St. Louis) 
L-glutamate Sigma-Aldrich (St. Louis) 
L-glutamine  Life Technologies (Grand Island) 
L-histidine Roth (Karlsruhe) 
L-isoleucine Merck (Darmstadt) 
L-leucine Roth (Karlsruhe) 
L-lysine Sigma-Aldrich (St. Louis) 
L-methionine Merck (Darmstadt) 
LoFlo ForMedium (Norfolk) 
L-phenylalanine Roth (Karlsruhe) 
L-proline Roth (Karlsruhe) 
L-serine Roth (Karlsruhe) 
L-threonine Roth (Karlsruhe) 
L-tryptophane Sigma-Aldrich (St. Louis) 
L-tyrosine AppliChem (Darmstadt) 
Luer lock syringes Hartenstein (Würzburg) 
L-valine Roth (Karlsruhe) 
Methanol Roth (Karlsruhe) 
MgCl2 x 6 H20 Roth (Karlsruhe) 
MgSO4 x 7 H20 Merck (Darmstadt) 
Millex 0.2 µm filters Milipore (Billerica) 
N-methyl-N-[trimethylsilyl]-trifluoroacetamide Sigma-Aldrich (St. Louis) 
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N-[tert-butyldimethyl-silyl]-N-methyl-
trifluoroacetamide 
Sigma-Aldrich (St. Louis) 
NH4Cl Fluka (Buchs) 
NaCl Roth (Karlsruhe) 
Na2HPO4 Fluka (Buchs) 
NaOH Roth (Karlsruhe) 
PFA  Sigma-Aldrich (St. Louis) 
Poly-L-lysine Sigma-Aldrich (St. Louis) 
Phusion polymerase  Thermo Fisher Scientific (Waltham) 
Rapid flow filter units Hartenstein (Würzburg) 
Restriction enzymes  Thermo Fisher Scientific (Waltham) 
RPMI 1640  Life Technologies (Grand Island) 
Saponin Sigma Aldrich (St. Louis) 
Sodium citrate x 2 H2O Fluka (Buchs) 
Sucrose Roth (Karlsruhe) 
T4 DNA ligase  New England Biolabs (Ipswich) 
Tert-butyl-dimethyl-silylchlorid Sigma-Aldrich (St. Louis) 
Trimethylsilyl propanoic acid Sigma-Aldrich (St. Louis) 
Tryptone / peptone from casein Roth (Karlsruhe) 
[U-13C6]glucose Sigma-Aldrich (St. Louis) 
[U-13C3]glycerol Sigma-Aldrich (St. Louis) 
[U-13C3]serine Sigma-Aldrich (St. Louis) 
[U-14C6]inositol American Radiolabeled Chemicals (St. Louis) 
Vectashield mounting medium Vector Laboratories (Cambridgeshire) 
Whatman glass microfiber filter GE Healthcare (Little Chalfont) 
Yeast extract BD Biosciences (Franklin Lakes) 
Standard laboratory materials and reagents were used in addition to the listed items. 
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2.1.3 Media and Buffers 
Deionised, distilled H2O was used in all recipes and protocols. 
2.1.3.1 Legionella pneumophila 
Charcoal Yeast Extract (CYE) Agar (Feeley et al., 1979) 
Component Amount/Litre Supplier 
ACES 10 g AppliChem 
Bacto yeast extract 10 g BD Biosciences 
Activated charcoal powder p.a. 
puriss 
2 g Fluka 
Agar 15 g BD Biosciences 
L-cysteine 0.4 g in 10 ml H2O Sigma 
FeN3O9 x 9 H2O 0.25 g in 10 ml H2O Sigma 
Antibiotic   
Chloramphenicol 5 mg Roth 
Kanamycin 10 mg Roth 
 
Dissolve ACES and yeast extract in 950 ml H2O, adjust pH to 6.9 using 10 M KOH and then fill 
up to 1 l with H2O. Weigh out charcoal and agar into a Schott bottle, followed by the ACES/yeast 
extract solution.  Add a stirbar and autoclave the medium. After sterilisation, let the solution cool 
down to 50°C. Add filter-sterilized L-cysteine and then the Fe(NO3)3 solution (10 ml each per 1 l 
agar). This has to be done dropwise to prevent precipitation. Add antibiotic solutions as required. 
Distribute the homogenised mixture into standard petri dishes. Let the plates dry for 1 day at 
room temperature. Store at 4°C in the dark. 
 
ACES Yeast Extract (AYE) Medium (Horwitz and Maxfield, 1984) 
Component Amount/Litre Supplier 
ACES 10 g AppliChem 
Bacto yeast extract 10 g BD Biosciences 
L-cysteine 0.4 g in 10 ml H2O Sigma 
FeN3O9 x 9 H2O 0.25 g in 10 ml H2O Sigma 
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Antibiotic   
Chloramphenicol 5 mg Roth 
Kanamycin 50 mg Roth 
 
Dissolve ACES and yeast extract in 950 ml H2O. Dissolve L-cysteine and Fe(NO3)3 in 10 ml H2O 
each separately. Now dropwise add the cysteine solution while stirring, followed by the iron 
solution. Adjust pH to 6.9 using 10 M KOH, then fill up to 1 l with H2O. If necessary add 
antibiotics at the indicated concentrations. Filter the medium through a layer of 7 glass fiber 
filters and repeat the procedure once. At last, sterilise the medium using a 0.2 µm filter cartouche 
and store it at 4°C in the dark.   
 
Chemically Defined Medium (CDM) adapted from (Ristroph et al., 1981) 
Component Amount/Litre Supplier 
ACES 10 g AppliChem 
L-arginine 350 mg Merck 
L-cysteine 400 mg Sigma 
L-isoleucine 470 mg Merck 
L-leucine 640 mg Roth 
L-methionine 200 mg Merck 
L-threonine 330 mg Roth 
L-valine 480 mg Roth 
L-serine 650 mg Roth 
L-proline 115 mg Roth 
L-phenylalanine 350 mg Roth 
L-aspartate 510 mg Sigma 
L-glutamate 600 mg Sigma 
L-histidine 150 mg Roth 
L-lysine 650 mg Sigma 
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L-tryptophane 100 mg Sigma 
L-tyrosine 400 mg AppliChem 
NH4Cl 315 mg Fluka 
NaCl 50 mg Roth 
CaCl2 x 2 H2O 25 mg Roth 
KH2PO4 1180 mg Fluka 
MgSO4 x 7 H2O 70 mg Merck 
Fe-pyrophosphate hydrate 250 mg Sigma 
 
Weigh out all components, except Fe-pyrophosphate, and dissolve them in 950 ml H2O. Adjust 
pH to 6.5 using 10 M KOH. Now dissolve Fe-pyrophosphate, fill up to 1 l with H2O, filter 
sterilise and store at 4°C in the dark. The medium can be stored for up to 3 weeks. 
 
Minimal Defined Medium (MDM) 
Component Amount/Litre Supplier 
ACES 10 g AppliChem 
L-arginine 350 mg Merck 
L-cysteine 400 mg Sigma 
L-isoleucine 470 mg Merck 
L-leucine 640 mg Roth 
L-methionine 200 mg Merck 
L-threonine 330 mg Roth 
L-valine 480 mg Roth 
L-serine 650 mg Roth 
L-proline 115 mg Roth 
L-phenylalanine 350 mg Roth 
NH4Cl 315 mg Fluka 
NaCl 50 mg Roth 
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CaCl2 x 2 H2O 25 mg Roth 
KH2PO4 1180 mg Fluka 
MgSO4 x 7 H2O 70 mg Merck 
Fe-pyrophosphate hydrate 250 mg Sigma 
 
Weigh out all components, except Fe-pyrophosphate, and dissolve them in 950 ml H2O. Adjust 
pH to 6.5 using 10 M KOH. Now dissolve Fe-pyrophosphate, fill up to 1 l with H2O, filter 
sterilise and store at 4°C in the dark. The medium can be stored for up to 3 weeks. 
 
Carbon Enriched Minimal Defined Medium (CE MDM) 
The recipe is identical to MDM but additionally 4.6 g (= 3.7 ml) glycerol and 1.98 g D-glucose 
monohydrate are added. All components, except Fe-pyrophosphate are dissolved in 950 ml H2O. 
Adjust pH to 6.5 using 10 M KOH. Now dissolve Fe-pyrophosphate, filter sterilise and store at 
4°C in the dark. The medium can be stored for up to 3 weeks. 
 
2.1.3.2 Escherichia coli 
Luria-Bertani (LB) Agar 
Component Amount/Litre Supplier 
LB agar Lennox 32 g Invitrogen 
Antibiotic   
Ampicillin 100 mg Roth 
Chloramphenicol 30 mg Roth 
Kanamycin 30 mg Roth 
 
Dissolve LB agar in 1 l H2O, autoclave and let cool down to 50°C before pouring plates. Add 
antibiotics at indicated concentrations if necessary. Let plates dry for 1 day and store at 4°C in the 
dark.  
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Luria-Bertani (LB) Medium 
Component Amount/Litre Supplier 
Luria Bertani broth base 
Lennox 
20 g Invitrogen 
 
Dissolve LB broth base in 1 l H2O, autoclave and let cool down to 50°C. Add antibiotics at 
indicated concentrations as for LB agar. Store at room temperature. 
 
Transformation Buffer 1 (TFB1) for Chemically Competent E. coli 
 
Component Amount/Litre Supplier 
Potassium acetate 2.82 g (30 mM) Roth 
KCl  7.46 g (100 mM) Roth 
CaCl2 x 2 H2O 1.48 g (10 mM)  Roth 
MnCl 6.3 g (50 mM) Roth 
Glycerol 150 ml (15%) Roth 
 
Dissolve all components in 950 ml H2O and adjust pH to 5.8 using 0.2 M acetic acid. Fill up to 
1 l and filter sterilise the buffer. Store 40 ml aliquots at -20°C. 
 
Transformation Buffer 2 (TFB2) for Chemically Competent E. coli 
Component Amount/Litre Supplier 
MOPS  0.42 g (10 mM). Roth 
CaCl2 x 2 H2O 1.11 g (75 mM) Roth 
KCl  0.074 g (10 mM) Roth 
Glycerol 15 ml (15%) Roth 
 
Dissolve all components in 950 ml H2O and adjust pH to 6.5 using KOH. Fill up to 1 l and filter 
sterilise the buffer. Store 4 ml aliquots at -20°C. 
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2.1.3.3 Dictyostelium discoideum 
HL5 medium (Watts and Ashworth, 1970)  
Component Amount/Litre Supplier 
D(+)-glucose monohydrate  11 g Fluka 
BBL yeast extract  5 g BD Biosciences 
Bacto proteose peptone  5 g BD Biosciences 
Bacteriological peptone 5 g Oxoid 
Na2HPO4 0.355 g (2.5 mM) Fluka 
KH2PO4 0.34 g (2.5 mM) Fluka 
 
Weigh out all components in 950 ml H2O and adjust pH to 6.5 with 1 M KOH or 1 M HCl. Fill 
up to 1 l, autoclave and store at 4°C. 
 
SorC Buffer (Malchow et al., 1972) 
Component Amount/Litre Supplier 
Na2HPO4 0.28 g (2 mM) Fluka 
KH2PO4 2.04 g (15 mM) Fluka 
CaCl2 x 2 H2O 7.35 mg (50 µM) Roth 
 
Dissolve Na2HPO4 and KH2PO4 in 950 ml H2O and adjust pH to 6.0 using 1 M KOH. Then add 
CaCl2 x 2 H2O, fill up to 1 l with H2O, autoclave and store at 4°C.  
 
Homogenisation buffer (Derre and Isberg, 2004) 
Component Amount/Litre Supplier 
HEPES  4.77 g (20 mM) Roth 
Sucrose  85.58 g (250 mM) Roth 
EGTA  0.19 g (0.5 mM) Roth 
 
Dissolve all components in 950 ml H2O, adjust pH to 7.2 with 1 M HCl or 1 M NaOH, fill up to 
1 l with H2O, filter sterilise the buffer and store at 4°C. 
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2.1.3.4 Acanthamoeba castellanii 
PYG Medium (Moffat and Tompkins, 1992) 
Component Amount/Litre Supplier 
Bacto proteose peptone  20 g BD BioSciences 
BBL yeast extract  1 g BD BioSciences 
MgSO4 x 7 H2O 10 ml (of a 0.4 M stock) Roth 
CaCl2 x 2 H2O 8 ml (of a 0.05 M stock) Roth 
Sodium citrate x 2 H2O 3.4 ml (of a 1 M stock) Roth 
Fe(NH4)2 x 7 H2O  20 mg Roth 
Na2HPO4 10 ml (of a 0.25 M stock) Roth 
KH2PO4 10 ml (of a 0.25 M stock) Fluka 
D(+)-glucose monohydrate 19.8 g Fluka  
 
Dissolve proteose peptone and yeast extract in 900 ml H2O. Prepare and sterilise stocks of all 
other components and add the indicated amounts. Adjust the pH to 6.5 with 1 M HCl, then add 
50 ml of a 2 M glucose solution (= 19.8 g glucose monohydrate in 50 ml H2O). Fill up to 1 l. 
Filter the medium through a layer of 7 glass fiber filters and repeat the procedure once. At last, 
sterilise the medium using a 0.2 µm filter cartouche and store it at 4°C. 
 
LoFlo Medium  
Component Amount/Litre Supplier 
LoFlo base  16.8 g ForMedium 
 
Dissolve LoFlo base in water, autoclave and store at room temperature. 
 
Ac Buffer (Moffat and Tompkins, 1992) 
Component Amount/Litre Supplier 
MgSO4 x 7 H2O 985.9 mg (4 mM) Oxoid 
CaCl2  44 mg (0.4 mM) BD 
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Sodium citrate x 2 H2O 999 mg (3.4 mM) AppliChem 
Na2HPO4 x 7 H2O 86 mg (0.05 mM) Fluka 
KH2PO4 2.5 mg (2.5 mM) Fluka 
NH4Cl 2.6 mg (0.05 mM) Fluka 
FeSO4  7.55 mg (0.05 mM) Merck 
 
Dissolve all components in 950 ml H2O, adjust pH to 6.5 using 1 M HCl, fill up to 1 l, autoclave 
and store at 4°C. 
 
2.1.3.5 RAW 264.7 Macrophages 
Phosphate-Buffered Saline (PBS) (10 x stock solution) 
Component Amount/Litre Supplier 
MgSO4 x 7 H2O 80 g AppliChem 
CaCl2  
2 g  Fluka 
Sodium citrate x 2 H2O 
14.2 g  Fluka 
Na2HPO4 x 7 H2O 
2.4 g  Fluka 
 
Dissolve all components in 950 ml H2O, adjust pH to 7.4 with 1 M NaOH or 1 M HCl, fill up to 
1l, autoclave and store at room temperature. 
 
2.1.4 Strains, Plasmids, Oligonucleotides and Antibodies 
Strain Relevant properties* Reference 
E. coli   
TOP10  Invitrogen 
L. pneumophila   
JR32 Virulent L. pneumophila serogroup 1 strain 
Philadelphia 
(Sadosky et al., 1993) 
GS3011 (∆icmT) L. pneumophila JR32 icmT3011::Km (Segal and Shuman, 1998) 
CM01 (∆glpD) L. pneumophila JR32 glpD::Km This study 
CM02 (∆iolT) L. pneumophila JR32 lpg1653::Km This study 
2.  Materials and Methods 
 
59 
 
CM03 (∆iolG) L. pneumophila JR32 lpg1652::Km This study 
AK01 (∆lqsT) L. pneumophila JR32 lqsT::Km (Kessler et al., 2013) 
AK02 (∆lqsS- ∆lqsT) L. pneumophila JR32 lqsS-lqsT::Km (Kessler et al., 2013) 
NT02 (∆lqsA) L. pneumophila JR32 lqsA::Km (Tiaden et al., 2010) 
NT03 (∆lqsR) L. pneumophila JR32 lqsR::Km (Tiaden et al., 2007) 
NT05 (∆lqsS) L. pneumophila JR32 lqsS::Km (Tiaden et al., 2010) 
LM1376 (∆rpoS) L. pneumophila JR32 rpoS4::Tn903dGent (Hales and Shuman, 1999b) 
A. castellanii  ATCC 30234 
D. discoideum   
Ax3  (Zhou et al., 1995) 
RAW 264.7 Murine macrophage cell line ATCC TIB-71 
* Abbreviations: Km, kanamycin. 
 
Plasmids Description* Reference 
pCM003 pLAW344, iolT::Km This study 
pCM004 pMMB207C-gfp(ASV) This study 
pCM007 pMMB207C-piolT-gfp(ASV) This study 
pCM018 pLAW344, glpD::Km This study 
pCM020 pCR33-M45-iolT This study 
pCM021 pCR33-M45-glpD This study 
pCM022 pLAW344, iolG::Km This study 
pCR033 Legionella expression vector, ∆mobA, RBS, 
M45-(Gly)5, Cm (=pMMB207C-RBS-M45) 
(Weber et al., 2006) 
pJBA132 pUC18-luxR-PluxI-RBS-gfp(ASV) (Andersen et al., 2001) 
pLAW344 oriT (RK2), oriR (ColE1), sacB, Cm, Ap (Wiater et al., 1994b) 
pMMB207C Legionella expression vetor, ∆mobA, -RBS, 
Cm 
(Weber et al., 2006) 
pNT028 pMMB207C, gfp (constitutive) (Tiaden et al., 2007) 
pSW001 pMMB207C-RBS-dsred (constitutive dsred) (Mampel et al., 2006) 
pUC4K oriR (pBR322), Ap, MCS::Km Amersham 
*Abbreviations: Ap, ampicillin; Cm. chloramphenicol; Km, kanamycin 
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Oligonucleotide Sequnce (5’ – 3’)* Description 
glpD-BamHI-sen-
Kompl 
GGAGATGGATCCATGGATCAGGTTTTTGATG glpD for 
complementation 
glpD-SalI-ant-
Kompl 
TTGATGGTCGACTTAGTGAAATACGAGCTC glpD for 
complementation 
glpD-LB-XbaI-sen TATGCTTCTAGAAAACTGGTTTATCACCTGTATT
GAG 
500 bp 5’-flanking 
region of glpD 
glpD-LB-SalI-ant GAACTAGTCGACGCTATTGACCAGGGAACAAG 500 bp 5’-flanking 
region of glpD 
glpD-RB-SalI-sen CAGCATGTCGACTTGTTGCGCCAATTCTTTTA 500 bp 3’-flanking 
region of glpD 
glpD-RB-XbaI-ant CAAAAATCTAGAGAATCAGGTGGGTTGGTGTC 500 bp 3’-flanking 
region of glpD 
iol-660-sen-Seq TACTGGGGAGTAGTTTGTGTGC seq. primer of iolT 
iol-1347-sen-Seq TCAGTGGTACTTTGATCGCA seq. primer of iolT 
iol-2051-sen-Seq CATCTCGAACAAATTATTACAGCG seq. primer of iolT 
iol-2744-sen-Seq GATGGACTACAAGCCTTGCG seq. primer of iolT 
iol-3459-sen-Seq TATGCGATTTGATTGTTGGG seq. primer of iolT 
iol-7042-ant-Seq GAAGTCGTAAGCAATTCGGC seq. primer of iolT 
iol-6351-ant-Seq CCCAATCCCTCTGCGTACT seq. primer of iolT 
iol-5655-ant-Seq AAAGCCCATTTGGAAGCTGT seq. primer of iolT 
iol-4942-ant-Seq TTTTTGTTTGGCATAGGCG seq. primer of iolT 
iol-4241-ant-Seq AAAATAAATTTTCGTTTTCCGTTTC seq. primer of iolT 
iolG-1400up-sen ATGAACAAGGGAATGAAC seq. primer of iolG 
iolG-511-sen ATATTTATGGACATGTCT seq. primer of iolG 
iolG-451-sen CGAATTACTTCTCGTGAT seq. primer of iolG 
iolG-301-ant TATCTCTTCTTCATTCAA seq. primer of iolG 
iolG-1400down-ant GTCTAACTCAAGCATATTAGA seq. primer of iolG 
iolG-850bp-up CCGCTGGATAATGATTAA seq. primer of iolG 
iolG-850bp-down GATTTTGCCTGTAATAGA seq. primer of iolG 
iolG-LB-XbaI-sen GGCCAGTCTAGAATAATATTCAGCAGGAATTG 800 bp 5’-flanking 
region of iolG 
iolG-LB-SalI-ant TTTCATGTCGACTCCATAATTAAATTAAATTTTG
C 
800 bp 5’-flanking 
region of iolG 
iolG-RB-SalI-sen AGTTGAGTCGACTATGAAACAGTTTCCCGG 800 bp 3’-flanking 
region of iolG 
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iolG-RB-XbaI-ant CGAGCATCTAGATCTCCTAATTTAACAAC 800 bp 5’-flanking 
region of iolG 
iolT-400bp-XbaI-ant TCCCTTTCTAGAGTAACTATCTGTCCCTAATG PiolT 400 bp for 
pCM007 
iolT-BamHI-sen-
Kompl 
ACAGATGGATCCATGAACAAGGGAATGAAC iolT for 
complementation 
iolT-SalI-ant-Kompl TCTTTTGTCGACTTAATCCATAATTAAATTAAAT
TTTGC 
iolT for 
complementation 
iolT-LB-XbaI-sen AATATGTCTAGACAATTGTCTTTGGCAGCAGA 500 bp 5’-flanking 
region of iolT 
iolT-LB-SalI-ant CTGTTCGTCGACGATGTTATCACGGCCAGGTT 500 bp 5’-flanking 
region of iolT 
iolT-RB-SalI-sen TCGAATGTCGACAGTAGGTGCGGGAAGAATTG 500 bp 3’-flanking 
region of iolT 
iolT-RB-XbaI-ant TCAAGGTCTAGATATTGAGGTTTTGCGCCATC 500 bp 3’-flanking 
region of iolT 
* Restriction sites are underlined 
 
Antibody Origin Label Supplier 
anti-SidC rabbit none affinity-purified (Weber et al., 2006) 
anti-rabbit IgG donkey DYLight650 Abcam (Cambridge) 
anti-rabbit IgG bovine Rhodamine Santa Cruz (Dallas) 
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2.2 Methods 
2.2.1 Legionella pneumophila 
2.2.1.1 Cultivation of Legionella pneumophila 
Bacterial strains are listed in section 2.1.4. L. pneumophila strains were grown from glycerol 
stocks for 2-3 days on CYE agar plates. Bacteria were suspended from CYE agar plates to a 
starting OD600 of 0.1 in AYE broth using a 13 ml plastic tube and then grown at 37°C on a 
turning wheel. Bacteria reached infectious state after approximately 21-22 h at OD600 of 3.0. 
Cells were checked for motility and homogeneity of shape with an inverted light microscope (40x 
objective). 
For growth experiments in chemically defined medium (CDM), minimal defined medium 
(MDM) or carbon enriched minimal defined medium (CE MDM), bacteria were resuspended 
from CYE agar plates to a starting OD600 of 0.1 in CDM and grown at 37°C on a turning wheel to 
a maximum OD600 of 1.0. Cultures were diluted to OD600 of 0.1 in CDM, MDM or CE MDM and 
further incubated for 48 h at 37°C on a turning wheel. 
Cultures and agar plates were supplemented with chloramphenicol (Cm, 5 µg/ml) or kanamycin 
(Km, 50 µg/ml in broth or 10 µg/ml in agar plates), if necessary. See section 2.1.3.1 for media 
recipes.  
 
2.2.1.2 Legionella pneumophila Glycerol Stocks 
L. pneumophila liquid cultures were grown approximately 18 h at 37°C, mixed 1:2 with sterile 
50% glycerol in cryo tubes, frozen in liquid nitrogen and stored at -80°C. 
 
2.2.1.3 Preparing Electrocompetent Legionella  pneumophila 
L. pneumophila was resuspended from AYE agar plates to a starting OD600 of 0.1 in AYE 
medium and grown at 37°C to prestationary growth phase. 1 ml of that culture was added to 
30 ml AYE in a baffled flask. The culture was grown to an OD600 between 0.3 and 0.5, cooled on 
ice, then washed three times with sterile, ice-cold 10% glycerol (10 ml, 2.5 ml, and 160 µl). 
Aliquots of 25 µl were frozen in liquid nitrogen and stored at -80°C until use. 
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2.2.1.4 Transformation of Legionella pneumophila by Electroporation 
25 µl electro-competent L. pneumophila (section 2.2.1.3) were thawed on ice, mixed with 100 ng 
of plasmid and incubated on ice for 2 min. The bacteria were transferred into a 2 mm gap 
electroporation cuvette and electroporation occurred at 2.5 kV, 200 Ω and 25 µF. Bacteria were 
washed out of the cuvette with 600 µl AYE, given into a 1.5 ml reaction tube and incubated at 
37°C and 800 rpm in a shaking incubator. After 5 h cells were plated on selective CYE agar 
plates.  
 
2.2.2 Escherichia coli 
2.2.2.1 Inoculation, Growth and Storage 
E. coli strains were grown from glycerol stocks on LB agar plates at 37°C overnight. Liquid 
cultures were made in LB liquid medium and incubated at 37°C on a turning wheel. Agar plates 
and medium were supplemented with chloramphenicol (Cm, 30 µg/ml, kanamycin (Km, 
30 µg/ml) or ampicilin (Ap, 100 µg/ml) if required. See section 2.1.3.2 for media recipies. 
 
2.2.2.2 Glycerol Stocks of Escherichia coli 
A mature liquid culture of E. coli was mixed 1:2 with sterile 50% glycerol in cryo tubes, frozen 
in liquid nitrogen and stored at -80°C. 
 
2.2.2.3 Preparation of Chemocompetent Escherichia coli  
1 ml of a late-exponential culture of E. coli strain TOP10 was added to a baffled flask containing 
100 ml LB medium. The flask was incubated at 37°C and 180 rpm in an incubation cabinet, until 
the culture reached an OD600 of 0.5. Cells were cooled on ice and centrifuged at 2100 x g for 
10 min at 4°C. The pellet was resuspended in 40 ml ice-cold TFB1 (section 2.1.3.2) and again 
centrifuged. The pellet was then resuspended in 4 ml ice-cold TFB2 (section 2.1.3.2), aliquots of 
50 µl were made, frozen in liquid nitrogen and stored at -80°C.  
 
2.2.2.4 Transformation of Competent Cells by Heat Shock 
Chemocompetent E. coli cells (section 2.2.2.3) were thawed on ice, mixed with with 50-100 ng 
plasmid and incubated on ice for 20 min. The bacteria were then incubated at 42°C for 1 min, 
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placed on ice shortly and mixed with 800 µl LB medium. After incubating the cells at 37°C and 
800 rpm in a shaking incubator for 1 h, bacteria were plated onto selective LB agar. 
 
2.2.3 Dictyostelium discoideum 
2.2.3.1 Cultivation of Dictyostelium discoideum 
D. discoideum was grown axenically at 23°C in HL5 medium (section 2.1.3.3). 1 x 104 cells/ml 
were seeded into 75 cm2 tissue culture flasks containing 10 ml HL5 medium. After 2-3 days at 
23°C or when cells reached 80% confluence, cells were subcultured by removing the old 
medium, adding 10 ml new HL5 medium and tapping off the cells. Cells were diluted 1:100 in 
10 ml HL5, transferred to a new cell culture flask and again incubated at 23°C.  
 
2.2.3.2 Storage of Dictyostelium discoideum  
D. discoideum was grown to 80% confluence in one 75 cm2 cell culture flask. Old medium was 
removed and cells were resuspended in 9 ml freezing medium consisting of 80% HL5, 10% FCS 
and 10% DMSO. Aliquots of 1 ml were distributed into cryo tubes and placed in a cryogenic 
freezer box filled with isopropanol, which was precooled for 1 h at 4°C. Cells were frozen 
at -80°C overnight in this box and subsequently stored in liquid nitrogen. When removing cells 
from cryogenic storage, the aliquots were rapidly thawed and immediately transferred to 9 ml 
HL5 in a 15 ml reaction tube. Cells were centrifuged once at 500 x g for 10 min and resuspended 
in 10 ml HL5 to remove DMSO. The cells were transferred to a cell culture flask and incubated at 
23°C.  
 
2.2.4 Acanthamoeba castellanii 
2.2.4.1 Cultivation of Acanthamoeba castellanii 
A. castellanii cells were cultivated in 10 ml PYG medium (section 2.1.3.4) in 75 cm2 cell culture 
flasks. When cells reached 80% confluence, cells were subcultured by removing the old medium, 
adding 10 ml new PYG medium and tapping off the cells. Cells were diluted 1:100 in 10 ml 
PYG, transferred to a new cell culture flask and again incubated at 23°C. 
2.2.4.2 Storage of Acanthamoeba castellanii 
A.castellanii was grown to 80% confluence in one 75 cm2 cell culture flask. Old medium was 
removed and cells were resuspended in 9 ml freezing medium consisting of 80% PYG, 10% FCS 
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and 10% DMSO. Aliquots of 1 ml were distributed into cryo tubes and placed in a cryogenic 
freezer box filled with isopropanol, which was precooled for 1 h at 4°C. Cells were frozen 
at -80°C overnight in this box and subsequently stored in liquid nitrogen. When removing cells 
from cryogenic storage, the aliquots were rapidly thawed and immediately transferred to 9 ml 
PYG in a 15 ml reaction tube. Cells were centrifuged once at 500 x g for 10 min and resuspended 
in 10 ml PYG to remove DMSO. The cells were transferred to a cell culture flask and incubated 
at 23°C.  
 
2.2.5 RAW 264.7 Macrophages 
2.2.5.1 Cultivation of RAW 264.7 Macrophages 
Murine RAW 264.7 macrophages were grown in 10 ml RPMI 1640 medium containing 2 mM 
L-glutamine and 10% heat-inactivated FCS in a 75 cm2 cell culture flask at 37°C in a humidified 
atmosphere containing 5% CO2. When cells reached 90% confluence, old medium was removed, 
10 ml new RPMI 1640 medium was added and cells were removed mechanically from the culture 
flask with a cell scraper. Cells were diluted 1:10 in 10 ml RPMI 1640 medium, transferred to a 
new cell culture flask and further incubated at 37°C and 5% CO2. 
 
2.2.5.1 Storage of RAW 264.7 Macrophages 
Murine RAW 264.7 macrophages were grown to 90% confluence in one 75 cm2 cell culture 
flask. Old medium was removed and cells were resuspended in 9 ml freezing medium consisting 
of 70% RPMI 1640, 20% FCS and 10% DMSO. Aliquots of 1 ml were distributed into cryo tubes 
and placed in a cryogenic freezer box filled with isopropanol, which was precooled for 1 h at 
4°C. Cells were frozen at -80°C overnight in this box and subsequently stored in liquid nitrogen. 
When removing cells from cryogenic storage, the aliquots were rapidly thawed and immediately 
transferred to 9 ml RPMI 1640 medium in a 15 ml reaction tube. Cells were centrifuged once at 
500 x g for 10 min and resuspended in 10 ml RPMI 1640 medium to remove DMSO. The cells 
were transferred to a cell culture flask and incubated at 37°C in a humidified atmosphere 
containing 5% CO2.  
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2.2.6 Construction of Vectors for Allelic Exchange, Gene Expression and GFP-Reporter 
Assays 
Standard protocols were used for cloning regarding PCR, restriction digest and ligation. Plasmids 
were isolated using kits from Macherey-Nagel. All PCR fragments and plasmids were sequenced 
(GATC, Konstanz). Primer and plasmids are listed in section 2.1.4. 
The allelic exchange vectors pCM003, pCM018 and pCM022 were constructed in a four-way 
ligation using 0.5-0.8 kB of 5’ and 0.5-0.8 kB of 3’ flanking regions of iolT (pCM003), glpD 
(pCM018) and iolG (pCM022), respectively, and a Km resistance cassette from vector pUC4K. 
For flanking regions of iolT, primer pairs iolT-LB-XbaI-sen, iolT-LB-SalI-ant and iolT-RB-SalI-
sen and iolT-RB-XbaI-ant were used. For flanking regions of glpD, primer pairs glpD-LB-XbaI-
sen, glpD-LB-SalI-ant and glpD-RB-SalI-sen, glpD-RB-XbaI-ant were used. For flanking regions 
of iolG, primer pairs iolG-LB-XbaI-sen, iolG-LB-SalI-ant and iolG-RB-SalI-sen, iolG-RB-XbaI-
ant were used. Amplified PCR products of these flanking regions were digested using the 
restriction enzymes SalI and XbaI. Plasmid pUC4K was digested with SalI yielding a 1.4 kB 
fragment containing the Km resistance cassette. Plasmid pLAW344 was digested using the 
restriction enzyme XbaI. Corresponding flanking regions and the Km resistance cassette were 
cloned into vector pLAW344 in a four-way ligation and transformed into E. coli TOP10. Cells 
were plated on LB agar containing Km to select for the Km resistance cassette. Plasmids were 
reisolated from single colonies, analysed by restriction digestion and sequenced. 
Vectors pCM020 and pCM021 for complementation of the mutant strains ∆iolT and ∆glpD were 
constructed using primer pairs iolT-BamHI-sen-Kompl, iolT-SalI-ant-Kompl or glpD-BamHI-
sen-Kompl, glpD-SalI-ant-Kompl, respectively. PCR products were digested using BamHI and 
SalI, cloned into pCR033 and transformed into E. coli TOP10. Cells were plated on LB agar 
plates containing Cm, plasmids were reisolated from single colonies, analysed by restriction 
digestion and sequenced. 
For the construction of plasmid pCM004, an instable form of GFP, GFP(ASV), was used. For 
that, plasmid pJBA132 was digested using XbaI and HindIII, yielding a 0.75 kB fragment 
containing gfp(ASV). This was cloned into plasmid pMMB207C and transformed into E. coli 
TOP10. Cells were plated on LB agar plates containing Cm, plasmids were reisolated from single 
colonies, analysed by restriction digestion and sequenced. The 400 bp promotor region of iolT 
was amplified using primer iolT-400bp-SacI-sen and iolT-400bp-XbaI-ant. The PCR product and 
plasmid pCM004 were digested using SacI and XbaI, ligated and transformed into E. coli TOP10. 
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Cells were plated on LB agar plates containing Cm, plasmids were reisolated from single 
colonies, analysed by restriction digestion and sequenced. 
 
2.2.7 Construction of Chromosomal Deletion Mutant Strains CM01, CM02 and CM03  
Allelic exchange by double homologous recombination using counter-selection on sucrose was 
performed as described (Wiater et al., 1994a; Tiaden et al., 2007). To construct mutants CM01 
(∆glpD), CM02 (∆iolT) and CM03 (∆iolG), L. pneumophila JR32 was transformed with 
pCM018, pCM003 or pCM022, respectively. Cells were plated on CYE plates containing Km 
and incubated for 5 days at 30°C. KmR colonies were selected and grown overnight in AYE broth 
containing Km (50 µg/ml). Cells were spotted on CYE plates with Km (10 µg/ml), CYE plates 
with Km (10 µg/ml) and 2% sucrose and CYE plates with Cm (5 µg/ml) and grown at 30°C to 
select for CmS/KmR/SucR colonies. Double-cross-over events and thus deletion mutants were 
confirmed by PCR and sequenced. 
 
2.2.8 Extracellular Growth Assays 
To investigate the influence of different carbon soures on extracellular growing bacteria, 
L. pneumophila wild-type and mutants ∆glpD, ∆iolT or ∆iolG were resuspended from CYE agar 
plates. Overnight cultures were inoculated with a starting OD600 of 0.1 in CDM and grown at 
37°C to an OD600 of maximum 1.0. Cultures were then diluted to OD600 = 0.1 in CDM or MDM. 
Glycerol or inositol at specific concentrations were added and cultures were further incubated for 
48 h at 37°C. The optical density was assessed at defined intervals. 
 
2.2.9 Intracellular Replication of Legionella pneumophila  
Intracellular replication of L. pneumophila was assessed using fluorescence-based single round 
assays and by determining the cfu. For single round assays a previously published protocol was 
used (Harrison et al., 2013). In brief: A. castellanii were grown in PYG medium and seeded out 
in 96-well plates such that 4 x 105 cells were present in each well. Plates were incubated 
overnight at 23°C to allow replication and resulted in a cell number of 8 x 105 cells per well. 
PYG medium was then exchanged with LoFlo medium. L. pneumophila strains harbouring 
plasmid pNT28 and constantly expressing GFP were resuspended from AYE plates to a starting 
OD600 of 0.1 in AYE/Cm (5µg/ml) and grown overnight at 37°C to an OD600 of 3. Bacteria were 
diluted in LoFlo medium (ForMedium), and amoeba were infected with L. pneumophila 
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(MOI 20). Infections were synchronised by centrifugation at 500 x g for 10 min. Glycerol, 
inositol or serine were added 4 h post infection to certain wells, and infected amoeba were 
incubated at 30°C. GFP fluorescence was measured in a plate spectrophotometer at specific 
intervals.  
Murine RAW 264.7 macrophages were grown in RPMI medium containing 5% FCS at 37°C/5% 
CO2. Infections were performed as described for assays with A. castellanii, but bacteria were 
diluted in RPMI medium prior to infection, and plates were incubated at 37°C/5% CO2. As the 
culture media used for these assays do not support growth of L. pneumophila, GFP fluorescence 
did only reflect intracellular replication. 
Intracellular growth of L. pneumophila was also assessed by determining the cfu. Specifically, 
A. castellanii or RAW 264.7 macrophages were suspended in PYG or RPMI medium, 
respectively. 2 x 104 cells per well were seeded into 96-well plates and incubated at 23°C 
(A. castellanii) or 37°C and 5% CO2 (RAW 264.7 macrophages) overnight, such that 4 x 10
4 
cells per well were present the next day. PYG medium was exchanged with AC buffer and RPMI 
medium was exchanged with fresh RPMI 1640 medium. Cells were then infected with 
L. pneumophila (MOI 0.1) and infection was synchronized by centrifugation at 500 x g for 
10 min. Cells were further incubated for 1 h, then washed with AC buffer or RPMI medium. 
Glycerol, inositol or serine was added 4 h post infection to certain wells. For complementation of 
the ∆glpD phenotype, mutant ∆glpD harbouring plasmid pCM021 was grown overnight with 
1 mM IPTG to induce expression of glpD. Infection and further treatment followed as described 
above. After 48 h (RAW 264.7 macrophages) or 72 h (A. castellanii), cells were lysed with 0.8% 
saponin and appropriate dilutions were plated on CYE agar plates to determine the cfu. 
 
2.2.10 Intracellular Growth of Legionella pneumophila in Coinfection Assays  
L. pneumophila wild-type and mutant strains to be tested were resuspended from CYE plates in 
AYE broth to a starting OD600 of 0.1 and incubated at 37°C untill the cultures reached an OD600 
of 3. Prior to infection A. castellanii cells were seeded in a 96-well plate in AC buffer, such that 
each well contained 5 x 104 cells. The plate was incubated for at least 1 h at 30°C. A. castellanii 
was then infected at a 1:1 ratio with L. pneumophila wild-type and mutant strain ∆glpD, ∆iolT or 
∆iolG respectively (MOI 0.01 each). Infection was synchronised by centrifugation at 500 x g for 
10 min, and the plate was incubated at 37°C for 1 h. AC buffer was changed and the plate further 
incubated at 37°C for three days. After three days fresh amoeba were seeded into a new 96-well 
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plate (5 x 104 cells per well) and incubated at 30°C for 1 h. Supernatant from the old 96-well 
plate was harvested and remaining cells in the wells were lysed with 0.8% saponin. Supernatant 
and lysate was combined, diluted 1:1000 and used to infect the fresh amoeba (50 µl per 200 µl 
amoeba culture). Aliquots of combined supernatant and lysate were plated on CYE agar plates 
and plates containing Km in parallel to determine cfu and to distinguish between wild-type and 
Km-resistant mutant bacteria. The freshly infected 96-well plate was further incubated at 37°C 
for another three days, then lysis and reinfection was repeated. Five rounds of infection were 
performed in total. 
 
2.2.11 Isotopologue Profiling of Extracellularly Growing Legionella pneumophila  
L. pneumophila wild-type or mutant ∆glpD were resuspended from CYE agar plates, diluted in 
CDM to a starting OD600 of 0.1 and grown overnight at 37°C such that the optical density was not 
higher than 1.0 the next day. Bacteria were then diluted to an OD600 of 0.1 in 100 ml MDM 
containing 50 mM [U-13C3]glycerol and incubated in an incubation cabinet at 37°C and 180 rpm 
for 48 h. An aliquot was then plated on CYE agar plates and cells were harvested by 
centrifugation at 3500 x g and 4°C for 15 min. The resulting cell pellet was washed twice with 
50 ml ice-cold AC buffer and once with 1 ml ice-cold AC-buffer, autoclaved at 120°C for 
20 min, freeze-dried and then stored at -20°C until analysis. 
For time course experiments with different carbon substrates, L. pneumophila wild-type was 
grown overnight in CDM with a starting OD600 of 0.1. The bacteria were then diluted to a starting 
OD600 of 0.1 in CE MDM that contained either 50 mM [U-
13C3]glycerol, 11 mM [U-
13C6]glucose 
or 6 mM [U-13C3]serine as labelled precursor and then cultivated in an incubation cabinet at 37°C 
and 180 rpm. After 12, 24, 36 and 48 h, 30 ml samples were taken, optical density was 
determined at 600 nm and an aliquot was plated on CYE agar plates. Samples were then 
centrifuged, washed, autoclaved, freeze-dried and stored as described above. 
 
2.2.12 Isotopologue Profiling of Legionella pneumophila Growing in Acanthamoeba 
castellanii  
For every bacterial strain to be tested, A. castellanii was grown in PYG medium in eight 75 cm2 
cell culture flasks to 80% confluence (~2 x 107 cells per flask). L. pneumophila wild-type or 
mutant ∆glpD were grown in AYE to infectious state. A. castellanii was then infected at an 
MOI 50 with either wild-type or ∆glpD, and infection was synchronised by centrifugation of the 
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cell culture flasks at 500 x g for 10 min. Flasks were incubated at 37°C for 1 h, then cells were 
washed once with 10 ml pre-warmed AC buffer to remove extracellular bacteria, overlaid with 
10 ml fresh AC buffer and further incubated at 37°C. 50 mM [U-13C3]glycerol, 11 mM 
[U-13C6]glucose or 6 mM [U-
13C3]serine was added to the flasks 5 h post infection and cells were 
further incubated at 37°C for another 10 h. 
Cells were then released from the flasks using a cell scraper, transferred to 50 ml reaction tubes, 
frozen at -80°C for 30 min and then thawed to room temperature to lyse the host cells. To harvest 
the eukaryotic fraction F1, the suspension was centrifuged at 200 x g and 4°C for 10 min. The 
supernatant was transferred to new 50 ml reaction tubes and the pellet, representing F1, was 
washed twice with 50 ml and once with 1 ml ice-cold AC buffer. The supernatant harvested after 
the first centrifugation was then centrifuged at 3500 x g and 4°C for 15 min. The emerging cell 
pellet contained L. pneumophila bacteria and represented fraction 2 (F2). The supernatant was 
again harvested and transferred to new 50 ml reaction tubes. The cell pellet of F2 was washed 
twice with 50 ml and once with 1 ml ice-cold AC buffer. Supernatant of F2 was filtered through 
0.22 µm pore filters to remove remaining bacteria, mixed with TCA to a final concentration of 
10% and then incubated on ice for 1 h. The suspension was then centrifuged at 4600 x g and 4°C 
for 30 min. The supernatant was taken off, and the resulting pellet (F3) contained cytosolic 
proteins of A. castellanii. Pellets of F1, F2 and F3 were autoclaved at 120°C for 20 min, freeze-
dried and stored at -20°C until analysis. Samples of F1 and F2 were subjected to microscopy and 
aliquots were plated on CYE agar plates. 
 
2.2.13 Sample Preparation of Protein-Derived Amino Acids, DAP and PHB for GC/MS 
Sample preparations and GC/MS measurements for isotopologue profiling (sections 2.2.13-
2.2.16) were performed by Ina Häuslein in the laboratory of Prof. Dr. Wolfgang Eisenreich (TU 
München) and evaluated by Christian Manske and Ina Häuslein at the Max von Pettenkofer-
Institute (LMU München). 
1 mg of bacterial cell pellet (section 2.2.11) or 1 mg of the fractions F1 and F2 (section 2.2.12) 
were resuspended  in 0.5 ml 6 M hydrochloric acid and incubated at 105°C for 24 h. The samples 
were dried under a stream of nitrogen and the residual pellet was dissolved in 200 µl acetic acid. 
A cation exchange column of Dowex 50Wx8 (H+ form, 200-400 mesh, 5 x 10 mm) was washed 
with 1 ml methanol and 1 ml ultrapure water and then used to purify the samples. To this end, the 
column was developed with 2 ml distilled water, resulting in eluate 1, and then with 1 ml 4 M 
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ammonium hydroxide, resulting in eluate 2. The eluates were then dried under a stream of 
nitrogen at 70°C. 
Eluate 1 was dissolved in 100 µl N-methyl-N-(trimethylsilyl)-trifluoroacetamide and incubated at 
40°C and 110 rpm in a shaking incubator for 30 min. This procedure resulted in trimethylsilyl 
(TMS) derivatives of 3-hydroxybutyric acid derived from polyhydroxybutyrate (PHB) that were 
used for GC/MS analysis. 
The dried residual sample of eluate 2 was dissolved in 50 µl dry acetonitrile and 50 µl N-(tert-
butyldimethyl-silyl)-N-methyl-trifluoroacetamide containing 1% tert-butyl-dimethyl-silylchlorid 
and incubated at 70°C for 30 min. The resulting mixture of tert-butyl-dimethylsilyl derivates 
(TBDMS) of amino acids and DAP was used for further GC/MS analysis. Due to acid 
degradation, the amino acids tryptophan and cysteine could not be detected with this method. 
Furthermore, the hydrolysis condition led to the conversion of glutamine and asparagine to 
glutamate and aspartate.  
 
2.2.14 Sample Preparation of Methanol-Soluble Metabolites for GC/MS  
5 mg freeze-dried bacterial pellet (section 2.2.11) was resuspended in 1 ml cold methanol, and 
0.8 g of 0.25-0.5 mm glass beeds were added. The cells were lysed mechanically using a 
ribolyser. The lysate was centrifuged at 2300 x g for 10 min, and the supernatant was transferred 
to a new reaction tube and then dried under a stream of nitrogen. The residual sample was then 
dissolved in 50 µl dry acetonitrile and 50 µl N-(tert-butyldimethyl-silyl)-N-methyl-
trifluoroacetamide containing 1% tert-butyl-dimethyl-silylchlorid and kept at 70°C for 30 min. 
This procedure resulted in a mixture of tert-butyl-dimethylsilyl (TBDMS) derivatives of polar 
metabolites and fatty acids that were subjected to GC/MS analysis. 
 
2.2.15 Sample Preparation of Mannose for GC/MS  
5 mg freeze-dried bacterial pellet (section 2.2.11) or 1 mg of fraction F1 or fraction F2 (section 
2.2.12) were dissolved in 0.5 ml 3 M methanolic HCl and incubated at 80°C overnight. The 
solution was cooled to room temperature; the supernatant was transferred to a new reaction tube 
and then dried under a stream of nitrogen. The residual sample was then dissolved in a mixture of 
1 ml acetone and 20 µl concentrated H2SO4 and incubated at room temperature for 1 h. Then 2 ml 
saturated NaCl solution and 2 ml saturated Na2CO3 were added and the mixture was extracted 
two times with 3 ml ethyl acetate. The organic phases were harvested and dried under a stream of 
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nitrogen. The residue was dissolved in a mixture of 100 µl ethyl acetate and 100 µl acetic 
anhydride and incubated overnight at 60°C. The sample was again dried under a stream of 
nitrogen and finally dissolved in 100 µl anhydrous ethyl acetate. The resulting mixture of 
diisopropylidene/acetate derivatives was used for further GC/MS analysis 
 
2.2.16 Gas Chromatography/Mass Spectrometry and Isotopologue Analysis 
Samples from sections 2.2.13-2.2.15 were analyzed by GC/MS using a QP2010 Plus gas 
chromatograph/mass spectrometer equipped with a 30 m long and 0.25 mm wide silica capillary 
column with 0.25 µm film thickness and a quadrupole detector working with 70 eV electron 
impact ionization. 0.1 to 6 µl of sample was injected in 1:5 split mode with an helium inlet 
pressure of 70 kPa , an interface temperature of 260°C and a sampling rate of 0.5 s. All samples 
were measured three times (technical replicates).  
To analyse amino acids (section 2.2.13) the silica column was held at 150°C for 3 min and then 
developed with an upward gradient of 7°C/min to a final temperature of 280°C that again was 
held for 3 min. The following amino acids with corresponding retention times in brackets were 
detected and isotopologue calculations were performed with m/z [M-57]+ or m/z [M-85]+: alanine 
(6.7 min), glycine (7.0 min), valine (8.5 min), leucine (9.1 min), isoleucine (9.5 min), proline 
(10.1 min), serine (13.2 min), phenylalanine (14.5 min), aspartate (15.4 min), glutamate 
(16.8 min), lysine (18.1 min), histidine (20.4 min) and tyrosine (21.0 min). 
To detect diaminopimelic acid (DAP) (section 2.2.13) the column was held at 280°C for 3 min 
and then with an upward temperature gradient of 10°C/min to a final temperature of 300°C that 
was again held for 3 min. The TBDMS-derivative of DAP was detected at a retention time of 
6.2 min and isotopologue calculations were performed with m/z [M-57]+. 
To analyse 3-hydroxybutyric acid derived from polyhydroxybutyrate (PHB) (section 2.2.13), the 
column was held at 70°C for 3 min and then developed with a first upward temperature gradient 
of 10°C/min to a final temperature of 150°C and afterwards with a second upward temperature 
gradient of 50°C min−1 to a final temperature of 280°C that was held for 3 min. The TMS-
derivative of 3-hydroxybutyric acid, was detected at a retention time of 9.1 min, and isotopologue 
calculations were performed with m/z [M-15]+.  
For the analysis of methanol-soluble metabolites (section 2.2.14) the column was heated at 100°C 
for 2 min and then developed with a first upward temperature gradient of 3°C/min to a final 
temperature of 234°C, a second upward temperature gradient of 1°C/min to a final temperature of 
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237°C, and a third upward temperature gradient of 3°C/min to a final temperature of 260°C. 
TBDMS-derivatives of lactate with retention times in brackets were detected and isotopologue 
calculations were performed with m/z [M-57]+: lactate (17.8 min), 3-hydroxybutyric acid 
(21.6 min), succinic acid (27.5 min), fumaric acid (28.7 min), malic acid (39.1 min), palmitic acid 
(44.0 min), stearic acid (49.4 min) and citric acid (53.25 min). 
For diisopropylidene/acetate derivatives of sugars (section 2.2.15) the column was heated at 
150°C for 3 min and then developed with a first temperature gradient of 10°C/min to a final 
temperature of 220°C, and with a second temperature gradient of 50°C/min to a final temperature 
of 280°C that was held for 3 min. Isotopologue calculations were performed with m/z 287 
[M-15]+, a fragment which still contained all C-atoms of mannose. 
Data was collected and analysed using LabSolution software. The analysis involved the 
determination of unlabeled derivatized metabolites, determination of isotopologue distributions 
of labelled metabolites and correction of 13C-incorporation with regard to the natural abundances 
of 13C-isotopes in the derivatized metabolites. Retention times and mass fragments of derivatized 
metabolites that were used for all isotopologue calculations are documented in Supplementary 
Table 5.1. 
With the isotopologue profiling method it is possible to reconstruct the reaction pathways of 
certain substrates, as different metabolic pathways often lead to the same intermediates of central 
metabolism, e.g. pyruvate, acetyl-CoA, glyceraldehyde-3-phosphate and so on. Metabolic 
intermediates, derived from fully 13C-labelled substrates have defined 13C-patterns or 
isotopologue profiles depending on the metabolic pathway they are derived from. Pyruvate for 
example, a compound with three carbon atoms, can have one, two or three 13C-labelled C-atoms. 
The mass of pyruvate would change with each 13C-atom making it heavier than unlabeled 
pyruvate. The method of MS does not allow determining the exact position of these labelled 
C-atoms but can draw conclusions regarding the number of labelled C-atoms in a compound 
depending on the mass of the compound. Pyruvate for example could have a mass with one, two 
or three more nucleons depending on the number of 13C-labelled atoms, which would be 
annotated M+1, M+2 or M+3 in the isotopologue profile. From the percentage of these mass 
fragments the overall enrichment in a compound can be estimated. 
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2.2.17 Radioactive Labelling of Legionella pneumophila 
L. pneumophila JR32, ∆iolT or ∆iolG were grown in AYE broth to an OD600 of 2.8. For 
complementation of ∆iolT the mutant was grown in AYE broth with 1 mM IPTG to allow 
expression of iolT. The cultures were then supplemented with 10 mM inositol that was spiked 
with 1% of a 1:10 dilution [U-14C6]inositol (specific activity of 300 mCi/mmol). The cells were 
then further incubated at 37°C with gentle shaking, and 200 µl samples were taken after 0, 10, 20, 
30, 60 and 90 minutes. The samples were filtered through cellulose acetate (CA) filter disks (pore 
size 0.25 µm), and filters were washed three times with PBS. Filter-associated radioactivity was 
determined in a liquid scintillation counter with EcoLume scintillation cocktail. 
In another experimental setup, L. pneumophila JR32 and ∆rpoS were grown in AYE broth. 
200 µl samples were taken at OD600 of 0.5, 1.0, 2.0 and 3.0. Cells were then incubated with 
10 mM inositol spiked with 1% of a 1:10 dilution of [U-14C6]inositol for 30 min and then filtered, 
washed and measured as described above. 
For determining protein-associated radioactivity, L. pneumophila JR32, ∆iolT or ∆iolG were 
grown in AYE broth to an OD600 of 2.0. Cultures were then supplemented with 10 mM inositol 
spiked with 1% of a 1:10 dilution of [U-14C6]inositol and further incubated at 37°C with gentle 
shaking. 200 µl samples were taken after 0, 2, 4, 6 and 8 hours, mixed with 1 ml 50% 
trichloroacetic acid and incubated on ice for 1 h. Samples were then filtered through cellulose 
nitrate filter disks (pore size: 0.45 µm) and filters were washed three times with PBS. Filter-
associated radioactivity was determined in a liquid scintillation counter with EcoLume 
scintillation cocktail. 
 
2.2.18 GFP Reporter Experiments 
L. pneumophila JR32, ∆rpoS or lqs mutant strains, harbouring plasmid pCM007 were grown 
overnight in AYE/Cm broth to an OD600 of 1.5-2.0. Bacteria were then diluted in AYE/Cm to an 
initial OD600 of 0.1 in a black 96-well clear bottom plate, and 10 mM inositol or 6 mM serine was 
added to assigned wells. The plate was then incubated in a shaking incubator at 37°C and 
600 rpm for 24 h. Every hour the optical densitiy and GFP fluorescence was measured using a 
microtitre plate reader. 
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2.2.19 Uptake of 2-NBDG and (Immuno-) Fluorescence Experiments 
2.5 x 105 cells of D. discoideum in 0.5 ml HL5 medium were seeded onto poly-L-lysine coated 
sterile coverslips in a 24-well plate and incubated overnight at 23°C, such that around 5 x 105 
cells were present on each coverslip. Cells were infected with L. pneumophila wild-type, ∆iolT, 
∆iolG or ∆icmT harbouring plasmid pSW001 (constitutive dsRed expression) at a MOI of 10. 
Infection was synchronized by centrifugation at 500 x g for 10 min. Cells were incubated for 1 h 
at 25°C, then supernatant was taken off and 0.5 ml SorC (D. discoideum) per well was added. 
After that, 20 µM 2-Deoxy-2[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG), a 
fluorescent glucose analog, was added and cells were further incubated at 25°C for 30 min. The 
cells were washed with SorC or PBS, and cover slips were then mounted on glass slides using 
Vectashield supplemented with 1 µg/ml DAPI to stain DNA. The samples were analyzed using a 
Leica TCS SP5 confocal microscope (HCX PLAPO CS, objective 63x/1.4-0.60 oil).  
When homogenisation of infected cells was necessary for immuno-fluorescence microscopy, 
cells were treated as follws: 8.5 x 105 D. discoideum cells per well were seeded in a 6-well plate, 
grown overnight and infected with the desired strain at an MOI of 25. For each strain, three wells 
were used. Infection was performed at 25°C for 1 h, then cells were washed with SorC and 
20 µM 2-NBDG was added. Cells were further incubated for 30 min at 25°C, washed with SorC, 
suspended in homogenisation buffer (section 2.1.3.3) and lysed by nine passages through a cell 
homogeniser using an exclusion size of 8 µm. This step was performed on ice. The homogenate 
was then centrifuged onto poly-L-lysine coated cover slips, followed by an antibody stain against 
SidC. To this end, coverslips were incubated with blocking solution (5% calf serum in SorC) for 
1 h and then incubated with 30 µl of an antibody against SidC (diluted 1:100 in blocking 
solution) for 1 h at room temperature. Cover slips were washed three times with SorC, and then 
30 µl of appropriate secondary antibodies coupled to DyLight650 or Rhodamine (diluted 1:200 in 
blocking solution) were added and incubated for 30 min with the samples. Cover slips were 
washed with SorC and then mounted onto glass slides using Vectashield. 
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3.  Results 
 
3.1 Designing a New Chemically Defined Legionella Growth Medium 
One goal of this thesis was the examination of inositol and glycerol as carbon sources for 
L. pneumophila by applying different growth assays and isotopologue profiling. For this purpose 
a new Legionella growth medium was developed based on a chemically defined medium 
(Ristroph et al., 1981) with minor adjustments (Eylert et al., 2010) (see section 2.1.3.1 for 
composition). The aim was to reduce the available amino acids to an extent that growth was still 
feasible but de novo synthesis of several amino acids by the bacteria would be necessary to allow 
protein synthesis. The growth of L. pneumophila depends on certain essential amino acids like 
arginine, cysteine, isoleucine, leucine, methionine, threonine and valine, while serine is believed 
to be the major carbon substrate for L. pneumophila during extracellular growth (Tesh and Miller, 
1981; Eylert et al., 2010). This is in line with our findings, showing that a medium that only 
contained these essential amino acids or chemically defined medium (CDM) without serine did 
not sustain growth of L. pneumophila, and the bacteria did not replicate within the course of 48 h 
(Figure 3.1 A). Interestingly, the addition of serine to the essential amino acid medium did also 
not restore growth, showing that even if serine is the major carbon substrate of L. pneumophila, it 
is not sufficient as a sole source of carbon and energy (Figure 3.1 A). Subsequently, single non-
essential amino acids were depleted from the medium and it was observed that leaving out 
histidine, lysine, proline, tryptophan or aspartate did not alter growth compared to CDM after 
48 h (Figure 3.1. B). Furthermore, in media without aspartate and histidine or aspartate and 
tryptophan the bacteria did reach optical densities comparable to growth in CDM, but depletion 
of lysine or proline in addition to aspartate significantly reduced growth (Figure 3.1 B). As a next 
step, a medium was used that lacked all amino acids, which had no significant growth altering 
effect in the previous experiments, namely histidine, aspartate, tryptophan, lysine and glutamate. 
This medium (DM) did not allow the bacteria to reach optical densities as high as in CDM after 
72 h of growth (Figure 3.1 C), but it still allowed replication efficient enough for the bacteria to 
produce the brown pigment and apparently reach the transmissive state as judged by shape and 
motility of the cells (data not shown).  
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Figure 3.1: Designing a new Legionella growth medium. L. pneumophila wild-type was grown, in all experiments, 
at 37°C with a starting OD600 of 0.1. Growth in CDM, CDM without serine, a medium only containing essential 
amino acids (Ess) or additional serine (Ess + Ser) was assessed after 48 h (A). Defined media lacking single amino 
acids or pairs of amino acids were compared, and the optical density was measured after 48 h of growth (B). 
Comparison of optical densities after 72 h of growth in CDM and defined medium (DM) lacking His, Lys, Asp, Trp 
and Glu (C). Growth curve comparison of L. pneumophila wild-type grown in DM and DM lacking Tyr, Phe or Phe 
and Tyr (D). Amino acids are shown in three letter code (adapted from Häuslein, Manske et al., 2015). 
 
Finally, the impact of aromatic amino acids on L. pneumophila growth was assessed. A medium 
without tyrosine supported growth comparable to growth in DM over the course of 72 h. 
Depletion of phenylalanine and phenylalanine and tyrosine on the other side significantly reduced 
growth (Figure 3.1 D). Phenylalanine seems to be more important for L. pneumophila than 
tyrosine, as this amino acid can also be directly synthesized from phenylalanine in the reaction 
catalyzed by phenylalanine hydroxylase (phhA). This is why the final new defined medium 
contained phenylalanine, but not tyrosine. Salt composition and iron concentration was not 
altered compared to CDM, but the new medium was depleted of aspartate, glutamate, histidine, 
lysine, tryptophan and tyrosine in the end. This new medium was named minimal defined 
medium (MDM) (for composition see section 2.1.3.1). 
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3.2 Analysis of the Glycerol Metabolism of Legionella pneumophila 
3.2.1 Glycerol Promotes Intracellular Growth of Legionella pneumophila 
Early studies using radiolabeled glycerol and bacteria grown in defined medium suggested that 
glycerol might be metabolized by L. pneumophila (Tesh et al., 1983). Furthermore, the 
transcriptome of L. pneumophila growing inside human macrophages showed that the expression 
of glycerol kinase (lpg1414) and glycerol-3-phosphate dehydrogenase (glpD) was 2- or almost 
4-fold upregulated compared to bacteria growing in broth, indicating  that glycerol might play a 
role during intracellular growth of L. pneumophila (Faucher et al., 2011). 
 
Figure 3.2: Glycerol has no influence on extracellularly growing L. pneumophila. Extracellular growth of 
L. pneumophila wild-type (WT) and ∆glpD in CDM (A) or MDM (B) with and without 50 mM glycerol. Bacteria 
were diluted to a starting OD600 of 0.1, glycerol was added at the beginning of the experiment and optical density at 
600 nm was determined at the time points indicated. Graphs are representatives of three independent experiments. 
Shown are mean and SD of triplicates (adapted from Häuslein, Manske et al., 2015). 
 
Using defined media, glycerol had no influence on extracellularly growing Legionella (Figure 
3.2). The addition of 50 mM glycerol to L. pneumophila wild-type or ∆glpD growing in CDM 
(Figure 3.2 A) or MDM (Figure 3.2 B) did not lead to altered growth compared to untreated 
bacteria. In AYE broth, growth of wild-type and mutant ∆glpD was indistinguishable (data not 
shown), but the mutant did grow slower in MDM and exhibited a longer lag phase than the wild-
type although it did reach optical densities comparable to wild-type bacteria after 48 h of growth 
(Figure 3.2 B). As for wild-type, the addition of 50 mM glycerol did not influence growth of 
∆glpD. 
The impact of glycerol on intracellularly growing L. pneumophila was assessed using 
fluorescence-based assays, colony-forming units (cfu) and coinfection experiments (see sections 
2.2.9 and 2.2.10). The glycerol-3-phosphate dehydrogenase GlpD is not essential for successful 
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replication of L. pneumophila, as the mutant strain ∆glpD did grow like wild-type in all 
intracellular replication assays (Figure 3.3 A-C). When glycerol was added to infected 
macrophages 4 h post infection, higher cell numbers were obtained for wild-type L. pneumophila 
in stationary growth phase indicated by higher fluorescence levels (Figure 3.3 A) and a greater 
number of cfu after 48 h of intracellular growth (Figure 3.3 B).  
  
Figure 3.3: Glycerol promotes intracellular growth of L. pneumophila. Murine macrophages were infected 
(MOI 20) with L. pneumophila wild-type (WT) or ∆glpD harboring plasmid pNT28 (constitutive GFP expression). 
50 mM glycerol was added 4 h post infection and replication was determined by fluorescence (A). For cfu-assays, 
murine macrophages were infected (MOI 0.1) with L. pneumophila wild-type (WT), ∆glpD or ∆glpD harbouring 
plasmid pCM021 (expression of glpD). 50 mM glycerol was added 4 h post infection, cells were lysed 48 h post 
infection and cfu were determined (1 way ANOVA test with Dunett`s multiple comparison test: p* < 0.05, p*** 
< 0.0001) (B). A. castellanii was infected (MOI 20) with L. pneumophila wild-type (WT) or ∆glpD harbouring 
pNT28. Glycerol was added 4 h post infection and replication was determined by fluorescence (C). For coinfection 
assays, A. castellanii were infected with L. pneumophila wild-type (WT) and ∆glpD at a 1:1 ratio (MOI 0.01 each). 
Cells were lysed three days post infection and bacteria were used to infect fresh amoeba. Cell numbers were 
determined by cfu (D). Data in (A)-(D) are representatives of three independent experiments. Mean and SD of 
triplicates are shown (adapted from Häuslein, Manske et al., 2015). 
 
When comparing the intracellular growth curves of wild-type bacteria with and without glycerol, 
it was evident that the addition of glycerol did not lead to faster intracellular growth, as the levels 
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of fluorescence were comparable with and without glycerol (Figure 3.3 A). However, it rather 
seemed that glycerol might be used in later stages of intracellular growth, as fluorescence and 
therefore the number of intracellular bacteria increased in the late exponential growth phase 
leading to higher cell numbers in the stationary growth phase (Figure 3.3 A). This positive 
growth effect of glycerol was dependent on GlpD as it was not observed in the ∆glpD mutant and 
the phenotype could be complemented by providing glpD on a plasmid (Figure 3.3 B). The 
influence of glycerol on intracellular growing L. pneumophila was also analyzed in infected 
A. castellanii. Previous studies of the L. pneumophila transcriptome during intracellular 
replication in A. castellanii showed the upregulation of glpD and lpg1414 in a similar way than 
during growth in macrophages (Brüggemann et al., 2006), although not as pronounced. 
Nevertheless, addition of 50 mM glycerol to infected amoeba 4 h post infection promoted growth 
of L. pneumophila dependent on glpD (Figure 3.3 C). These results indicate that glycerol has a 
growth stimulating effect on L. pneumophila growing in different host cells. Lastly, coinfections 
of A. castellanii with wild-type and mutant ∆glpD showed that the mutant had a replication 
disadvantage compared to wild-type bacteria as it was outcompeted within 6 days (Figure 3.3 D), 
although it had no growth defect in all other intracellular assays. Glycerol might therefore be not 
essential for intracellular growth, but the metabolism of glycerol seems to provide a certain 
growth advantage to L. pneumophila.  
 
3.2.2 Deciphering the Metabolism of Glycerol in vitro  
Although glycerol had no apparent effect on extracellular growing bacteria (section 3.2.1), 
analyzed glycerol metabolism by L. pneumophila using isotopologue profiling, a method based 
on the incorporation of 13C-atoms derived from labelled precursors, e.g. [U-13C3]glycerol 
(U meaning that all C-atoms in glycerol are 13C-labelled). Metabolism of these precursors leads 
to 13C-enrichment in amino acids and intermediates of central metabolism, allowing the 
determination of the overall enrichment and isotopologue composition in these metabolites by 
GC/MS (see section 2.2.16 for details, especially regarding the evaluation of different mass 
fragments in the isotopologue profiles). The 13C-excess of a metabolite indicates how much of 
that metabolite in the bacterial cell was 13C-labelled. The isotopologue profile, on the other hand, 
describes the relative fraction of isotopologues within that 13C-labelled metabolite population and 
specifies how many C-atoms of a metabolite were 13C-labelled. The first experiments with 
L. pneumophila grown in AYE or CDM did not result in significant 13C-enrichment in any 
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metabolite measured (data not shown). MDM (see section 3.1) was therefore used in all further 
isotopologue experiments. L. pneumophila wild-type and mutant ∆glpD were grown in MDM in 
presence of 50 mM [U-13C3]glycerol as precursor for isotopologue profiling. The bacteria were 
grown for 48 h, so that they reached the stationary growth phase, as determined in extracellular 
growth experiments (Figure 3.2 B). Cells were harvested and the overall 13C-enrichment in amino 
acids, PHB, lactate, fatty acids, intermediates of the TCA cycle and mannose was measured. 
 
Figure 3.4: Glycerol metabolism of L. pneumophila in vitro. L. pneumophila wild-type (WT) and ∆glpD were 
grown in MDM containing 50 mM [U-13C3]glycerol and incubated at 37°C for 48 h. Cells were harvested, and the 
13C-excess (in mol% as color map) of protein-derived amino acids, diaminopimelic acid (DAP), polyhydroxybutyrate 
(PHB), methanol-soluble metabolites and mannose was quantified by GC/MS (A). The relative fractions (in %) of 
13C-isotopologues (M+1 to M+6) of histidine, mannose and lactate from L. pneumophila WT and ∆glpD were 
determind (B). Amino acids are shown in three letter code. Mean and SD from three independent experiments is 
shown. For numerical values refer to Supplementary Tables 5.2 and 5.3 (Published in Häuslein, Manske et al., 2015). 
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Growth in MDM indeed showed that glycerol was metabolized by L. pneumophila in a glpD-
dependent manner (Figure 3.4 A). Significant label (here defined as a 13C-excess greater than 
0.5%) was detected in lactate (0.97%), DAP (0.74%), malic acid (0.70%), 3-hydroxybutyric acid 
(0.61%), stearic acid (0.60%) and glutamate (0.55%). However, the highest enrichment was 
found in histidine (3.01%) and in mannose (5.75%), which allowed certain conclusions regarding 
the metabolism of glycerol (Figure 3.4 A). Fructose or rather fructose-6-phosphate and fructose-
1,6-bisphosphate are central metabolites of gluconeogenesis. Mannose or mannose-6-phosphate, 
which were measured here, are synthesized from fructose-6-phosphate in the reaction of 
mannose-6-phosphate isomerase (lpg2374) (only mannose could be detected here, as sample 
preparation for isotopologue profiling resulted in dephosphorylation of sugars, see section 
2.2.15). The isotopologue profile of mannose mainly displayed M+3 (~ 46%) and to a minor 
extent M+6 (~ 8.6%), reflecting how fully labelled 13C-glycerol entered central metabolism at the 
stage of dihydroxyacetone-phosphate/glyceraldehyde-3-phosphate, then being converted to 
fructose-1,6-bisphosphate in the reverse reaction of fructose-1,6-bisphosphate aldolase and 
further on to fructose-6-phosphate and finally mannose-6-phosphate (Figure 3.4 B). M+3 label in 
mannose is therefore derived from the fusion of one fully labeled and one unlabeled 
glyceraldehyde-3-phosphate molecule and M+6 accordingly via the conversion of two fully 
labeled molecules.  
Histidine is synthesized from ribose-5-phosphate within the PPP. The enrichment in histidine 
(Figure 3.4 A) shows that glycerol was first shuffled into gluconeogenesis and then into the PPP, 
where histidine was derived from. As L. pneumophila does not have a 6-phosphogluconate-
dehydrogenase, only the non-oxidative parts of the PPP can take place. Hence, the key metabolite 
for entry into the PPP would not be glucose-6-phosphate but rather fructose-6-phosphate. This is 
in line with the observed isotopologue pattern of histidine (Figure 3.4 B). The isotopologue 
profile of histidine showed a large M+2 fraction (~ 40%) and a large M+3 fraction (~ 25%), both 
derived from transketolase reactions between glyceraldehyde-3-phosphate and fructose-6-
phosphate (Figure 3.4 B). Section 4.2, Figure 4.1 outlines detailed information of carbon flow 
towards mannose and histidine, and provides explanations for the observed isotopologue profiles 
of these metabolites. 
No significant incorporation of 13C-label into any of the metabolites mentioned above was 
measured for the glpD mutant. This demonstrated that the metabolism of glycerol was entirely 
dependent on GlpD. Interestingly, only lactate was significantly 13C-enriched (0.71%, Figure 
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3.4 A) in the mutant strain, and the isotopologue profile of lactate was identical for both wild-
type and the mutant, showing only completely M+3 labelled lactate (Figure 3.4 B). No 
enrichment was measurable in essential amino acids (Ile, Leu, Ser, Val), alanine as derivative of 
pyruvate, amino acids derived from the TCA cycle (Asp, Lys, Pro) and generally in intermediates 
of the TCA cycle (succinic, fumaric and citric acid) for wild-type or the mutant strain (Figure 
3.4 A). Taken together, these results showed that glycerol was predominantly metabolized in the 
gluconeogenic pathway and the PPP by L. pneumophila. The numerical values of 13C-excess and 
isotopologue profiles are shown in Supplementary tables 5.2 and 5.3 respectively. 
 
3.2.3 Time-dependent Glycerol Metabolism in Comparison to Other Carbon Substrates 
The metabolism of glycerol was assessed in relation to other carbon sources. As it is known that 
serine and glucose are metabolized by L. pneumophila in vitro (Eylert et al., 2010), the 
metabolism of these carbon sources was chosen to be compared to glycerol. The newly developed 
MDM contains 6 mM serine as an essential amino acid. In the following experiments, the 
medium was further enriched by adding 11 mM glucose and 50 mM glycerol. One of these 
carbon sources, serine, glucose or glycerol, was added as 13C-labelled compound and cells were 
harvested after 12 h, 24 h, 36 h or 48 h.  Based on the findings from extracellular growth 
experiments in MDM, these time points were chosen to represent early exponential (12 h), 
exponential (24 h), late exponential (36 h) and stationary (48 h) growth phase (compare section 
3.2.1).  The 13C-enrichment in protein derived amino acids, DAP, PHB, polar metabolites and 
mannose was determined for all substrates used. The new adjusted medium was termed “carbon 
enriched minimal defined medium” (CE MDM).  
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Figure 3.5: 
13
C-excess (in mol%) in amino acids, polar metabolites and mannose of L. pneumophila wild-type 
grown in CE MDM. L. pneumophila wild-type was grown in CE MDM with either 50 mM [U-13C3]glycerol (A), 
11 mM [U-13C6]glucose (B) or 6 mM [U-
13C3]serine (C) as precursor. After 12 h, 24 h, 36 h and 48 h, samples were 
taken and incorporation of 13C-label into protein derived amino acids, DAP and PHB (A-C) for all time points was 
determined. Incorporation of label into methanol-soluble metabolites and mannose was determined only after 48 h of 
growth (D). Color map correlates to mean and SD of three independent experiments. For numerical values refer to 
Supplementary Tables 5.4, 5.5 and 5.6 (Published in Häuslein, Manske et al., 2015). 
 
As in the in vitro experiments in MDM with 13C-glycerol as carbon source, growth in CE MDM 
resulted in incorporation of 13C-label into histidine (3.00% after 48 h) and mannose (4.51% after 
48 h) (Figure 3.5 A, D). Histidine and mannose were by far the highest labelled metabolites with 
13C-glycerol as precursor. To a minor extent, 13C-label was also found in lactate (1.44%), DAP 
(0.80%), glutamate (0.77%), alanine (0.61%), malic acid (0.55%), PHB (0.52%) and aspartate 
(0.49%) after 48 h of growth (Figure 3.5 A, D). Significant label in any metabolite was only 
found after 36 h and 48 h of growth with glycerol as labelled precursor, indicating that glycerol 
was only used in late exponential and stationary growth phase. The isotopologue patterns for 
histidine, lactate and mannose were determined (Figure 3.6). Similar to growth in MDM, the 
pattern of lactate was completely M+3. The isotopologue pattern of histidine showed a large M+3 
fraction (31.66%), and large M+1 (22.48%) and M+2 portions (35.70%). The largest 
isotopologue in mannose was also M+3 (40.59%), reflecting how glycerol was directly used to 
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make fructose and then mannose. The large M+1 and M+2 fractions in histidine are again derived 
from transketolase reactions with glyceraldehyde-3-phosphate and fructose-6-phosphate as 
precursor (Figure 3.6). In summary, also in the presence of glucose as additional carbon source, 
glycerol was metabolized by L. pneumophila in the gluconeogenic pathway and the PPP to 
produce histidine and mannose. 
 
Figure 3.6: Isotopologue profiles of metabolites from experiments with [U-
13
C3]glycerol as precursor. Patterns 
of metabolites from growth experiments with L. pneumophila wild-type in CE MDM with 50 mM [U-13C3]glycerol 
as precursor that showed significant enrichment after 48 h are shown. A minimum of 1.00% 13C-enrichment was 
chosen as threshold here. Columns indicate the relative fraction (in %) of isotopologues (M+1 to M+18) from three 
technical replicates. For numerical values refer to Supplementary Tables 5.7 and 5.8 (Adapted from Häuslein, 
Manske et al., 2015). 
 
Glucose as precursor rendered the highest label in histidine (20.72%) and mannose (31.88%) 
after 48 h of growth (Figure 3.5 B, D). Additionally, several other metabolites were also 
significantly labelled with 13C-glucose as precursor; the threshold here was defined as 1% 
incorporation. After 48 h of growth, alanine (4.26%), aspartate (2,61%), glutamate (2.36%), 
lysine (2.73%), proline (1.43%), DAP (3.64%), PHB (1.64%), 3-hydroxybutyric (1.45%), 
succinic (1.46%), fumaric (1.50%), malic (2.16%), palmitic (1.38%) and stearic acid (1.52%) 
were significantly 13C-labelled (Figure 3.5 B, D). Significantly labelled metabolites were already 
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found after 12 h of growth, especially histidine was already highly labelled at early stages of 
growth (9.16% after 12 h) and the 13C-excess was constantly rising over time (Figure 3.5 B). The 
isotopologue pattern of mannose revealed the route of glucose catabolism. The largest portion of 
mannose was M+3 (30.20%) and M+6 (31.50%) labelled, while histidine was, like in the 
experiments with glycerol, mainly M+2 (37.25%) and M+3 (21.61%) labelled with a greater 
portion of M+5 (14.62%) (Figure 3.7). 
 
Figure 3.7: Isotopologue profiles of metabolites from experiments with [U-
13
C6]glucose as precursor. Patterns 
of metabolites from growth experiments with L. pneumophila wild-type in CE MDM with 11 mM [U-13C6]glucose as 
precursor that showed significant enrichment after 48 h are shown. A minimum of 1.00% 13C-enrichment was chosen 
as threshold here. Columns indicate the relative fraction (in %) of isotopologues (M+1 to M+18) from three technical 
replicates. For numerical values refer to Supplementary Tables 5.7 and 5.8  (Adapted from Häuslein, Manske et al., 
2015). 
 
The major route of glucose metabolism for L. pneumophila is the ED pathway (Eylert et al., 
2010; Harada et al., 2010), where glucose enters central metabolism on the stages of 
glyceraldehyde-3-phosphate and pyruvate, two C3-bodies. Mannose is then derived from 
gluconeogenesis with fructose-6-phosphate as precursor (M+3 and M+6), and labelled fructose-
6-phosphate is also used for the reactions of the PPP where histidine is derived from. The M+5 
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isotopologue in histidine is the result of the greater portion of fully labelled fructose, of which 
fully labelled ribose-5-phosphate, the precursor for histidine, is derived from. The main flow of 
carbon from glucose is directed to mannose and histidine, but to a small amount also in the 
direction of the TCA cycle, as seen by the 13C-enrichment in TCA intermediates and amino acids 
(Figure 3.5 B, D). Intermediates of the TCA (succinic, fumaric and malic acid) and amino acids 
derived from the TCA cycle (Asp and Glu) were mainly M+1 and M+2 labelled (Figure 3.7). The 
latter derived from fully labeled acetyl-CoA entering the TCA cycle, while the single label could 
be a result of a decarboxylation reaction of α-ketoglutarate dehydrogenase or multiple rounds of 
TCA cycle, where unlabeled acetyl-CoA was transferred onto labelled oxaloacetate. Glucose was 
used in part also for fatty acid synthesis (1.38% palmitic and 1.52% stearic acid labelled) (Figure 
3.5 D), but the isotopologue pattern of these fatty acids was mainly M+2 (74.65% and 59.60%, 
respectively), showing the minor carbon flow from glucose to acetyl-CoA, the metabolic 
precursor for fatty acid synthesis (Figure 3.7). Alanine, as a direct derivative of pyruvate, was 
consequentially mainly M+3 (59.89%) labelled (Figure 3.7). In summary, glucose was, like 
glycerol, predominantly used for gluconeogenesis and PPP, but to a small amount also fed into 
the TCA cycle and fatty acid synthesis. 
Serine was the carbon source that was used most effectively by L. pneumophila. When fed with 
[U-13C3]serine as precursor, 
13C-enrichment could be detected in the same metabolites as in the 
time series experiments with labelled glucose (Figure 3.5 C, D). 
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Figure 3.8: Isotopologue profiles of metabolites from experiments with [U-
13
C3]serine as precursor. Patterns of 
metabolites from growth experiments with L. pneumophila wild-type in CE MDM with 6 mM [U-13C3]serine as 
precursor that showed significant enrichment after 48 h are shown. A minimum of 1.00% 13C-enrichment was chosen 
as threshold here. Columns indicate the relative fraction (in %) of isotopologues (M+1 to M+18) from three technical 
replicates. For numerical values refer to Supplementary Tables 5.7 and 5.8  (Adapted from Häuslein, Manske et al., 
2015). 
 
Additionally, glycine, proline and of course serine were 13C-labelled. The overall excess in all 
metabolites measured was much higher than in experiments with glycerol or glucose as 
precursors, confirming the central role of serine as carbon source for L. pneumophila. 
Interestingly, the enrichment in all metabolites peaked at 24 h and dropped steadily afterwards 
(Figure 3.5 C). Significantly labelled metabolites after 24 h of growth were serine (91.61%), 
alanine (74.60%), histidine (62.05%), DAP (55.02%), lysine (50.22%), PHB (39.16%), aspartate 
(34.34%), glutamate (29.00%) and glycine (28.58%). After 48 h also polar metabolites and 
mannose were found to be highly 13C-enriched, ranging between 3.53% enrichment in succinic 
acid and 40.40% in mannose (Figure 3.5 D). The isotopologue pattern of mannose was 
comparable with that derived from experiments with 13C-glucose and showed large M+3 
(28.34%) and M+6 (29.67%) labelled portions (Figure 3.8). Furthermore, histidine was highly 
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13C-enriched, and the pattern was comparable to that from experiments with glucose, which 
shows that carbon flow from serine did also occur into gluconeogenesis and the PPP (Figure 3.8). 
However, the overwhelming part of label was found in metabolites derived from the lower parts 
of glycolysis and the TCA cycle, which illustrates how serine was preferably used by 
L. pneumophila. 
Glycine, as a direct derivative of serine, was almost completely M+2 (95.02%) labelled, which 
shows its direct synthesis from serine in the reaction catalyzed by serine 
hydroxymethyltransferase (glyA) (Figure 3.8). Alanine is again mainly M+3 labelled (81.43%), 
as it is synthesized from pyruvate (Figure 3.8). Glutamate was highly 13C-enriched (29.00% after 
24 h), and the pattern reflects high flux from serine into acetyl-CoA, which then enters the TCA 
cycle. In addition to M+1 (27.39%) and M+2 (37.11%), and like in experiments with glucose as 
precursor, also M+3 (18.62%), M+4 (11.16%) and M+5 (5.71%) label was measured in 
glutamate (Figure 3.8), indicating that α-ketoglutarate, the precursor of glutamate, had to be 
enriched with a more complex isotopologue pattern as well. This is only possible, when a higher 
flux of labelled metabolites is directed into the TCA cycle. Proline is made directly from 
glutamate, and consistently, the isotopologue pattern of proline was almost identical to that of 
glutamate (Figure 3.8). Label in proline was only found after 36 h and 48 h of growth, but not in 
earlier stages (Figure 3.5 C). As part of the growth medium, proline was apparently taken up and 
used efficiently by L. pneumophila and was only then synthesized de novo after it was consumed 
from the medium. 
Aspartate is made from oxaloacetate, which is an intermediate of the TCA cycle, or directly 
synthesized from pyruvate in the reaction catalyzed by pyruvate carboxylase (lpg0466). The M+3 
(24.48%) isotopologue that was measured for aspartate is the result of the direct synthesis from 
pyruvate, while the M+1 (28.29%), M+2 (35.03%) and M+4 (12.44%) families are the result of 
one or more rounds of TCA cycle, resulting in differentially labelled oxaloacetate (Figure 3.8). 
DAP is synthesized from aspartate and pyruvate, so the M+3 (32.48%) fraction in DAP was 
presumably again derived from fully labelled pyruvate. All other isotopologue fractions resulted 
from differentially labelled pyruvate and aspartate (Figure 3.8). Lysine is then made from DAP in 
a decarboxylation reaction, so all fractions except M+7 were also found in the isotopologue 
pattern of lysine (Figure 3.8). 
The aforementioned high flux of serine into acetyl-CoA and the TCA cycle is also reflected in the 
isotopologue profile of the fatty acids palmitic and stearic acid, which mainly showed M+2, 
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M+4, M+6, M+8, M+10 and M+12 labelling (Figure 3.8). Acetyl-CoA is the precursor of the 
C2-building blocks of fatty acids, and the fractional profile therefore is the result of a large 
number of fully labelled acetyl-CoA molecules. This was different from the results obtained with 
13C-glucose as precursor, where mostly M+2 label was detected in the fatty acids, proving a low 
flow of labelled acetyl-CoA into fatty acid biosynthesis (Figure 3.7). Taken together, serine was, 
compared to glycerol and glucose, used as the most efficient carbon substrate and catabolized 
most efficiently in the lower parts of glycolysis and the TCA cycle. The numerical values of 
13C-excess and isotopologue profiles of all time course experiments are shown in Supplementary 
Tables 5.4-5.6 and 5.7-5.8, respectively.  
 
3.2.4 Phosphorylated Metabolites are Preferred Substrates for Legionella pneumophila 
As CE MDM contained glycerol and glucose as carbon sources in addition to serine, which could 
not be omitted as an essential amino acid, it was tested if glycerol and glucose influenced each 
others metabolism. To that end, time course experiments with L. pneumophila wild-type growing 
in MDM with 50 mM [U-13C3]glycerol or 50 mM [U-
13C3]glycerol and 11 mM glucose (Figure 
3.9 A) and also experiments in MDM containing 11 mM [U-13C6]glucose or 11 mM 
[U-13C6]glucose and 50 mM glycerol (Figure 3.9 B) were performed. Cells were cultured for 
48 h, samples were taken after 12 h, 24 h, 36 h and 48 h, and 13C-excess was determined. As 
histidine was always the highest labelled amino acid in previous experiments, only the 13C-excess 
in histidine was compared here.  
In experiments with 13C-glycerol, the addition of glucose led to a drop of 20-25% in 
13C-enrichment in histidine (Figure 3.9 A). Significant label in histidine was again only measured 
after 36 h of growth. This showed that glycerol was also metabolized in the presence of glucose, 
but that glucose had an influence on the metabolism of glycerol. In labelling experiments with 
13C-glucose, the addition of glycerol did not lead to significant changes in 13C-excess in histidine 
(Figure 3.9 B). Therefore, glycerol and glucose seem to be co-metabolized independently by 
L. pneumophila with glucose as the preferred carbon substrate. 
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Figure 3.9: Co-metabolism of glycerol and glucose by L. pneumophila and phosphorylated sugars as preferred 
substrates. L. pneumophila wild-type was grown in MDM with either 50 mM [U-13C3]glycerol (
13
C-Glyc) or  
50 mM [U-13C3]glycerol and 11 mM glucose (Glc) (A), 11 mM [U-
13C6]glucose (
13
C-Glc) or 11 mM 
[U-13C6]glucose and 50 mM glycerol (Glyc)  (B) or 11 mM [U-
13C6]glucose and 11 mM glucose-6-phosphate 
(Glc-6P)  (C). After 12 h, 24 h, 36 h and 48 h samples were taken and incorporation of 13C-label into histidine (A-C) 
for all time points was determined. Shown are mean and SD of three technical replicates. For numerical values refer 
to Supplementary Table 5.9. 
 
An interesting observation was made, when growth with 11 mM 13C-glucose alone was compared 
to growth with 11 mM 13C-glucose and 11 mM unlabeled glucose-6-phosphate present in the 
medium at the same time. The addition of phosphorylated glucose led to a significant drop in 
13C-enrichment in histidine over the time course of the experiment (Figure 3.9 C). 13C-excess 
dropped over 50% compared to experiments with labelled glucose alone, while the extracellular 
growth per se was not affected. This observation allows the conclusion that phosphorylated 
carbohydrates might be the better substrates for L. pneumophila. The numerical values of 
13C-excess of co-metabolism experiments are shown in Supplementary Table 5.9. 
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3.2.5 Metabolism of Glycerol, Glucose and Serine is Restricted to Certain Pathways 
For a better overview of the time-dependent metabolism of glycerol, glucose and serine, four 
metabolites were chosen that were not present in CE MDM medium and therefore had to be 
synthesized de novo by L. pneumophila. Furthermore, the four metabolites were chosen to 
represent different metabolic pathways and/or intermediates. Alanine, with pyruvate as precursor, 
histidine, derived from the PPP, diaminopimelic acid (DAP), synthesized through the TCA and 
from pyruvate, as well as PHB, with acetyl-CoA as precursor, were chosen, and 13C-excess in 
these metabolites was followed over 48 h. The following graphs are based on the data obtained in 
section 3.2.3 from time-series experiments in CE MDM with 13C-glycerol, 13C-glucose or 
13C-serine as precursors. 
 
Figure 3.10 Analysis of carbon flux from different substrates into metabolic markers. The 13C-enrichment in 
alanine, histidine, DAP and PHB over time of L. pneumophila wild-type grown in CE MDM with 50 mM 
[U-13C3]glycerol (A), 11 mM [U-
13C6]glucose (B) or 6 mM [U-
13C3]serine (C) as precursor was compared. The ratio 
of 13C-excess in histidine to 13C-excess in alanine with 13C-glycerol, 13C-glucose or 13C-serine as substrate reveals 
carbon fluxes into gluconeogenesis/PPP or the TCA cycle (D). For numerical values refer to Supplementary Table 
5.10 (Published in Häuslein, Manske et al., 2015). 
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Histidine was the highest labelled metabolite, when growing with 13C-glycerol as precursor and 
label was only detected after 36 h and 48 h of growth (Figure 3.10 A). Glycerol was therefore 
only used in later stages of L. pneumophila growth. With 13C-glucose as precursor, histidine was 
also the highest labelled metabolite that was monitored here. However, incorporation of 13C-label 
into histidine did occur already at early time points (12 h) and increased continuously over time. 
The overall enrichment in all metabolites was also higher compared to experiments with 
13C-glycerol (Figure 3.10 B). 13C-enrichment in all metabolites from experiments with 13C-serine 
as precursor peaked already after 24 h and dropped steadily afterwards. Alanine was the highest 
labelled metabolite, and the overall excess in all metabolites was much higher compared to the 
experiments with 13C-glycerol and 13C-glucose (Figure 3.10 C). Serine was therefore used as the 
most effective carbon source here, which was metabolized during all growth phases. Glycerol, on 
the other hand, is obviously only used in the stationary growth phase, while glucose is used 
continuously, but mainly as precursor for histidine synthesis. 
To illustrate how a carbon substrate was preferably used by L. pneumophila, the ratio of 
13C-excess in histidine and 13C-excess in alanine was plotted against time (Figure 3.10 D). A high 
ratio indicated that carbon flux was mainly directed towards the PPP, while a small value 
indicated flow towards the lower parts of glycolysis, as alanine is made from pyruvate, and into 
the TCA cycle. Serine as precursor yielded a ratio that stayed below 1 throughout the course of 
the experiment, indicating that carbon flow from serine was mainly directed towards the TCA. 
The complete opposite was observed for carbon flow from glucose. Here, the ratio was high, 
indicating a preferred flow into the PPP towards histidine. The ratio was dropping slightly after 
36 h, when glycerol was also used as a carbon substrate. Also here the ratio was high, indicating 
that the carbon flow from glycerol was also mainly directed towards the PPP. The low ratio that 
was observed for glycerol at 12 h and 24 h was a result of the low overall enrichments in alanine 
and histidine and does not indicate that the carbon flow was directed towards the TCA, as 
significant enrichments with 13C-glycerol as precursor were only obtained after 36 h of growth 
(Figure 3.10 D). These results clearly showed that glycerol and glucose were not as efficiently 
used as a carbon source by L. pneumophila as serine and that the flow from these substrates was 
mainly restricted towards gluconeogenesis and the PPP, while the flow from serine was 
preferentially directed towards the TCA cycle. 
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3.2.6 In vivo Metabolism of Glycerol Leads to the Synthesis of Mannose 
The role that glycerol and other substrates play for the intracellular metabolism of 
L. pneumophila was examined in infected A. castellanii. Previous studies already showed that 
L. pneumophila imported labeled amino acids from A. castellanii fed with 13C-glucose prior to 
infection (Schunder et al., 2014). One goal of present study was to test, if it is possible that a 
carbon substrate added to infected cells might be used directly by intracellular L. pneumophila. 
To this end, A. castellanii was infected with either L. pneumophila wild-type or ∆glpD (see 
section 2.2.12). [U-13C3]glycerol, [U-
13C6]glucose or [U-
13C3]serine was added to the infected 
amoebae 5 h post infection. After 15 h the cells were lysed and a protocol was used to separate 
the bacteria from eukaryotic cell debris (Schunder et al., 2014). This protocol yielded three 
fractions: one with eukaryotic cell debris/components (F1), one containing L. pneumophila (F2) 
and one comprised of soluble proteins/factors (F3). The 13C-excess and isotopologue patterns of 
protein-derived amino acids, DAP, PHB and mannose were determined for all fractions, but since 
F1 and F3 yielded identical results, only F1 was considered here. All amino acids that had been 
measured in previous experiments were also analyzed, but for the sake of simplicity, only amino 
acids that yielded significant enrichments are shown (Ala, Asp, Glu, Gly, Ser). Fatty acids and 
TCA intermediates could not be monitored, as these metabolites would have required sample 
sizes (bacterial cell mass) that were not obtainable with in vivo assays. Samples were subjected to 
microscopy and aliquots were plated on CYE agar plates to check for bacterial contaminations of 
F1 as well as purity of F2. Additionally, the amount of DAP, as a compound specific for bacteria, 
was monitored in F1. DAP never exceeded 10%, so it was concluded that bacterial contamination 
in this fraction was below that value. All infections were performed in AC buffer, which does not 
contain any nutrients, so the used precursors were the only available carbon substrates in these 
assays. To check if the infection with L. pneumophila would influence the metabolism of 
A. castellanii, uninfected amoebae were used and fed with 13C-glycerol, 13C-glucose or 
13C-serine. 
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Figure 3.11: 
13
C-excess in amino acids, DAP, PHB and mannose of L. pneumophila grown in A. castellanii. 
Amoeba were infected (MOI 50) with L. pneumophila wild-type (WT), mutant ∆glpD or used uninfected. 50 mM 
[U-13C3]glycerol (A), 11 mM [U-
13C3]glucose (B) or 6 mM [U-
13C3]serine (C) was added 5 h post infection. Cells 
were lysed 15 h post infection and eukaryotic cell debris (F1) and L. pneumophila cells (F2) were separated. 
13C-excess (in mol%) of Ala, Asp, Glu, Gly, Ser, DAP, PHB and mannose was analyzed. Data shown corresponds to 
mean and SD of two independent experiments. For numerical values refer to Supplementary Table 5.11 (Published in 
Häuslein, Manske et al., 2015). 
 
Glycerol seems to be a favoured carbon substrate for A. castellanii, as the amoeba did incorporate 
13C-label from glycerol effectively into all amino acids measured, alanine (17.83%) and 
glutamate (10.65%) being the examples with the highest 13C-enrichment (Figure 3.11 A). 
Intriguingly, upon infection with L. pneumophila wild-type or mutant ∆glpD, the incorporation 
dropped so drastically that no significant enrichment in any amino acid in F1 was detectable 
anymore. Furthermore, no label in the amino acids measured was detectable in fractions F2 of 
wild-type and ∆glpD infected A. castellanii (Figure 3.11 A). Uninfected amoeba fed with 
13C-glucose did incorporate significant amounts of 13C-label into alanine (5.98%), aspartate 
(2.33%) and glutamate (3.09%) (Figure 3.11 B). Again, upon infection with L. pneumophila, 
there was a significant drop in 13C-incorporation in F1, but under these conditions alanine 
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(2.06%), glutamate (1.28 %), DAP (5.18%) and PHB (3.91%) were found to be enriched in 
13C-label in fraction F2. With 5.18% 13C-excess DAP was the highest labelled metabolite in F2 of 
wild-type infected amoeba (Figure 3.11 B). Serine was not as efficiently metabolized by 
A. castellanii as for example glycerol (Figure 3.11 C). The amoeba did take up 13C-serine, but it 
was apparently used directly for protein synthesis for the most part and not metabolized. The 
highest 13C-enrichment was found in protein-derived serine (12.63%) and its direct derivative 
glycine (5.43%). When infected, significant higher enrichment was observed in fraction F1, 
especially in alanine (6.85%), aspartate (1.36%) and glutamate (2.66%), while the incorporation 
levels into serine stayed at the same level as for uninfected amoeba (12.52%) (Figure 3.11 C). 
High 13C-enrichments were also detected in F2 of wild-type infected amoeba fed with serine. 
Under these conditions, DAP, PHB and serine each reached levels over 30.00 %. Serine was, 
similar to results in vitro, used for synthesis of amino acids, as high 13C-incorporation did occur 
into all amino acids measured, especially alanine with 17.90% enrichment. In all in vivo 
experiments, no label occurred in histidine in any L. pneumophila containing fractions (F2), 
suggesting that this amino acid is intracellularly not synthesized de novo, but taken up from the 
host cell. 
 
Figure 3.12: Analysis of mannose from L. pneumophila grown in A. castellanii. Amoebae were infected (MOI 
50) with L. pneumophila wild-type (WT) or ∆glpD. 50 mM [U-13C3]glycerol (A), 11 mM [U-
13C3]glucose (B) or 
6 mM [U-13C3]serine (C) was added 5 h post infection. Cells were lysed 15 h post infection and eukaryotic cell 
debris (F1) and L. pneumophila cells (F2) were separated. 13C-excess of mannose in F1 and F2 was analyzed. Mean 
and SD of two independent experiments are shown. For numerical values refer to Supplementary Table 5.11 
(Published in Häuslein, Manske et al., 2015). 
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Anyway, the most interesting conclusions were drawn from analyzing mannose. Fraction F2 of 
wild-type infected amoeba fed with 13C-glycerol resulted in a significant label in mannose 
(Figure 3.12 A). Significantly less label was detected in fraction F1. Furthermore, almost no label 
in mannose was measured in F1 and F2 of ∆glpD infected amoeba, showing that enrichment in 
wild-type F2 was dependent on GlpD (Figure 3.12 A). Also, the eukaryotic fraction F1 of wild-
type infected A. castellanii fed with 13C-glucose did not yield significant label in mannose, 
whereas mannose in fraction F2 was highly enriched (4.47%) (Figure 3.12 B). Experiments with 
13C-serine as precursor resulted in no incorporation into mannose, neither in F1 nor in F2 (Figure 
3.12 C). 
 
 
Figure 3.13: Isotopologue pattern of mannose from L. pneumophila wild-type grown in A. castellanii. The 
isotopologue pattern of mannose from Legionella containing fractions F2 of wild-type infected A. castellanii fed 
with [U-13C3]glycerol (A) or [U-
13C6]glucose (B) are shown. Columns indicate the relative fraction (in %) of 
13C-isotopologues (M+1 to M+6). Data shown represent mean and SD of two independent experiments. For 
numerical values refer to Supplementary Table 5.12 (Adapted from Häuslein, Manske et al., 2015). 
 
The isotopologue pattern of mannose from in vivo experiments with 13C-glycerol as precursor 
revealed that the sugar was mostly M+3 (~ 68%) labelled, suggesting that glycerol was directly 
used for gluconeogenesis to make fructose and subsequently mannose (Figure 3.13 A). The 
pattern reflected that of mannose from in vitro experiments relatively well (compare Figure 
3.4 B). Furthermore, the lack of significant label in mannose with L. pneumophila ∆glpD proved 
that 13C-incorporation into mannose was a result of direct uptake of glycerol into the LCV and 
direct synthesis of mannose from glycerol by L. pneumophila (Figure 3.12 A). The isotopologue 
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pattern of mannose from in vivo experiments with 13C-glucose was also almost identical to that of 
L. pneumophila grown in CE MDM (compare Figure 3.7), displaying mainly M+3 (~ 30%) and 
M+6 (~ 38%) (Figure 3.13 B). Furthermore, as no incorporation in F1 was detectable here 
(Figure 3.12 B), it was concluded that also glucose was taken up directly from the host cell 
(M+6) and metabolized by the bacteria (M+3). The numerical values of 13C-excess and 
isotopologue profiles of all in vivo experiments are documented in Supplementary Tables 5.11 
and 5.12, respectively. 
Taken together, it was shown that glycerol also serves intracellularly as a carbon substrate and is 
used exclusively for anabolic reactions by L. pneumophila, similar to results obtained in vitro. 
Glycerol and glucose can reach the bacteria inside the LCV without being metabolized by the 
amoeba, expanding the intracellular diet of L. pneumophila from only amino acids to sugars as 
additional carbon source. The absence of label in mannose, when fed with 13C-serine, suggests 
that, similar to growth in vitro, flow of carbon from different substrates might be preferentially 
directed to certain pathways by intracellular growing L. pneumophila. 
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3.3 Analysis of the Inositol Metabolism of Legionella pneumophila 
3.3.1 A Putative Inositol Degradation Cluster in the Genome of Legionella pneumophila 
Myo-inositol (here referred to as “inositol”) is used as the sole source of carbon by many bacteria, 
including Bacillus subtilis (Yoshida et al., 2008), Lactococcus casei (Colas et al., 2015) or 
Salmonella enterica (Kröger and Fuchs, 2009). Genes involved in inositol catabolism are 
organized in operons in these organisms (see section 1.3.2 for details). Interestingly, also the 
genome of L. pneumophila harbors a group of genes putatively involved in inositol metabolism 
(Figure 3.14). 
 
Figure 3.14: The lpg1653- lpg1649 operon of L. pneumophila. The gene cluster contains five genes predicted to be 
involved in inositol metabolism, including the putative inositol transporter Lpg1653, and the inositol catabolism 
proteins IolG, IolCB, IolD and IolE. 
 
The gene cluster of interest is located in a 7 kB large region on the L. pneumophila chromosome 
and contains five genes, lpg1653-lpg1649. The genes are organized in an operon as predicted by 
the DOOR2 database of prokaryotic operons (Mao et al., 2009) and the prokaryotic operon 
database (http://operons.ibt.unam.mx/OperonPredictor/) with a predicted promoter in the 400 bp 
region between the genes lpg1653 and lpg1654. The proteins in this operon are annotated as IolG 
(lpg1652), a myo-inositol-2-dehydrogenase, IolCB (lpg1651), a combined 5-dehydro-2-
deoxygluconokinase and 5-deoxy-glucuronate isomerase protein, IolD (lpg1650), an inositol 
catabolism hydrolase protein and IolE (lpg1649), an inosose dehydratase. These proteins show 
sequence identities between 30% and 50% with the corresponding proteins of B. subtilis and 
S. enterica. The first gene in the lpg1653-lpg1649 operon is annotated as D-xylose proton 
symporter and shares some homology to the inositol transporter proteins IolT of B. subtilis and 
S. enterica (Figure 3.14). The operon is found in several L. pneumophila strains including 
Philadelphia 1, Paris, Lens, Corby and Alcoy and is also present in the genome of 
L. longbeachae. Therefore, Legionella spp. are probably able to metabolize inositol.  
The only proteins missing in the genome of L. pneumophila that were described to be involved in 
inositol metabolism in other organisms, are the bisphosphate aldolase IolJ and the malonate-
semialdehyde-dehydrogenase IolA (see section 1.3.2). Interestingly, also no homologue of the 
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major regulator protein IolR is found by sequence homology in the genome of L. pneumophila. 
Thus, the expression of the iol operon seems to be regulated differently than in B. subtilis 
(Yoshida et al., 2008) or S. enterica (Kröger and Fuchs, 2009). 
 
3.3.2 Characterization of Lpg1653 as an Inositol Transporter and Utilization of Inositol by 
Legionella pneumophila 
To test whether L. pneumophila can metabolize inositol, the role of the putative inositol 
degradation cluster was assessed using different growth assays. To this end, mutant strains 
lacking lpg1653, the putative inositol transporter, or lacking iolG (lpg1652), the inositol 
dehydrogenase, were constructed. Growth of these mutants was monitored in different media in 
presence or absence of inositol. In AYE broth, growth of wild-type, ∆lpg1653 or ∆iolG was 
indistinguishable, and the addition of 10 mM inositol did not alter growth of any strain tested 
(data not shown). The lpg1653 mutant grew like wild-type bacteria in CDM and MDM and again, 
the addition of 10 mM inositol did not influence the growth of either strain (Figure 3.15 A, B). 
Even though inositol did not have a growth-stimulating effect in all media tested, it was analyzed 
whether L. pnumophila can take up and utilize inositol. To this end, the bacteria were grown to 
late exponential growth phase and then incubated with radiolabelled 14C-inositol. Cells were spun 
onto filter disks, washed, and cell-associated radioactivity on the filters was determined using a 
liquid scintillation counter. Indeed, wild-type bacteria did take up 14C-inositol; cell associated 
radioactivity was maximum after 30 min (Figure 3.15 C). On the other hand, no cell-associated 
radioactivity was measured for the lpg1653 mutant. This uptake defect was complemented by 
expressing lpg1653 from a plasmid (pCM020) (Figure 3.15 C). Thus, Lpg1653 was identified as 
an inositol transporter, and the protein was termed IolT in reference to the described inositol 
transporters from B. subtilis and S. enterica (Yoshida et al., 2008; Kröger et al., 2010). 
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Figure 3.15: Characterization of L. pneumophila IolT as an inositol transporter. Extracellular growth of 
L. pneumophila wild-type (WT) and mutant ∆iolT (∆lpg1653) in CDM (A) or MDM (B) with and without 10 mM 
inositol. Optical density at 600 nm was determined at the time points indicated. L. pneumophila WT, ∆iolT or ∆iolT 
harbouring plasmid pCM020 (iolT under control of Ptac) were grown to late exponential growth phase, 10 mM 
inositol mixed with 1% [U-14C6]inositol was added, and cells were further incubated. After 0, 10, 20, 30, 60 and 90 
minutes, samples were taken, cells were spun onto cellulose acetate filter disks, and cell-associated radioactivity was 
measured using a liquid scintillation counter (C). L. pneumphila WT or mutant ∆iolT were grown to exponential 
growth phase, 10 mM inositol mixed with 1% [U-14C6]inositol was added, and cells were further incubated. After 0, 
2, 4, 6 and 8 h samples were taken and mixed with 50% trichloroacetic acid. Samples were incubated on ice for 1 h, 
spun onto cellulose nitrate filter disks, washed, and filter-associated radioactivity was determined using a liquid 
scintillation counter (D). Data in (A)-(D) are representatives of three independent experiments. Mean and SD of 
triplicates are shown (A)-(C). 
 
To test, whether inositol was catabolized and incorporated into cell matter by L. pneumophila 
radioactive inositol was used. To this end, exponentially growing L. pneumophila were incubated 
with 14C-inositol for several hours. Every two hours, samples were taken and mixed with 
trichloroacetic acid to precipitate proteins. The samples were then spun onto cellulose nitrate 
filter disks, and incorporation of radioactivity into the acid-insoluble fraction was measured using 
a liquid scintillation counter. For wild-type bacteria, radioactivity was rising steadily over time, 
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indicating that inositol was also used as precursor for macromolecules, while no radioactivity was 
detectable in the acid-insoluble fractions of an iolT mutant (Figure 3.15 D). 
 
Figure 3.16: Inositol metabolism of L. pneumophila in dependence of IolG. Extracellular growth of 
L. pneumophila wild-type (WT) and mutant ∆iolG in CDM (A) or MDM (B) with and without 10 mM inositol. 
Optical density at 600 nm was determined at the time points indicated. L. pneumophila WT or ∆iolG were grown to 
late exponential growth phase, 10 mM inositol mixed with 1% [U-14C6]inositol was added and cells were further 
incubated. After 0, 10, 20, 30, 60 and 90 minutes, samples were taken. Cells were spun onto cellulose acetate filter 
disks and cell-associated radioactivity was measured using a liquid scintillation counter (C). L. pneumphila WT or 
∆iolG were grown to exponential growth phase, 10 mM inositol mixed with 1% [U-14C6]inositol was added and cells 
were further incubated. After 0, 2, 4, 6 and 8 h samples were taken and mixed with 50% trichloroacetic acid. 
Samples were incubated on ice for 1 h, spun onto cellulose nitrate filter disks, washed, and filter-associated 
radioactivity was determined using a liquid scintillation counter (D). Data in (A)-(D) are representatives of three 
independent experiments. Mean and SD of triplicates are shown (A)-(B). 
 
An L. pneumophila ∆iolG mutant strain was characterized in the same way as ∆iolT by growth in 
different media and determination of uptake and usage of 14C-inositol. Again, the mutant lacking 
the inositol dehydrogenase IolG grew like wild-type bacteria in CDM and MDM, and the 
addition of 10 mM inositol did not alter growth of the bacteria (Figure 3.16 A, B). By using 
14C-inositol, it was shown that the iolG mutant was able to transport inositol (Figure 3.16 C), but 
was not able to use inositol as precursor for macromolecules, as no radioactivity was detected in 
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the acid insoluble fractions of ∆iolG (Figure 3.16 D). The mutant strain was therefore able to 
transport inositol, but could not metabolize it. 
In summary, we showed that L. pneumophila possesses a gene cluster (lpg1653-lpg1649), which 
is used to metabolize inositol, and IolT (Lpg1653) was identified as an inositol transporter. 
Inositol did not stimulate growth of L. pneumophila, but was used as precursor for 
macromolecules. 
 
3.3.3 Expression of iolT is Regulated by RpoS and the Availability of Serine 
In B. subtilis, the expression of all genes linked to inositol metabolism is regulated by IolR, 
which represses the expression of iol genes in absence of inositol (Yoshida et al., 2008). No 
homologue for IolR was found in the genome of L. pneumophila, so the expression of the iol 
gene cluster has to be regulated differently. As no other promotor as the iolT promotor is 
predicted within the operon (see section 3.3.1), a reporter plasmid was constructed with an 
unstable GFP variant (ASV) under control of PiolT (pCM007). This reporter was used to test the 
expression of iolT and hence the whole iol operon under different conditions. 
The addition of 10 mM inositol did not alter the expression of iolT as measured by GFP 
fluorescence levels in wild-type bacteria (Figure 3.17 A). Therefore, the expression of iolT seems 
not to be regulated by the availability of inositol. Interestingly, the addition of 6 mM serine to 
AYE broth did result in higher expression levels of iolT, shifting the expression maximum from 
around 14 h to around 16 h of growth (Figure 3.17 A). The highest expression levels of iolT were 
therefore obtained in the late exponential growth phase of L. pneumophila.  
The Lqs system is known to be part of the stationary-phase regulatory network of L. pneumophila 
(Tiaden et al., 2007). To assess whether the Lqs system regulates the expression of the iol 
operon, the expression of iolT was also tested in a mutant strain lacking the response regulator 
LqsR. Here, no differences compared to wild-type bacteria were detectable and again, addition of 
inositol had no influence on the expression of iolT, while 6 mM serine did enhance the expression 
(Figure 3.17 B). This was also analyzed in other lqs mutants, but the same results as for wild-type 
were obtained for ∆lqsA, ∆lqsS, ∆lqsT and ∆lqsS-∆lqsT mutants (Figure 3.18). Therefore, the 
expression of iolT is not regulated by the lqs system of L. pneumophila. 
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Figure 3.17: Expression of iolT is regulated by RpoS and the availability of serine. Exponentially growing 
cultures of L. pneumophila wild-type (WT) (A), ∆lqsR (B) or ∆rpoS (C) harboring plasmid pCM007 (unstable GFP 
(ASV) under control of PiolT) were diluted to a starting OD600 of 0.1 in AYE broth. Cells were grown at 37°C with 
10 mM inositol, 6 mM serine or without the addition of additional nutrients (A)-(C). Optical density at 600 nm and 
GFP fluorescence was measured every hour for 24 h and results were plotted with RFU as a function of OD600 over 
time (A)-(C). L. pneumophila WT or mutant ∆rpoS were grown to an OD600 of 0.5, 1.0, 2.0 and 3.0. At that points, 
samples were taken and 10 mM inositol mixed with 1% [U-14C6]inositol was added and the bacteria were further 
incubated for 30 min. Cells were spun onto cellulose acetate filter disks, washed and filter-associated radioactivity 
was determined in a liquid scintillation counter (D). Data in (A)-(D) are representatives of three independent 
experiments. Mean and SD of triplicates are shown. 
 
The sigma factor RpoS is a central regulator of intracellular replication and differentiation in 
L. pneumophila and regulates many genes in stationary growth phase (Zusman et al., 2002; 
Hovel-Miner et al., 2009). To test whether RpoS controls the expression of the iol operon, the 
PiolT reporter construct was transformed into a L. pneumophila ∆rpoS mutant strain. Expression 
levels of iolT in the rpoS mutant strain were significantly lower compared to wild-type bacteria. 
Also, the addition of serine had no influence on the expression of iolT in the ∆rpoS strain 
anymore (Figure 3.17 C). Therefore, iolT seems to be regulated by RpoS. This finding was 
confirmed in experiments measuring the uptake of 14C-inositol at different stages of 
L. pneumophila growth. At an OD600 of 0.5 (early exponential growth phase), wild-type and 
∆rpoS did not transport inositol, as no cell-associated radioactivity was measured for either strain 
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(Figure 3.17 D). However, while for wild-type bacteria increased radioactivity was detectable at 
OD600 of 1.0 (exponential growth phase), 2.0 (late exponential growth phase) and 3.0 (stationary 
growth phase), no cell-associated radioactivity was measured for ∆rpoS at all time points (Figure 
3.17 D). In summary, these results show that the growth phase- and serine-dependent expression 
of iolT is regulated by RpoS. Highest levels of iolT expression were obtained in the late 
exponential growth phase, but L. pneumophila was able to transport inositol already at earlier 
stages of its growth cycle. 
 
 
Figure 3.18: Expression of iolT is not regulated by lqs genes. Exponentially growing cultures of L. pneumophila 
wild-type (WT) (A), ∆lqsA (B), ∆lqsS (C), ∆lqsT (D) or ∆lqsS-∆lqsT (E) harboring plasmid pCM007 (unstable GFP 
(ASV) under control of PiolT) were diluted to a starting OD600 of 0.1 in AYE broth. Cells were grown at 37°C with 
10 mM inositol, 6 mM serine or without additional nutrients (A)-(E). Optical density at 600 nm and GFP 
fluorescence was measured every hour for 24 h, and results were plotted with RFU as a function of OD600 over time 
(A)-(E). Data are representatives of three independent experiments. Mean and SD of triplicates are shown. 
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3.3.4 Inositol Promotes Intracellular Growth of Legionella pneumophila 
Similar to genes involved in glycerol metabolism (see section 3.2.1), the expression of genes of 
the iol cluster was upregulated upon intracellular growth of L. pneumophila in human 
macrophages (Faucher et al., 2011). The genes, except the inositol transporter iolT, were 2-fold 
upregulated showing that also inositol might play a role during intracellular growth of 
L. pneumophila. Moreover, the IolBC genes, encoding the combined transferase kinase protein of 
L. pneumophila were also almost 2-fold upregulated in post-exponential growth phase compared 
to exponential growth phase. 
The impact of inositol on intracellular growth of L. pneumophila was assessed using colony 
forming units (cfu), fluorescence based assays, as well as co-infection assays (see sections 2.2.9 
and 2.2.10). Addition of 20 mM inositol concomitant with infection or 2 h or 4 h post infection to 
infected A. castellanii cells, yielded higher bacterial cell numbers based on increased 
fluorescence levels (Figure 3.19 A-C). This was dependent on iolT, and addition of inositol to 
∆iolT did not result in higher fluorescence levels, but the mutant grew like wild-type (Figure 3.19 
A-C). Inositol did not lead to faster growth of exponentially growing bacteria, but did lead to 
higher cell numbers after 24 h and at later time points of infection, suggesting that inositol might, 
like glycerol, only be used in later stages of infection (Figure 3.19 A-C). Addition of 20 mM 
inositol to L. pneumophila wild-type growing in A. castellanii or murine macrophages did also 
result in a greater number of cfu after 72 or 48 h of intracellular growth, respectively (Figure 3.19 
D, E). This positive growth effect was not observed for the iolT mutant, although the mutant was 
not impaired in intracellular growth per se (Figure 3.19 D, E). However, the mutant was slowly 
outcompeted by wild-type bacteria in co-infection assays within 15 days, indicating that the iolT 
mutant had a fitness disadvantage compared to the wild-type strain, although iolT was not 
essential for intracellular growth (Figure 3.19 F).  
3.  Results 
 
107 
 
 
Figure 3.19: Inositol promotes intracellular growth of L. pneumophila dependent on iolT. A. castellanii was 
infected (MOI 20) with L. pneumophila wild-type (WT) or ∆iolT harbouring plasmid pNT28 (constitutive GFP 
expression). 20 mM inositol was added concomitant with infection (A), 2 h (B) or 4 h post infection (C), and 
intracellular replication was determined by fluorescence. A. castellanii (D) or murine macrophages (E) were infected 
(MOI 0.1) with L. pneumophila WT or mutant strain ∆iolT. 20 mM inositol was added 4 h post infection, cells were 
lysed 72 h (D) or 48 h (E) post infection, and cfu were determined by plating out appropriate dilutions on CYE agar 
plates (Student´s t-test *p < 0.05). For co-infection assays, A. castellanii was infected with L. pneumophila WT and 
∆iolT at a 1:1 ratio (MOI 0.01 each). Cells were lysed three days post infection and bacteria were used to infect fresh 
amoeba. Cell numbers were determined by cfu (F). Data in (A)-(F) are representatives of three independent 
experiments. Mean and SD of triplicates are shown. 
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Figure 3.20:  Inositol promotes intracellular growth of L. pneumophila dependent on iolG. A. castellanii was 
infected (MOI 20) with L. pneumophila wild-type (WT) or ∆iolG harbouring plasmid pNT28 (constitutive GFP 
expression). 50 mM inositol was added 4 h post infection and replication was determined by fluorescence (A). 
A. castellanii was infected (MOI 0.1) with L. pneumophila WT or mutant strain ∆iolG. 20 mM inositol was added 
4 h post infection, cells were lysed 72 h post infection and cfu were determined by plating out appropriate dilutions 
on CYE agar plates (B) (Student´s t-test ***p < 0.001). For co-infection assays, A. castellanii was infected with 
L. pneumophila WT and ∆iolG at a 1:1 ratio (MOI 0.01 each). Cells were lysed three days post infection and bacteria 
were used to infect fresh amoeba. Cell numbers were determined by cfu (C). Data in (A)-(C) are representatives of 
three independent experiments. Mean and SD of triplicates are shown. 
 
The intracellular growth of L. pneumophila in presence or absence of inositol was also tested in 
the ∆iolG mutant strain. While the addition of inositol to wild-type bacteria resulted in higher 
fluorescence levels (Figure 3.20 A) and higher cfu numbers (Figure 3.20 B), the addition of 
inositol to ∆iolG did not. The mutant did intracellularly grow like wild-type but was outcompeted 
by the wild-type strain within 6 days in co-infection assays (Figure 3.20 C). In summary, inositol 
had a positive effect on intracellular growth of L. pneumophila, resulting in higher cell numbers. 
The observed phenotype was dependent on the inositol transporter IolT or the inositol 
dehydrogenase IolG, and the mutant strains were outcompeted by wild-type bacteria. Therefore, 
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inositol is likely a carbon source of L. pneumophila during intracellular growth in different host 
cells. 
 
3.3.5 Analysis of Substrate Uptake into LCVs of Infected Host Cells 
As inositol had a positive effect on intracellular growth of L. pneumophila, the question was 
whether this was a result of the direct metabolism of inositol by the bacteria or an indirect effect, 
where the host cells metabolized inositol and the bacteria then benefited from more available 
metabolites like amino acids. One prerequisite for the direct metabolism of inositol or any other 
substrate by L. pneumophila would be the accessibility of the LCV for substrates supplied from 
the outside to infected host cells.  
To test whether substrates reach the LCV, we added a fluorescent glucose analogue, 2-(N-(7-
Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) to infected D. discoideum 
cells 1 h post infection. Subsequently, we monitored by fluorescence microscopy whether 
2-NBDG can reach the bacteria inside the LCV or not. Indeed, when D. discoideum was infected 
with either wild-type, or ∆iolT or ∆iolG mutant bacteria, the amoeba did take up 2-NBDG and 
the glucose analogue was found in close proximity to the intracellular bacteria as seen by green 
fluorescence surrounding the bacteria (Figure 3.21 A). This was quantified by counting 2-NBDG 
positive LCVs in whole infected amoeba, and it was found that around 60% of all LCVs were 
positive for the fluorescent glucose analogue. No difference between wild-type, ∆iolT or ∆iolG 
was observed (Figure 3.21 B). The LCV was therefore accessible for the substrate added to 
infected cells. When D. discoideum was infected with an ∆icmT mutant and 2-NBDG was added 
1 h post infection, significantly less 2-NBDG-positive LCVs were found. Only around 30% of all 
Legionella-containing compartments that were counted were 2-NBDG-positive, showing that 
uptake of 2-NBDG was in part dependent on a functional T4SS. 
These findings were also confirmed by monitoring LCVs in homogenates from D. discoideum 
infected with wild-type L. pneumophila. The infected cells were homogenized after incubation 
with 2-NBDG, washed thoroughly and then stained for SidC, a L. pneumophila effector protein 
specifically found on LCV membranes. Again, a high number of 2-NBDG-positive LCVs was 
determined (Figure 3.22). As the samples were washed several times in the course of the 
experiments, the observed fluorescence had to be inside membrane-confined compartments, 
confirming that 2-NBDG was taken up into the LCVs of infected host cells. 
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Figure 3.21: Accumulation of 2-NBDG in LCVs within D. discoideum. D. discoideum was infected (MOI 10) 
with L. pneumophila (Lpn) wild-type (WT), ∆icmT, ∆iolT or ∆iolG harbouring plasmid pSW001 (constitutive dsred 
expression) for 1 h. Cells were washed and incubated with 20 µM 2-NBDG for 30 min. After that, cells were 
washed, fixed with PFA, stained with DAPI and subjected to fluorescence microscopy. 2-NBDG-positive LCVs are 
marked with white arrows; scale bars 5 µm (A). The number of 2-NBDG-positive LCVs was quantified from three 
independent experiments. At least 50 LCVs were counted per experiment (B). The pictures shown are representatives 
of at least three independent experiments. 
Abbreviations: Lpn, Legionella pneumophila; 2-NBDG, 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-
deoxyglucose. 
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In summary, the LCV is accessible for substrates after infection, suggesting that inositol and 
other substrates can reach the bacteria inside the compartment and can subsequently be 
metabolized directly by L. pneumophila. This notion is in agreement with the finding that the 
observed positive growth effect inside different host cells was dependent on IolT and IolG (see 
section 3.3.4). The fact that the vacuole containing the ∆icmT mutant did not take up 2-NBDG as 
efficiently as the other strains tested indicates that the acquisition of substrates from the host cell 
might be dependent on the T4SS-induced communication with the endosomal network of the host 
cell. This might occur through macropinocytotic processes and vesicle fusion events and/or 
through host cell transporters that could facilitate the uptake of different substrates into the LCV. 
 
 
 
 
Figure 3.22: 2-NBDG-positive LCVs in homogenates from L. pneumophila-infected amoeba. D. discoideum was 
infected (MOI 10)  with L. pneumophila wild-type (WT) harbouring plasmid pSW001 (constitutive dsred 
expression) for 1 h. Cells were washed and further incubated with 20 µM 2-NBDG for 30 min. Cells were washed 
and homogenized using a ball homogenizer with 8 µm exclusion size. Samples were then fixed with PFA on poly-L-
lysine coated coverslips and stained for SidC. Samples were subjected to fluorescence microscopy. White arrows 
indicate 2-NBDG-positive LCVs. Scale bars: 5 µm. 
Abbreviations: Lpn, Legionella pneumophila; 2-NBDG, 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-
deoxyglucose. 
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4.  Discussion 
 
The knowledge about the metabolism of L. pneumophila was restricted for some time to the 
preference of amino acids for nutrition. In particular, it was neglected what possibilities the 
intracellular milieu could offer for the bacteria and how metabolism could influence the course of 
the infection. This study now documents that L. pneumophila metabolizes glycerol and inositol in 
vitro as well as in vivo. Furthermore it shows that amino acids like serine and carbohydrates like 
glucose and glycerol have particular metabolic fates when being metabolized by the bacteria, a 
principle that also seems to be employed by other intracellular pathogens like L. monocytogenes 
or M. tuberculosis to ensure effective and successful intracellular replication. 
 
4.1 The Metabolism of Inositol by Legionella pneumophila and its Regulation 
The genome of L. pneumophila harbors a cluster of genes associated with the catabolism of 
inositol, which are organized in an operon (see section 3.3.1). However, no gene for the 
bisphosphate aldolase iolJ and the malonate semialdehyde dehydrogenase iolA are found within 
the operon or elsewhere in the genome. The Kyoto Encyclopedia of Genes and Genomes 
(KEGG) predicts that MmsA (Lpg0129) catalyzes the reaction of IolA in L. pneumophila 
(http://www.genome.jp/kegg/kegg2.html). IolA normally converts malonate semialdehyde into 
acetyl-CoA, releasing CO2 and producing one molecule NADH/H
+ in the course. However, 
MmsA is annotated as a methylmalonate semialdehyde dehydrogenase that oxidizes 
methylmalonate semialdehyde to propionyl-CoA, producing one molecule NADH/H+ in the 
process. Whether the inositol catabolism in L. pneumophila produces methylmalonate or 
malonate semialdehyde is not known. However, the enzyme corresponding to MmsA in 
B. subtilis was found to catalyze both reactions with methylmalonate semialdehyde and malonate 
semialdehyde as substrates, producing propionyl- and acetyl-CoA, respectively (Stines-Chaumeil 
et al., 2006; Talfournier et al., 2011). L. pneumophila MmsA shares some homologies with 
B. subtilis MmsA, and it is possible that the Legionella enzyme also has a wider substrate 
spectrum than just methylmalonate semialdehyde. 
A substitution for the missing IolJ on the other hand is harder to find. IolJ catalyzes the aldolase 
reaction with 2-deoxy-5-keto-D-gluconate-6-phosphate as substrate, which yields one molecule 
dihydroxyacetone phosphate and the aforementioned malonate semialdehyde. S. enterica also has 
no homologue of iolJ in its genome, but other than L. pneumophila can grow on inositol as sole 
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source of carbon and energy (Kröger and Fuchs, 2009). At this point, it is not possible to propose 
multi-substrate specificities of other aldolases that could make up for the missing IolJ. It is 
possible that L. pneumophila employs a novel inositol catabolic pathway as shown for 
Thermotoga maritima (Rodionova et al., 2013). However, this is not likely as all other enzymes 
in the iol cluster resemble enzymes that were described in B. subtilis and S. enterica. Indeed, 
L. pneumophila seems to metabolize inositol as suggested in experiments performed with 
radioactive 14C-inositol (see section 3.3.2). While the addition of inositol did not have a growth 
stimulating effect in different chemically defined media, upon incubation of the bacteria with 
14C-inositol, radioactivity was efficiently incorporated into the acid-insoluble fraction of the cell 
indicating that inositol is used as a precursor for macromolecules. As this was dependent on IolT 
and IolG one can assume that this was by virtue of inositol metabolism (see section 3.3.2). 
Further investigations on the fate of inositol in the bacterial cell would help to elucidate the 
mechanisms of inositol metabolism and could also clarify, if and how inositol contributes to the 
bipartite metabolism of L. pneumophila (see section 4.3). 
The inositol metabolism in other bacteria like B. subtilis, S. enterica or L. casei is regulated by 
the repressor protein IolR (Yebra et al., 2007; Yoshida et al., 2008; Kröger et al., 2010). In the 
absence of inositol, IolR binds to the operator sites of regulated genes and blocks their 
transcription. If inositol is available, a catabolic intermediate of inositol metabolism acts as a 
derepressor of IolR. The regulator detaches from the operator sites, thus allowing expression of 
inositol metabolism genes and the transporter gene iolT (Yoshida et al., 1997; Yoshida et al., 
2008). No homologue of IolR is found in the genome of L. pneumophila, and accordingly, the 
addition of inositol had no influence on the expression of iolT (see section 3.3.3). However, the 
expression of iolT was up-regulated by the addition of serine and down-regulated in a ∆rpoS 
mutant (see section 3.3.3). 
Availability of nutrients, especially amino acids, constitutes an important factor for 
L. pneumophila for the regulation of the phenotypic switch between replication and transmission 
and vice versa. As long as amino acids are available, expression of virulence traits is repressed 
(Byrne and Swanson, 1998), and only when nutrients become limiting the bacteria will undergo a 
transcriptional switch and express virulence traits (see also section 1.2.4). Transporters of the Pht 
family, like the threonine transporter PhtA or the valine transporter PhtJ, were shown to be 
essential for the intracellular differentiation to the replicative form (Sauer et al., 2005; Chen et 
al., 2008). Furthermore, arginine is important for the switch to replication inside the host. The 
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availability of arginine allows the expression of genes that are repressed by the regulator ArgR in 
absence of the amino acid. The regulator is crucial for maximal intracellular replication in 
A. castellanii (Hovel-Miner et al., 2010). 
It is currently not known, whether serine also acts on regulatory proteins and how it influences 
gene expression patterns of L. pneumophila, but as the amino acid is a major carbon source for 
the bacteria, a role for serine in the regulatory network of Legionella is likely. The effect of serine 
on gene expression might also be indirect and linked to the overall metabolic state of the bacterial 
cell. As long as amino acids are not limiting, the ppGpp-synthase RelA is not activated. The 
second ppGpp-synthase of L. pneumophila, SpoT, senses the metabolic condition of the cell 
through the state of fatty acid biosynthesis and is activated by a reduction in the rate of fatty acid 
biosynthesis. As long as this is not the case, SpoT acts as a ppGpp-hydrolase and assures that the 
transmissive phenotype is not expressed and bacteria can replicate (Dalebroux et al., 2009; 
Edwards et al., 2009). Isotopologue profiling with 13C-serine as precursor showed high carbon 
flux from serine into fatty acids, and therefore, a high rate of fatty acid biosynthesis occurs when 
serine was present (see section 3.2.3). This in consequence would lead to ppGpp-hydrolase 
activity of SpoT, which could also influence the second regulator of inositol metabolism, the 
alternative sigma factor RpoS. 
In a L. pneumophila rpoS deletion mutant, the expression of iolT was drastically reduced and also 
serine did not enhance the expression anymore (see section 3.3.3). In line with these results is the 
finding of Trigui et al. who observed the downregulation of iolG in an rpoS mutant upon 
extracellular growth in water (Trigui et al., 2015). In E. coli RpoS is believed to be the central 
stress sigma factor as ∆rpoS mutants of E. coli are much more sensitive to stress (Hengge-Aronis, 
1993; 2002). An L. pneumophila ∆rpoS mutant, on the other hand, retains stress resistance, but is 
not able to replicate inside protozoan hosts anymore (Hales and Shuman, 1999b; Hovel-Miner et 
al., 2009). Therefore, RpoS is believed to be a key regulator of genes associated with intracellular 
multiplication in L. pneumophila (Hovel-Miner et al., 2009). RpoS regulates a plethora of genes 
including Icm/Dot-translocated effector proteins, small regulatory RNAs as well as two 
component systems, and is mainly associated with virulence related genes. However, RpoS was 
also shown to positively regulate genes associated with carbohydrate metabolism during 
exponential growth (Hovel-Miner et al., 2009), and inositol transport was also highest in 
exponential growth phase (see section 3.3.3). At that point the ppGpp concentration in the cell is 
low due to the availability of nutrients (e.g. serine) and the resulting ppGpp-hydrolase activity of 
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SpoT. When nutrients become limiting and ppGpp concentrations rise, the stability and activity 
of RpoS will change and the expression profile switches to the transmissive pattern (Zusman et 
al., 2002; Hovel-Miner et al., 2009). This link might explain the observed interplay of serine and 
RpoS in the regulation of inositol metabolism in the exponential growth phase of L. pneumophila. 
Regulatory proteins downstream of RpoS could also be responsible for the regulation of inositol 
metabolism. RpoS controls the expression of the arginine repressor ArgR. The expression of 
argR was twelve-fold upregulated in ∆rpoS, and thus, the intracellular growth defect of ∆rpoS 
might be due to the inability of the bacteria to express the arg regulon upon infection (Hovel-
Miner et al., 2009; Hovel-Miner et al., 2010). ArgR does not regulate the iol operon of 
L. pneumophila (Hovel-Miner et al., 2010), but the observed downregulation of iolT in ∆rpoS 
could be due to the disturbed expression of one or several other regulators downstream of RpoS. 
The Legionella quorum sensing system (Lqs) might be one of those regulators, as it was shown 
that the expression of iolG was two-fold upregulated in a mutant lacking the two sensor kinases 
LqsS and LqsT in stationary growth phase (Kessler et al., 2013). Moreover, the lqs system is 
regulated by RpoS (Tiaden et al., 2007) and could therefore be responsible for the 
downregulation of the iol operon in stationary growth phase. 
The overall picture of regulatory processes regarding inositol metabolism is still vague, but the 
involvement of RpoS suggests that the carbohydrate could be used as an intracellular carbon 
source by L. pneumophila. Indeed, inositol promoted intracellular growth dependent on IolT and 
IolG in A. castellanii and murine macrophages (see section 3.3.4). Furthermore, mutants lacking 
the inositol transporter IolT or the inositol dehydrogenase IolG had a severe fitness disadvantage 
compared to wild-type bacteria, without being impaired for intracellular growth per se (see 
section 3.3.4). The catabolism of inositol is therefore not essential for intracellular growth of 
L. pneumophila, but provides the bacteria with certain fitness benefits. As the observed positive 
growth effect of inositol was dependent on the inositol transporter IolT and also on IolG, one can 
assume that it was due to the direct metabolism of inositol inside the host cell and not due to a 
secondary effect, where inositol was metabolized by the host and the bacteria would then profit 
from host metabolites, such as amino acids or glucose. Also, the transcriptome of L. pneumophila 
growing in macrophages suggests that inositol is used as a carbon source by the bacteria, since 
the expression of iolG and iolCB was over two-fold upregulated compared to exponentially 
growing bacteria (Faucher et al., 2011). Inositol might therefore serve the intracellular nutrition 
of L. pneumophila. The LCV is likely accessible for inositol post infection, as the compound 
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promoted intracellular growth when added to the infected cells several hours after the infection 
(see section 4.4). 
Other intracellular pathogens also utilize inositol in context with infection. Mycobacterium spp. 
use inositol to synthesize mycothiol that serves many functions including detoxification and 
protection from oxidative damage. The compound is essential for the bacteria and is discussed as 
an antitubercular drug target (Movahedzadeh et al., 2004; Nilewar and Kathiravan, 2014). 
However, it is unclear whether the bacteria import inositol intracellularly or if they rely on de 
novo synthesis, although inositol transporter activity has been proven for M. smegmatis at least in 
vitro (Movahedzadeh et al., 2004; Newton et al., 2006). S. enterica uses inositol as a source of 
carbon and energy, and it was shown that the metabolism of inositol is regulated by IolR and the 
availability of inositol (Kröger and Fuchs, 2009). In addition, bicarbonate/CO2 acts as a positive 
regulator of inositol catabolism genes in Salmonella, which is believed to be an adaption to a life 
in the gut, where bicarbonate concentrations exceed those that were sufficient to initiate 
transcription of inositol genes. The interplay between IolR and bicarbonate/CO2 supposedly 
assures that inositol concentrations are high enough before gene expression is initiated (Kröger et 
al., 2011). It is not known to date whether S. enterica also metabolizes inositol upon intracellular 
growth or just uses the carbohydrate as an extracellular carbon and energy source. 
Taken together, available evidence indicates that inositol is metabolized by L. pneumophila, 
preferably during intracellular growth, although also extracellular uptake and metabolism of 
inositol was shown. These results extend the proven metabolic capacities of L. pneumophila by 
another carbon source and help to understand the nutrition of Legionella spp. particularly inside 
host cells. 
 
4.2 The Metabolism of Glycerol by Legionella pneumophila 
A defined L. pneumophila deletion mutant lacking the glycerol-3-phosphate dehydrogenase GlpD 
was constructed in this study and used to analyze the metabolism of glycerol under extra- and 
intracellular conditions. As predicted by transcriptome data (Faucher et al., 2011), glycerol had 
no influence on the extracellular growth of wild-type or ∆glpD similar to inositol (see section 
4.1). The glpD mutant exhibited a somewhat longer lag-phase than wild-type bacteria, but 
reached similar optical densities after 48 h growth in different chemically defined media (see 
section 3.2.1). The reason for that might be a disturbed energy balance and/or a disturbed 
phospholipid biosynthesis within the cell. Glycerol-3-phosphate is a precursor for the 
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biosynthesis of phospholipids. The glpD mutant could still produce glycerol-3-phosphate from 
glycerol in the reaction catalyzed by glycerol kinase Lpg1414, which is an ATP consuming 
reaction. In E. coli it was shown that GlpD is a central enzyme at the junction of respiration, 
glycolysis and phospholipid biosynthesis and important for the energy homeostasis of the cell, as 
it is an integral part of the electron transport chain in the inner membrane of E. coli (Yeh et al., 
2008). The conversion of glycerol-3-phosphate to dihydroxyacetone phosphate is not only 
important for glycolysis, but also delivers FADH2 for the respiratory chain. The longer lag-phase 
of L. pneumophila ∆glpD might therefore also reflect a disturbed energy homeostasis, which 
would require certain adaptions to allow efficient cell growth and division. Nothing is known 
about membrane association and regulation of GlpD in L. pneumophila so far. Intracellularly, 
glycerol promoted growth of wild-type L. pneumophila in murine macrophages and 
A. castellanii, which was dependent on GlpD. In competition experiments, the mutant had a 
significant growth disadvantage compared to wild-type, although the mutant was not impaired in 
intracellular growth per se (see section 3.2.1). This suggested that glycerol might preferentially 
be used as an intracellular carbon source by L. pneumophila, but isotopologue profiling showed 
that glycerol was used in later growth phases also in broth, although it did not enhance 
extracellular growth (see section 3.2.1, 3.2.2 and 3.2.3). 
The genomes of L. pneumophila (Cazalet et al., 2004; Chien et al., 2004; Steinert et al., 2007) 
and L. longbeachae (Cazalet et al., 2010; Kozak et al., 2010) encode a complete glycolytic and 
ED pathway, as well as an incomplete PPP lacking 6-phosphogluconate dehydrogenase and the 
transaldolase. Glucose was already described as a carbon substrate for L. pneumophila and is 
preferentially metabolized via the ED pathway (Eylert et al., 2010; Harada et al., 2010). The data 
presented in this thesis now prove activity of the gluconeogenic pathway as well as the PPP, as 
13C-incorporation from labelled glycerol, glucose or serine occurred into mannose and histidine 
(see section 3.2.2 and 3.2.3). Mannose or rather mannose-6-phosphate is derived from fructose-6-
phosphate in the reaction catalyzed by the mannose-6-phsophate isomerase RfbA, and therefore, 
depends on the gluconeogenic production of fructose-6-phosphate, at least with serine and 
glycerol as precursors. An integral enzyme of gluconeogenesis is fructose-1,6-bisphosphatase 
that converts fructose-1,6-bisphosphate to fructose-6-phosphate, which serves as precursor in 
mannose biosynthesis. An enzyme with homology to known fructose-1,6-bisphosphatases is not 
found in the genomes of Legionella spp., and only phosphofructokinase, the enzyme catalyzing 
the forward reaction, is annotated (Cazalet et al., 2004; Chien et al., 2004; Cazalet et al., 2010). 
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Yet, the flow of 13C-label into mannose, especially from serine and glycerol as substrate, and the 
fact that mannose was mainly M+3 and M+6 labelled in all isotopologue experiments indicates 
activity of the gluconeogenic pathway. An earlier study also described that the enzymatic activity 
of fructose-1,6-bisphophatase in L. pneumophila cell extracts was ten-fold higher than that of 
phosphofructokinase, clearly indicating that carbon flow is favorably directed towards 
gluconeogenesis rather than glycolysis (Keen and Hoffman, 1984). Also, when analyzing the 
phosphofructokinase of L. pneumophila, encoded by lpg1913 (alias pfkA), it becomes evident that 
PfkA of L. pneumophila bears homology to eukaryotic and bacterial PfkA enzymes that use 
pyrophosphate rather than ATP as cofactor and are therefore reversible (Arimoto et al., 2002; 
Costa dos Santos et al., 2003). Taken together, the available data suggests that PfkA of 
L. pneumophila might also function as an enzyme catalyzing the forward (glycolytic) as well as 
the reverse (gluconeogenic) reaction between fructose-6-phosphate and fructose-1,6-
bisphosphate. 
Fructose-6-phosphate, together with glyeraldehyde-3-phosphate, is then the central metabolite for 
entry into the PPP, as L. pneumophila does not have a 6-phosphogluconate-deghydrogenase, an 
essential enzyme for the oxidative part of the PPP. Since histidine was found to be 13C-enriched 
in all in vitro isotopologue experiments, the non-oxidative part of the PPP is active, as histidine is 
derived from ribose-5-phosphate. Another enzyme missing in the genome of Legionella spp. is 
the transaldolase enzyme (Cazalet et al., 2004; Chien et al., 2004; Cazalet et al., 2010). Figure 
4.1 shows the essential reactions of the “incomplete” PPP of L. pneumophila and illustrates 
where 13C-label in mannose and histidine was presumably derived from. 
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Figure 4.1: The PPP of L. pneumophila and occurrence of 
13
C-label in mannose and histidine. Shown are 
transketolase reactions (green rectangles) between fructose-6-phosphate and glyceraldehyde-3-phosphate for the 
interconversion of sugars for cell wall biosynthesis and histidine synthesis. 13C-label in mannose-6-phosphate and 
histidine is depicted by colored bars depending on the position and the precursor, the 13C-label was presumably 
derived from. 
Genes: rfbA, mannose-6-phosphate isomerase; rpe, ribulose-5-phosphate epimerase; rpiA, ribulose-5-phosphate 
isomerase; tktA, transketolase.  
 
The transketolase TktA transfers a C2-fragment from fructose-6-phosphate onto glyceraldehyde-
3-phosphate, resulting in erythrose-4- and xylulose-5-phosphate. In another transketolase reaction 
a C2-fragment from xylulose-5-phosphate is transferred onto ribose-5-phosphate, resulting in 
seduheptulose-7-phosphate and glyceraldehyde-3-phosphate (Figure 4.1). As ribose-5-phosphate 
cannot be made from glucose-6-phosphate in L. pneumophila, because of the missing 
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6-phosphogluconate-dehydrogenase, it is presumably synthesized from xylulose-5-phosphate in 
the reactions of ribulose-5-phosphate epimerase (Rpe) and isomerase (RpiA). This non-oxidative 
branch of the PPP is sufficient for the interconversion of sugars that are needed for the synthesis 
of cell wall components, purines and pyrimidines, but cannot provide NADPH/H+. However, as 
L. pneumophila employs the ED pathway for glucose catabolism (Eylert et al., 2010; Harada et 
al., 2010), the bacteria can synthesize NADPH/H+ via this pathway. 
In all isotopologue profiling experiments, at least with 13C-glycerol and 13C-glucose as 
precursors, histidine was mainly M+2 and M+3 labelled, indicating that either two or three 
C-atoms were labelled (see section 3.2.2. and 3.2.3). To a lesser extent also a fraction of M+5 
labelled histidine appeared. Figure 4.1 shows where these entities of labelled histidines were 
derived from. With 13C-glycerol as precursor, a part of the intracellular pool of glyceraldehyde-3-
phosphate will be fully labelled (M+3). Fructose-6-phosphate might be unlabeled, or M+3 or 
M+6 labelled, depending on the label of glyceraldehyde-3-phosphate and dihydroxyacetone 
phosphate. M+3-label in histidine is then presumably derived from fully labelled glyceraldehyde-
3-phosphate and unlabeled fructose-6-phosphate, resulting in three labelled carbon atoms in 
ribose-5-phosphate (Figure 4.1, red line). M+2 labelled histidine is derived from unlabeled 
glyceraldehyde-3-phosphate and fructose-6-phosphate, which has been M+3-labelled at the 
C-atoms that are transferred in the reaction of the transketolase and further onto ribose-5-
phosphate in the reactions of the ribulose-5-phosphate epimerase and isomerase (Figure 4.1, blue 
line). The fraction of M+5 labelled histidine then is a combination of fully labelled 
glyceraldehyde-3-phosphate and M+3 labelled fructose-6-phosphate (Figure 4.1). Mannose was 
mainly M+3 and M+6 labelled in all isotopologue profiling experiments. The label is simply 
derived from M+3 or M+6 labelled fructose-6-phosphate, which is converted to mannose-6-
phosphate by RfbA (Figure 4.1). 
When the glpD mutant was grown in vitro with 13C-glycerol as substrate, the only metabolite that 
was found to be significantly enriched was lactate (see section 3.2.2). This effect was 
independent of GlpD, as neither histidine nor mannose, that were both 13C-enriched in the wild-
type, nor were any other metabolites enriched in the mutant. A possible explanation for this might 
be the formation of methylglyoxal from glycerol. In Enterobacteriaceae, two glycerol 
assimilatory pathways exist (Subedi et al., 2008). One that involves the phosphorylation of 
glycerol to glycerol-3-phosphate by a glycerol kinase, followed by the conversion of glycerol-3-
phosphate to dihydroxyacetone phosphate catalyzed by a glycerol-3-phosphate dehydrogenase. In 
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L. pneumophila these reactions are catalyzed by lpg1414 and glpD respectively (Figure 4.2). The 
second pathway consists of the glycerol dehydrogenase GldA that forms dihydroxyacetone from 
glycerol, which is then phosphorylated to dihydroxyacetone phosphate in a kinase reaction. 
Furthermore, dihydroxyacetone can be converted non-enzymatically to methylglyoxal within the 
cell (Subedi et al., 2008). Methylglyoxal is a byproduct of different metabolic pathways and can 
also be generated non-enzymatically from glyceraldehyde-3-phosphate or dihydroxyacetone 
phosphate (Riddle and Lorenz, 1973; Cooper, 1984).  
 
 
 
Figure 4.2: Proposed metabolism of methylglyoxal by L. pneumophila. Methylglyoxal is a toxic metabolite that 
can be derived non-enzymatically from dihydroxyacetone phosphate, glyceraldehyde-3-phosphate or 
dihydroxyacetone. To detoxify methylglyoxal the compound  is converted to lactate by the glyoxalase system. In 
L. pneumophila ∆glpD, methylglyoxal could be derived from dihydroxyacetone directly made from glycerol, 
catalyzed by a glycerol dehydrogenase (supposedly lpg2250) (Published in Häuslein, Manske et al., 2015). 
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As methylglyoxal is toxic, it is converted to lactate by the glyoxalase system (Figure 4.2) 
(Cooper, 1984). The protein Lpg2250 of L. pneumophila is annotated as alcohol dehydrogenase 
with 27% identity to E. coli GldA and might be responsible for the formation of 
dihydroxyacetone in ∆glpD. Also, genes for both enzymes of the glyoxalase system (gloA and 
lpg1295) are present in the genome of L. pneumophila, which would explain the flow from 
glycerol into lactate in the ∆glpD mutant (Figure 4.2). 
 
4.3 The Bipartite Metabolism of Legionella pneumophila 
The metabolism of glycerol was also compared to that of other carbon sources, namely glucose 
and serine under in vitro growth conditions. Earlier studies already indicated that serine is the 
preferred carbon substrate for L. pneumophila (George et al., 1980; Eylert et al., 2010), which 
was also confirmed in this work. The amount of 13C-incorporation from 13C-serine was the 
highest in all experiments compared to experiments with 13C-glycerol and 13C-glucose (see 
section 3.2.3), which showed the preference for this carbon source. Also, glucose was readily 
used as a carbon source by L. pneumophila, but glycerol was only used in later growth stages, as 
incorporation of 13C-label was only found after 36 h and 48 h extracellular growth (see section 
3.2.2 and 3.2.3). Under extracellular growth conditions, glycerol seems to play only a minor role 
for L. pneumophila metabolism, while glucose and especially serine are preferred carbon sources. 
The ratio of 13C-excess in histidine as marker of the PPP and alanine as marker of the energy-
generating lower part of glycolysis and the flow into the TCA cycle was calculated (see section 
3.2.5), and it was found that glycerol and glucose were predominantly used as carbon sources for 
gluconeogenesis and the PPP, while carbon flow from serine was mainly restricted to the lower 
parts of glycolysis and the TCA cycle. These findings indicate that the metabolic fate of certain 
carbon sources is restricted to certain pathways resulting in a bipartite metabolism of 
L. pneumophila (Figure 4.3). 
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Figure 4.3: The bipartite metabolism of L. pneumophila. The metabolism of L. pneumophila is divided into two 
modules. Module 1 containing the ED pathway, gluconeogenesis and the PPP (red/blue rectangle) and module 2 
containing the TCA cycle (green cycle), amino acid (AA) and fatty acid (FA) synthesis. The thick colored arrows 
represent the main routes of carbon flow from glucose (blue), glycerol (red) and serine (green). The flow from 
glucose and glycerol is mainly restricted to the upper part of metabolism in module 1, while serine is mainly used in 
the lower energy-generating parts of metabolism in module 2. Glucose and serine do also play a minor part in 
module 2 (dotted blue arrow) or module 1 (dotted green arrow), respectively (Published in Häuslein, Manske et 
al., 2015). 
Abbreviations: 6-PG, 6-phosphogluconate; KDPG, 2-keto-3-desoxy-phosphogluconate; PPP, pentose phosphate 
pathway; PHB, poly-hydroxybutyrate; TCA, tricarbolic acid pathway; α-KGA, α-ketoglutaric acid; DAP, 
diaminopimelic acid. 
Genes: tktA, transketolase; rpe, ribulose-5-phosphate-epimerase; rpiA, ribulose-5-phosphate-isomerase; lpg1414, 
glycerol kinase; glpD, glycerol-3-phosphate dehydrogenase. 
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According to this model, the central carbon metabolism of L. pneumophila can be divided into 
two modules, of which module 1 comprises the ED pathway, the PPP and gluconeogenesis. This 
module provides NADPH/H+ from reactions of the ED pathway, as well as precursors for 
anabolic reactions, essential for the synthesis of cell wall components, nucleotides, histidine and 
aromatic amino acids. Module 2 comprises the lower part of the glycolytic pathway, as well as 
the TCA cycle and provides precursors for aliphatic amino acids as well as fatty acids and lipids. 
Importantly, module 2 is the major energy-generating part of metabolism. ATP is synthesized by 
substrate phosphorylation in the dehydration of glyceraldehyde-3-phosphate to 
3-phosphoglycerate and in the reaction of pyruvate kinase resulting in pyruvate. Furthermore, the 
TCA cycle supplies the cell with NADH/H+ and FADH2, which are used to synthesize ATP by 
oxidative phosphorylation via aerobic respiration. Accordingly, module 2 is the major energy 
providing part of metabolism, while module 1 is mainly energy-consuming, but essential for cell 
wall biosynthesis and hence cell division and proliferation. The experimental data presented here 
indicate that glucose and glycerol mainly serve module 1, while carbon flow from serine is 
mainly restricted to module 2 (Figure 4.3). Although this model is mainly based on data obtained 
from in vitro growth assays, in vivo data also support a bipartite intracellular metabolism of 
L. pneumophila (see section 3.2.6). Addition of 13C-glycerol to infected A. castellanii resulted in 
a GlpD-dependent incorporation of 13C-label into mannose. The same was observed with 
13C-glucose as precursor, but not with 13C-serine, where incorporation of 13C-label occurred into 
amino acids, DAP and PHB but not into mannose. These findings indicate that the concept of a 
bipartite metabolism might also apply for intracellularly growing L. pneumophila. 
At this point, it can only be speculated whether and how inositol fits into this model. Since 
13C-inositol is commercially not available, isotopologue profiling experiments could not be 
performed. Inositol presumably would enter central carbon metabolism at the stages of 
dihydroxyacetone-phosphate and acetyl-CoA, which would have been shuffled into the TCA 
cycle and used for fatty acid synthesis. Dihydroxyacetone-phosphate could be used both for 
gluconeogenesis, but also for energy generation. 
The concept of a modular metabolism seems to apply both for extracellular and intracellular 
growing L. pneumophila. Accordingly, glycerol might then also in vivo be used in later stages of 
intracellular growth, based on results obtained from in vitro experiments. At late stages of 
infection, the bacteria will switch from the replicative to the transmissive growth phase, lyse the 
LCV and eventually the host cell. The disintegration of host cell membranes through secreted 
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phospholipases might then also be the source of intracellular glycerol (Lang and Flieger, 2011). 
Other possible intracellular sources of glycerol will be discussed in section 4.4. 
Noteworthy, a modular metabolism is also employed by other intracellular bacterial pathogens 
(Figure 4.4). L. pneumophila uses serine for energy generation in the lower parts of glycolysis 
and the TCA cycle, while glycerol and glucose are employed for gluconeogenesis and the PPP 
(Figure 4.4 A). Listeria monocytogenes, an intracellular pathogen that dwells in the host cell 
cytoplasm, can grow on different nutrients as sole source of carbon and energy in vitro, including 
glucose and glycerol (Schneebeli and Egli, 2013). L. monocytogenes can import amino acids 
from the host cell, but only uses them directly for protein synthesis (Grubmüller et al., 2014). The 
major carbon sources for intracellularly growing Listeria seem to be glycerol and glucose-6-
phosphate, with glycerol being used mainly in the lower parts of glycolysis and the TCA cycle 
for energy generation and glucose-6-phosphate mainly in the PPP. Glucose, if at all, is only used 
to a minor extent, and glucose-6-phosphate is the preferred carbon substrate of L. monocytogenes 
(Grubmüller et al., 2014) (Figure 4.4 B). Similar to Legionella, Listeria also exhibits a bipartite 
metabolism, but this example also shows how a carbon substrate might be metabolized by 
different modules depending on the microorganism. 
M. tuberculosis, the causative agent of tuberculosis, also exhibits a modular metabolism. In vitro 
studies showed that co-catabolism of different substrates occurs and that depending on the 
substrate combination the metabolic fate of these nutrients is defined (de Carvalho et al., 2010). 
M. tuberculosis metabolizes glucose, glycerol and acetate at least under in vitro conditions. When 
fed with glucose and acetate, glucose is preferentially metabolized in the PPP and early steps of 
the glycolytic pathway, while acetate is mainly fed into the TCA cycle. The metabolic fate of 
glycerol, on the other hand, is dependent on its nutrient partner. When co-catabolized with 
glucose, the flow of carbon from glycerol is mainly directed towards the TCA cycle. However, 
when metabolized together with acetate, the flow is directed towards gluconeogenesis and the 
PPP (de Carvalho et al., 2010) (Figure 4.4 C). The major carbon source during intracellular 
growth is a C2-body, which presumably is acetate or acetyl-CoA, derived from β-oxidation of 
host lipids (Beste et al., 2013). Furthermore, glycolytic C3-compounds were shown to be carbon 
sources for M. tuberculosis. 
 
 
 
4.  Discussion 
 
126 
 
 
 
 
Figure 4.4: The modular metabolism of 
different intracellular pathogens. Comparison 
of central carbon metabolism of L. pneumophila 
(A), L. monocytogenes (B) and M. tuberculosis 
(C). Preferential flow of glucose (blue), glycerol 
(red), serine (green) and acetate (dark blue) 
into distinct pathways is indicated by thick 
colored arrows. 
Abbreviations: PPP, pentose phosphate 
pathway; TCA, tricarbolic acid pathway. 
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These C3-compounds could be derived from amino acids imported from the host cell, but also 
glycerol or glycerol-3-phosphate were discussed as potential carbon sources in vivo. Similar to 
extracellular growth, co-metabolism of different substrates is also occurring in vivo with 
preferential use of different carbon sources for certain pathways (Beste et al., 2013).  
Another pathogen, S. enterica, was also found to exploit a large number of different host 
nutrients in parallel in infected tissues with glycerol being the major carbon source for in vivo 
based on proteomic analysis (Steeb et al., 2013). Furthermore, also during intracellular growth, 
the bacteria seem to access and rely on several carbon sources for parallel exploitation (Steeb et 
al., 2013). Currently, no detailed flux analysis for intracellular growing S. enterica is available, 
and it is not known, whether these carbon sources are used for fixed metabolic pathways or not. 
Taking together all these findings, the concept of a modular metabolism appears to be a general 
concept for pathogens when replicating within their host cells. 
It is striking that glucose or glucose-6-phosphate always seems to be used preferentially through 
the PPP by Legionella and Listeria as well as by Mycobacterium. For L. pneumophila, a 
metabolic strategy, which relies on amino acids as substrates for energy generation and that uses 
carbohydrates like glucose mainly for anabolic purposes might put less nutritional stress on the 
host cell, thus allowing successful and prolonged infection compared to bacteria that would rely 
on glucose as substrate for energy generation. A reason for this might be that the intracellular 
level of glucose is a regulator for apoptosis in eukaryotes (Zhao et al., 2008). Apoptosis is 
initiated through two primary pathways: the mitochondrial, also called intrinsic, pathway and the 
death receptor, also called extrinsic, pathway (Danial and Korsmeyer, 2004). Glucose was found 
to directly affect the intrinsic pathway of apoptosis (Zhao et al., 2008). As long as intracellular 
levels of glucose are normal, anti-apoptotic proteins of the Bcl-2 family prevent cell death. If the 
intracellular levels of glucose are disturbed, the levels of Bcl-2 regulators decrease (Alves et al., 
2006; Zhao et al., 2007) and pro-apoptotic proteins are activated (Chi et al., 2000). Apparently, 
the status of glucose metabolism also changes prior to cell death (Zhao et al., 2008). The usage of 
glucose by intracellular pathogens in large amounts would therefore counteract the goal of a 
successful and prolonged infection of the host cell. This notion is supported by experimental data: 
L. monocytogenes and enteroinvasive E. coli both replicate inside the host cell cytoplasm, but use 
glucose for anabolic reactions (L. monocytogenes) or as main substrate for intracellular 
replication (E. coli). Interestingly, E. coli kills the same host cell much faster then 
L. monocytogenes (Götz et al., 2010; Grubmüller et al., 2014). The strategy of a bipartite 
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metabolism seems therefore to be a good adaption of L. pneumophila and other intracellular 
pathogens to an intracellular life-style. 
 
4.4 Substrate Uptake into LCVs 
It was shown in this study that L. pneumophila is able to metabolise glycerol and inositol in vitro 
and in vivo, and it was already known that the bacteria use amino acids, especially serine, and 
glucose as carbon sources (Eylert et al., 2010; Harada et al., 2010; Schunder et al., 2014). The 
prerequisite for the in vivo metabolism of different substrates is the accessibility of the LCV for 
nutrients from the host cell cytoplasm, but also for substrates added from the outside to the host. 
L. pneumophila exploits eukaryotic amino acid transporters to facilitate amino acid uptake into 
the LCV (Wieland et al., 2005). The transporter SLC1A5, which transports serine (Colas et al., 
2015), together with solute carrier proteins of the SLC7 family, are found in the proteome of 
purified LCVs and might facilitate the uptake of serine and other amino acids into the LCV 
lumen (Hoffmann et al., 2014a). Upon intracellular growth of L. pneumophila, many different 
amino acids are taken up from the host (Schunder et al., 2014), which are then imported into the 
bacterial cell by one of the various amino acid transporters (see section 1.2.1). In particular, 
serine is transported into the bacterial cell by the transporter SdaC (Figure 4.5).  
This work now provides evidence that glycerol and glucose added to infected cells can directly 
reach the bacteria inside the LCV and are used as carbon source by intracellular L. pneumophila. 
These results suggest that the LCV is accessible also for other carbon sources. However, the 
mode of uptake for these substrates is not clear. Glycerol could enter the host cell via diffusion or 
transport. Transport can be facilitated through aquaglyceroporines, which are common 
transporters in eukaryotes that take up water and glycerol. Interestingly, these porines were 
recently also shown to be involved in innate immunity (Zhu et al., 2011). The proteome of 
purified LCVs suggests that not glycerol but rather glycerol-3-phosphate might be more 
important for L. pneumophila in vivo, since the eukaryotic glycerol kinase (Gk) was identified in 
the LCV proteome. Gk could phosphorylate cytoplasmic glycerol to glycerol-3-phosphate, which 
subsequently might be transported by solute carriers of the SLC37 family that are also found in 
the proteome of LCVs (Hoffmann et al., 2014a). Furthermore, in the genome of L. pneumophila 
only a glycerol-3-phosphate transporter (GlpT) is annotated, suggesting that the bacteria may 
transport glycerol-3-phosphate rather than glycerol. Another possibility of making glycerol 
available inside the host might be the exploitation of vesicular bodies by L. pneumophila. Lipid 
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bodies (LBs) are intracellular organelles that are found in all cell types and exhibit a distinctive 
architecture. LBs consist of a core containing triacylglycerols and sterolesters surrounded by a 
phospholipid hemimembrane with associated proteins (Tauchi-Sato et al., 2002). These 
organelles were mainly associated with lipid storage in the past, but are now recognized as being 
involved in a variety of functions within the eukaryotic cell (Melo and Dvorak, 2012). LBs can 
fuse with several intracellular organelles including the phagosomes in cells of the immune system 
(Melo and Dvorak, 2012). Remarkably, Mycobacterium bovis and other Mycobacterium species 
were found to actively increase LB formation within their host cells (D'Avila et al., 2006) and 
LBs as source of nutrients for the pathogens have been discussed (Peyron et al., 2008; Mattos et 
al., 2011; Barisch et al., 2015). Whether LBs fuse with LCVs is not known, but it is imaginable 
that LBs could also constitute a nutrient source for L. pneumophila. The triacylglycerols released 
into the LCV lumen could be hydrolysed by type-II secreted phospholipases of L. pneumophila 
(Lang and Flieger, 2011), thus releasing fatty acids and glycerol inside the LCV (Figure 4.5). 
Secreted effector proteins of L. pneumophila could also play a role in the acquisition of inositol. 
LppA is a type-IV-translocated phytase of L. pneumophila that functions as a hexakisphosphate 
inositol (phytate) phosphatase in infected phagocytes (Weber et al., 2014a). Phytate is a major 
phosphorus storage compound in plants and the most abundant organic phosphorus compound in 
the environment (Turner et al., 2002). Furthermore, an L. pneumophila host amoeba, 
D. discoideum, produces phytate in millimolar quantities (Stephens and Irvine, 1990). Phytate is a 
strong chelator of iron, resistant to hydrolysis and could be used as an intracellular bacteriostatic 
component, by depriving intracellular pathogens of iron. LppA might promote intracellular 
replication by removing phytate and making iron available to L. pneumophila inside the cell 
(Weber et al., 2014a). Dephosphorylation of phytate might not only release iron, but would also 
yield inositol-phosphates or inositol, the sugar backbone of phytate, to be used by the bacteria. 
Inositol can also be taken up from the environment or be synthesized from glucose (Fischbach et 
al., 2006). Humans synthesize inositol especially in the kidney in amounts of up to 4 g per day, 
and the highest amounts are found in the brain (Castillo et al., 2000; Parthasarathy et al., 2006). 
Inositol transporters of the solute carrier family 5 and family 2 facilitate uptake of inositol in 
mammalian cells (Klaus et al., 2008) and perhaps, also into the LCV. IolT could then import 
inositol from the LCV lumen into the bacterial cell (Figure 4.5). 
The data presented here also show the direct uptake and metabolism of glucose by 
L. pneumophila growing intracellularly (see section 3.2.6). Glucose is taken up into eukaryotic 
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cells by members of the Slc2 family of solute carriers (Mueckler and Thorens, 2013) or other 
major facilitators (Wright et al., 1994). Solute carrier proteins are found in the plasma membrane 
of all eukaryotic cells (Palmada et al., 2006). The proteome of purified LCVs revealed that also 
glucose transporters are incorporated into the LCV membrane, for example SLC2A1 (Glut1) and 
SLC2A6 (Glut6). Interestingly, besides these two glucose transporters, also SLC37A2 is found in 
the proteome of purified LCVs (Hoffmann et al., 2014a). SLC37A2 is a phosphate-linked 
glucose-6-phosphate antiporter (Pan et al., 2011) that could be used by L. pneumophila to 
transport glucose-6-phosphate into the LCV. As suggested in the present work, phosphorylated 
carbohydrates might be the preferred carbon source for L. pneumophila (see section 3.2.4), which 
corresponds to the acquisition of sugar-phosphate transporters and phosphorylating enzymes (see 
above) into the LCV membrane. Furthermore, the genome of L. pneumophila only encodes the 
hexose-phosphate transporter UhpC, which, for example, is used by the intracellular pathogen 
Chlamydia pneumoniae to transport glucose-6-phosphate (Schwoppe et al., 2002). Also, 
L. monocytogenes relies on glucose-6-phosphate as substrate for intracellular growth (see section 
4.3). Thus, perhaps also L. pneumophila exploits both, glucose and glucose-6-phosphate, upon 
intracellular growth (Figure 4.5). 
The uptake of these substrates seems to be at least partially dependent on a functional Icm/Dot 
type IV secretion system. A fluorescent glucose analogue (2-NBDG) was found to be taken up 
into a high percentage of LCVs harbouring wild-type bacteria or inositol metabolism mutants. An 
icmT mutant on the other hand showed 50 % reduced uptake of 2-NBDG (see section 3.3.5). 
2-NBDG has been used to study glucose uptake and metabolism in different organisms, including 
E. coli (Natarajan and Srienc, 1999), yeast (Oh and Matsuoka, 2002), neurons (Itoh et al., 2004) 
and cancer cell lines (Cheng et al., 2006) and is presumably transported by canonical glucose 
transporters of the cell (Yamada et al., 2000). Import into wild-type LCVs could therfore be 
mediated through acquisition of host cell transporters via fusion of the LCV with ER exit site 
vesicles, which is happening shortly after bacterial uptake (Kagan and Roy, 2002). This vesicular 
fusion is dependent on the Icm/Dot T4SS, as vacuoles containing icm/dot mutants do not acquire 
ER vesicles as wild-type LCVs do (Kagan and Roy, 2002). The processes that lead to the fusion 
with these ER exit site vesicles are dependent on small GTPases and the non-canonical pairing of 
plasma membarane-derived t-SNARES with the ER-resident v-SNARE Sec22b (Arasaki and 
Roy, 2010; Finsel and Hilbi, 2015). The type IV-secreted effector protein SidM is responsible for 
this non-canonical SNARE fusion through activation of the small GTPase Rab1 (Arasaki et al., 
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2012). Other effector proteins are also involved in the acquisition of ER-derived vesicles. The 
L. pneumophila effector protein LseA shows close homology to eukaryotic Qc-SNARE receptor 
family and is presumably a mediator of membrane fusion in Golgi-associated pathways (King et 
al., 2015).  
 
Figure 4.5: Nutrient uptake of L. pneumphila inside host cells. L. pneumophila has several ways to take up 
substrates inside its host. Serine is imported into the cell by solute carrier proteins (orange) of the Slc1 and Slc7 
family, which have been identified on the LCV. SdaC is used as bacterial serine transporter. Glycerol can enter the 
cell via diffusion, aquaglyceroporines (red) or solute carrier (green) that could also transport glycerol-3-phosphate, 
which subsequently might be taken up by the bacteria with the transporter GlpT. Glucose is imported by several 
solute carrier transporters (green) and could reach the bacteria in form of glucose-6-phosphate or 
unpohosphorylated. The genome of L. pneumophila only harbours the glucose-6-phosphate transporter UhpC. 
Inositol can be derived from de novo synthesis with glucose as precursor, from transport via solute carrier (green) or 
from the dephosphorylation of phytate by the L. pneumophila type IV-secreted effector LppA. Import into the 
bacterial cell might be facilitated by IolT. Uptake of nutrients could also occur by fusion of lipid bodies (LB) with 
the LCV or macropinocytotic events (MP). 
Abbreviations: Gk, glycerol kinase; LB, lipid body; LCV, Legionella-containing vacuole; Lpn, Legionella 
pneumophila; MP; macropinosome; T4SS, type IV secretion system. 
 
 
4.  Discussion 
 
132 
 
A large number of effector proteins are also part of this interaction with the secretory pathway 
and the ER, for example by accumulating the lipid PtdIns(4)P in the LCV membrane and thus 
anchoring other effector proteins to the LCV (Weber et al., 2014b; Finsel and Hilbi, 2015). An 
icm/dot mutant obviously cannot translocate all these effector proteins, as it does not possess a 
functional T4SS. This could explain the reduced number of 2-NBDG-positive LCVs in the icmT 
mutant used in this study, as the mutant strain would be unable to redirect host cell transporters to 
the LCV. For heterotrophic plant cells it was shown that 2-NBDG, and therefore likely glucose as 
well, can also be taken up by endocytic processes and end up in vesicles and vacuoles (Etxeberria 
et al., 2005). Thus, endocytic processes like macropinocytosis, could also explain how 2-NBDG 
might reach L. pneumophila inside the host cell. D. discoideum, the host cell that was used here 
to test uptake of 2-NBDG, is able to take up fluid-phase material via macropinocytosis (Hacker et 
al., 1997) and could therefore also take up 2-NBDG through this process. Interestingly, 
macropinocytosis was recently also associated with the metabolism in cancer cells, as these cells 
upregulate macropinocytosis to take up and degrade proteins as amino acid supply (Commisso et 
al., 2013). Macropinocytosis or other endocytic processes might explain how nutrients are 
delivered to L. pneumophila inside the LCV, especially since our in vivo isotopologue profiling 
experiments showed that the substrates used reached the bacteria presumably unmetabolized (see 
section 3.2.6). Also other, yet unknown, substrates for L. pneumophila might reach the bacteria 
via this route (Figure 4.5). 
Taken together, numerous ways of uptake of different nutrients into the LCV likely exist, but 
they are far from being understood. Further efforts have to be taken to fully grasp the metabolic 
capacities that are available for L. pneumophila inside its host cell. 
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4.5 Concluding Remarks 
 
The metabolism of L. pneumophila still remains a rather uncharted field, and not much is known 
about the nutrition of the bacteria, especially in vivo. In this study, a new Legionella growth 
medium was developed and used to investigate the metabolism of inositol and glycerol in vitro 
and in vivo, as well as upon co-metabolism with the known substrates serine and glucose. The 
finding that glycerol and glucose were preferentially used for gluconeogenesis or in the upper 
parts of glycolysis, respectively, and serine was preferentially used for energy generation 
uncovered that L. pneumophila operates a bipartite metabolism. This concept might be a 
paradigm for intracellular pathogens and seems to be employed to dodge host cell defense 
programs, otherwise triggered by interfering with central host carbon metabolism. Inositol was 
found to be metabolized by L. pneumophila presumably also in vivo. The carbohydrate enhanced 
intracellular growth of L. pneumophila. Furthermore, the expression of the iol cluster was 
regulated by the sigma factor RpoS as well as by nutrient availability.  However, the regulation of 
metabolic processes and the modes of substrate uptake inside the host cell still demands further 
research. The insights gained thus far might also help to find new therapies for L. pneumophila, 
as the metabolism of pathogens is arising as a promising novel target for developing new and 
efficient treatments against pathogens (Murima et al., 2014).  
Further efforts should therefore be taken to fully grasp the metabolic interplay between 
L. pneumophila and its host cells, because “it is only by understanding the true behavior and 
requirements of the bacteria when growing in vivo that we shall learn how to prevent their 
multiplication and, hopefully, how to cause their death” (Ratledge, 1976). 
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Table 5.1: Retention time (RT) and mass fragments of derivatized metabolites used for isotopologue 
calculations. 
 
Metabolite RT  [min] [M-15]+ [M-57]+ [M-85]+ 
Ala 6.7  m/z 260  
Gly 7.0  m/z 246  
Val 8.5  m/z 288  
Leu 9.1   m/z 274 
Ile 9.5   m/z 274 
Pro 10.1   m/z 258 
Ser 13.2  m/z 390  
Phe 14.5  m/z 336  
Asp 15.4  m/z 418  
Glu 16.8  m/z 432  
Lys 18.1  m/z 431  
His 20.4  m/z 432  
Tyr 21.0  m/z 466  
DAP 6.3  m/z 589  
PHB 9.1 m/z 233   
Lactate 17.8  m/z 261  
3-Hydroxybutyric acid 21.6  m/z 275  
Succinic acid 27.5  m/z 289  
Fumaric acid 28.7  m/z 287  
Malic acid 39.1  m/z 419  
Palmitic acid 44.0  m/z 313  
Stearic acid 49.4  m/z 341  
Citric acid 53.3  m/z 591  
Mannose 8.7 m/z 287   
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Table 5.2: 13C-Excess (mol%) from [U-13C3]glycerol at 48 h. 
13C-Excess (mol%) of amino acids, DAP, PHB, polar 
metabolites and mannose from experiments with L. pneumophila wild-type and ∆glpD grown in MDM 
supplemented with 50 mM [U-13C3]glycerol for 48 h. Mean and standard deviation from three independent 
experiments are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 mM [U-13C3]glycerol L. pneumophila WT L. pneumophila ∆glpD 
Ala 0.34% ± 0.04% 0.23% ± 0.21% 
Asp 0.36% ± 0.05% 0.12% ± 0.02% 
Glu 0.55% ± 0.03% 0.20% ± 0.04% 
Gly 0.11% ± 0.04% 0.08% ± 0.02% 
His 3.01% ± 0.05% 0.06% ± 0.03% 
Ile 0.09% ± 0.01% 0.07% ± 0.02% 
Leu 0.01% ± 0.00% 0.01% ± 0.00% 
Lys 0.39% ± 0.02% 0.12% ± 0.01% 
Phe 0.07% ± 0.01% 0.06% ± 0.01% 
Pro 0.18% ± 0.01% 0.09% ± 0.01% 
Ser 0.10% ± 0.01% 0.12% ± 0.03% 
Tyr 0.10% ± 0.02% 0.08% ± 0.02% 
Val 0.12% ± 0.01% 0.13% ± 0.04% 
DAP 0.74% ± 0.09% 0.17% ± 0.08% 
PHB 0.12% ± 0.06% 0.00% ± 0.00% 
Lactate 0.97% ± 0.20% 0.71% ± 0.29% 
3-Hydroxybutyric acid 0.61% ± 0.05% 0.22% ± 0.06% 
Succinic acid 0.24% ± 0.03% 0.09% ± 0.02% 
Fumaric acid 0.32% ± 0.03% 0.15% ± 0.07% 
Malic acid 0.70% ± 0.16% 0.29% ± 0.05% 
Palmitic acid 0.15% ± 0.01% 0.07% ± 0.02% 
Stearic acid 0.60% ± 0.05% 0.44% ± 0.06% 
Citric acid 0.21% ± 0.03% 0.17% ± 0.01% 
Mannose 5.75% ± 0.65% 0.12% ± 0.08% 
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Table 5.3: Relative fractions of isotopologues (%) from [U-
13
C3]glycerol at 48 h. Relative fractions of 
isotopologues (%) of histidine, lactate and mannose from L. pneumophila wild-type and ∆glpD grown in MDM 
supplemented with 50 mM [U-13C3]glycerol for 48 h. M+x represents the mass of the unlabeled metabolite plus x 
labeled 13C-atoms. Mean and standard deviation from three independent experiments are shown. 
 
L. pneumophila WT + 50 mM [U-13C3]glycerol 
 
His Lactate Mannose 
M+1 21.5% ± 2.61% 0.00% ± 0.00% 17.93% ± 1.05% 
M+2 39.5% ± 0.69% 2.78% ± 2.67% 16.42% ± 2.23% 
M+3 24.6% ± 0.8% 97.12% ± 19.66% 45.47% ± 4.86% 
M+4 4.6% ± 0.31% 
 
6.10% ± 0.97% 
M+5 10.00% ± 0.72% 
 
5.52% ± 1.40% 
M+6 0.00% ± 0.00% 
 
8.57% ± 1.56% 
L. pneumophila ∆glpD + 50 mM [U-13C3]glycerol 
  
Lactate 
 
M+1 
 
0.00% ± 0.00% 
 
M+2 
 
2.78% ± 3.57% 
 
M+3 
 
97.22% ± 40.36% 
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Table 5.4: Kinetics of 13C-excess (mol%) from [U-13C3]glycerol. 
13C-excess (mol%) of amino acids, DAP, PHB, 
polar metabolites and mannose from time series experiments with L. pneumophila wild-type grown in CE MDM 
supplemented with 50 mM [U-13C3]glycerol. 
 
 
 
 
 
 
 
50 mM [U-13C3]glycerol 12 h 24 h 36 h 48 h 
Ala 0.36% ± 0.13% 0.37% ± 0.06% 0.54% ± 0.06% 0.61% ± 0.08% 
Asp 0.37% ± 0.04% 0.28% ± 0.07% 0.48% ± 0.01% 0.49% ± 0.03% 
Glu 0.68% ± 0.05% 0.55% ± 0.04% 0.74% ± 0.01% 0.77% ± 0.02% 
Gly 0.44% ± 0.16% 0.41% ± 0.21% 0.32% ± 0.18% 0.38% ± 0.15% 
His 0.33% ± 0.11% 0.66% ± 0.03% 2.70% ± 0.02% 3.00% ± 0.05% 
Ile 0.19% ± 0.02% 0.20% ± 0.04% 0.16% ± 0.01% 0.19% ± 0.03% 
Leu 0.11% ± 0.02% 0.05% ± 0.02% 0.10% ± 0.05% 0.03% ± 0.03% 
Lys 0.12% ± 0.03% 0.13% ± 0.03% 0.36% ± 0.02% 0.46% ± 0.01% 
Phe 0.17% ± 0.02% 0.20% ± 0.08% 0.18% ± 0.04% 0.15% ± 0.06% 
Pro 0.09% ± 0.04% 0.15% ± 0.02% 0.31% ± 0.03% 0.31% ± 0.02% 
Ser 0.10% ± 0.07% 0.17% ± 0.05% 0.13% ± 0.06% 0.14% ± 0.06% 
Tyr 0.12% ± 0.03% 0.19% ± 0.02% 0.10% ± 0.04% 0.24% ± 0.07% 
Val 0.05% ± 0.02% 0.05% ± 0.05% 0.03% ± 0.01% 0.03% ± 0.03% 
DAP 0.27% ± 0.03% 0.25% ± 0.07% 0.72% ± 0.15% 0.80% ± 0.05% 
PHB 0.42% ± 0.03% 0.27% ± 0.19% 0.29% ± 0.12% 0.52% ± 0.17% 
Lactate    1.44% ± 0.05% 
3-Hydroxybutyric acid    0.41% ± 0.06% 
Succinic acid    0.22% ± 0.01% 
Fumaric acid    0.29% ± 0.03% 
Malic acid    0.55% ± 0.14% 
Palmitic acid    0.19% ± 0.02% 
Stearic acid    0.30% ± 0.01% 
Citric acid    0.08% ± 0.01% 
Mannose    4.51% ± 0.12% 
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Table 5.5: Kinetics of 13C-excess (mol%) from [U-13C6]glucose. 
13C-Excess (mol%) of amino acids, DAP, PHB, 
polar metabolites and mannose from time series experiments with L. pneumophila wild-type grown in CE MDM 
supplemented with 11 mM [U-13C6]glucose. 
 
11 mM  [U-13C6]glucose 12 h 24 h 36 h 48 h 
Ala 1.44% ± 0.03% 2.25% ± 0.02% 3.57% ± 0.10% 4.26% ± 0.07% 
Asp 0.88% ± 0.02% 1.32% ± 0.07% 2.31% ± 0.03% 2.61% ± 0.04% 
Glu 0.94% ± 0.03% 1.30% ± 0.02% 2.08% ± 0.03% 2.36% ± 0.01% 
Gly 0.39% ± 0.05% 0.40% ± 0.03% 0.39% ± 0.06% 0.50% ± 0.04% 
His 9.16% ± 0.08% 15.15% ± 0.04% 18.74% ± 0.05% 20.72% ± 0.01% 
Ile 0.21% ± 0.02% 0.20% ± 0.01% 0.22% ± 0.01% 0.25% ± 0.01% 
Leu 0.00% ± 0.00% 0.37% ± 0.33% 0.15% ± 0.02% 0.34% ± 0.36% 
Lys 0.71% ± 0.00% 1.46% ± 0.04% 2.47% ± 0.05% 2.73% ± 0.04% 
Phe 0.13% ± 0.02% 0.15% ± 0.03% 0.17% ± 0.03% 0.13% ± 0.03% 
Pro 0.24% ± 0.04% 0.32% ± 0.02% 1.17% ± 0.05% 1.43% ± 0.04% 
Ser 0.23% ± 0.10% 0.28% ± 0.03% 0.22% ± 0.06% 0.44% ± 0.01% 
Tyr 0.04% ± 0.01% 0.07% ± 0.02% 0.03% ± 0.01% 0.06% ± 0.01% 
Val 0.04% ± 0.04% 0.07% ± 0.01% 0.04% ± 0.02% 0.08% ± 0.01% 
DAP 1.24% ± 0.14% 1.85% ± 0.13% 3.18% ± 0.08% 3.64% ± 0.08% 
PHB 0.92% ± 0.11% 1.17% ± 0.14% 1.53% ± 0.17% 1.64% ± 0.20% 
Lactate    0.29% ± 0.03% 
3-Hydroxybutyric acid    1.45% ± 0.08% 
Succinic acid    1.46% ± 0.03% 
Fumaric acid    1.50% ± 0.14% 
Malic acid    2.16% ± 0.28% 
Palmitic acid    1.38% ± 0.03% 
Stearic acid    1.52% ± 0.03% 
Citric acid    0.19% ± 0.05% 
Mannose    31.88% ± 0.08% 
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Table 5.6: Kinetics of 13C-excess (mol%) from [U-13C3]serine. 
13C-Excess (mol%) of amino acids, DAP, PHB, 
polar metabolites and mannose from time series experiments with L. pneumophila wild-type grown in CE MDM 
supplemented with 6 mM [U-13C3]serine. 
 
6 mM [U-13C3]serine 12 h 24 h 36 h 48 h 
Ala 56.77% ± 0.37% 74.60% ± 0.62% 66.83% ± 0.26% 64.03% ± 0.28% 
Asp 23.90% ± 0.17% 34.34% ± 0.19% 28.94% ± 0.14% 28.20% ± 0.15% 
Glu 21.57% ± 0.02% 29.00% ± 0.38% 21.99% ± 0.10% 20.38% ± 0.05% 
Gly 20.53% ± 0.14% 28.58% ± 0.27% 22.94% ± 0.18% 22.72% ± 0.05% 
His 35.79% ± 1.13% 62.05% ± 3.23% 56.35% ± 2.55% 55.88% ± 3.32% 
Ile 0.09% ± 0.01% 0.09% ± 0.00% 0.04% ± 0.01% 0.06% ± 0.02% 
Leu 0.00% ± 0.00% 0.01% ± 0.01% 0.00% ± 0.00% 0.00% ± 0.00% 
Lys 25.24% ± 0.12% 50.22% ± 0.22% 43.86% ± 0.21% 42.45% ± 0.21% 
Phe 0.17% ± 0.06% 0.13% ± 0.02% 0.14% ± 0.02% 0.12% ± 0.01% 
Pro 0.05% ± 0.04% 0.01% ± 0.02% 4.70% ± 0.14% 4.45% ± 0.06% 
Ser 71.13% ± 0.17% 91.61% ± 0.17% 64.59% ± 0.20% 60.83% ± 0.30% 
Tyr 0.25% ± 0.05% 0.12% ± 0.08% 0.11% ± 0.04% 0.12% ± 0.04% 
Val 0.16% ± 0.05% 0.16% ± 0.08% 0.09% ± 0.02% 0.07% ± 0.02% 
DAP 46.62% ± 0.17% 55.02% ± 0.12% 41.05% ± 0.21% 38.31% ± 0.24% 
PHB 29.97% ± 0.51% 39.16% ± 0.56% 16.75% ± 0.21% 15.70% ± 0.67% 
Lactate    0.31% ± 0.11% 
3-Hydroxybutyric acid    12.45% ± 0.31% 
Succinic acid    3.53% ± 0.09% 
Fumaric acid    5.63% ± 0.27% 
Malic acid    4.34% ± 0.19% 
Palmitic acid    32.64% ± 1.73% 
Stearic acid    34.26% ± 1.93% 
Citric acid    0.15% ± 0.01% 
Mannose    40.40% ± 0.59% 
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Table 5.7: Relative fractions of isotopologues (%) of amino acids, DAP and PHB from time series experiments. L. pneumophila wild-type was grown in 
CE MDM supplemented with either (i) 50 mM [U-13C3]glycerol, (ii) 11 mM [U-
13C6]glucose or (iii) 6 mM [U-
13C3]serine as precursor. Shown are isotopologue 
profiles (in %) of 48 h time points from time series experiments. M+x represents the mass of the unlabeled metabolite plus x labeled 13C-atoms. Mean and standard 
deviation from three independent experiments are shown. 
i) 50 mM [U-13C3]glycerol 
 Ala Asp Glu Gly His Lys Pro Ser DAP PHB 
M+1     22.48% ± 6.77%      
M+2     35.70% ± 0.40%      
M+3     31.66% ± 1.30%      
M+4     3.66% ± 0.12%      
M+5     6.53% ± 0.15%      
M+6     0.00% ± 0.00%      
M+7           
ii) 11 mM  [U-13C6]glucose 
 Ala Asp Glu Gly His Lys Pro Ser DAP PHB 
M+1 27.55% ± 3.52% 64.50% ± 2.70% 58.44% ± 0.67%  15.81% ± 0.14% 42.17% ± 2.04%   31.66% ± 3.54% 36.39% ± 8.65% 
M+2 12.52% ± 0.44% 24.08% ± 0.48% 38.30% ± 0.48%  37.35% ± 0.18% 31.25% ± 0.86%   26.49% ± 1.97% 61.95% ± 7.95% 
M+3 59.89% ± 0.57% 11.45% ± 0.29% 2.92% ± 0.13%  21.61% ± 0.08% 26.67% ± 0.42%   38.98% ± 1.39% 0.83% ± 0.72% 
M+4  0.00% ± 0.00% 0.04% ± 0.07%  10.62% ± 0.13% 0.00% ± 0.00%   0.60% ± 1.05% 0.98% ± 0.42% 
M+5   0.38% ± 0.01%  14.62% ± 0.12% 0.00% ± 0.00%   1.42% ± 0.44%  
M+6     0.00% ± 0.00% 0.00% ± 0.00%   0.80% ± 0.16%  
M+7         0.06% ± 0.06%  
iii) 6 mM [U-13C3]serine 
 Ala Asp Glu Gly His Lys Pro Ser DAP PHB 
M+1 10.19% ± 0.15% 28.29% ± 0.77% 27.39% ± 1.90% 4.97% ± 0.15% 13.37% ± 1.71% 11.45% ± 0,16% 43.36% ± 0.76% 11.45% ± 0.39% 12.44% ± 0.86% 31.06% ± 1.73% 
M+2 8.39% ± 0.16% 35.03% ± 0.42% 37.11% ± 1.01% 95.03% ± 0.30% 11.62% ± 1.43% 22.42% ± 0.29% 27.34% ± 1.48% 8.51% ± 0.11% 10.54% ± 0.87% 52.63% ± 1.99% 
M+3 81.43% ± 0.45% 24.48% ± 0.29% 18.62% ± 0.23%  17.43% ± 1.11% 26.21% ± 0.20% 19.25% ± 0.86% 80.04% ± 0.39% 32.48% ± 1.26% 6.08% ± 0.05% 
M+4  12.22% ± 0.05% 11.16% ± 0.27%  18.59% ± 0.33% 18.09% ± 0.19% 7.31% ± 0.62%  13.83% ± 0.26% 10.24% ± 0.79% 
M+5   5.71% ± 0.13%  15.43% ± 2.57% 14.54% ± 0.15% 2.79% ± 0.33%  14.88% ± 0.55%  
M+6     22.95% ± 2.80% 7.27% ± 0.08%   10.39% ± 0.88%  
M+7         5.43% ± 0.73%  
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Table 5.8: Relative fractions of isotopologues (mol%) of polar metabolites and mannose from time-series experiments. L. pneumophila wild-type was grown 
in CE MDM supplemented with either (i) 50 mM [U-13C3]glycerol, (ii) 11 mM [U-
13C6]glucose or (iii) 6 mM [U-
13C3]serine as precursor. Shown are isotopologue 
profilies (in %) of 48 h time points from time series experiments. M+x represents the mass of the unlabeled metabolite plus x labeled 13C-atoms. Mean and standard 
deviation from three independent experiments are shown. 
i) 50 mM [U-13C3]glycerol 
 Lactate 3-HBA Succinic acid Fumaric acid Malic acid Palmitic acid Stearic acid Mannose 
M+1 0.00% ± 0.00%       26.16% ± 3.13% 
M+2 2.77% ± 3.94%       20.00% ± 0.18% 
M+3 97.99% ± 1.40%       40.59% ± 0.71% 
M+4        5.81% ± 0.35% 
M+5        3.89% ± 0.42% 
M+6        3.53% ± 0.21% 
ii) 11 mM  [U-
13
C6]glucose 
 Lactate 3-HBA Succinic acid Fumaric acid Malic acid Palmitic acid Stearic acid Mannose 
M+1  39.96% ± 11.04% 51.77% ± 1.85% 45.44% ± 5.08% 59.08% ± 9.73% 17.20% ± 1.35% 30.10% ± 2.07%  10.82% ± 0.58% 
M+2  57.71% ± 1.69% 39.37% ± 1.16% 36.78% ± 4.81% 31.97% ± 9.58% 74.65% ± 0.84% 59.60% ± 2.63% 12.42% ± 0.41% 
M+3  1.19% ± 1.07% 8.86% ± 0.37% 15.21% ± 1.58% 8.55% ± 1.70% 2.64% ± 0.52% 3.41% ± 0.21% 30.20% ± 0.46% 
M+4  1.20% ± 0.35% 0.08% ± 0.14% 2.73% ± 1.75% 0.38% ± 0.66% 5.09% ± 0.23% 5.24% ± 0.25% 10.33% ± 0.37% 
M+5      0.26% ± 0.01% 0.41% ± 0.04% 4.76% ± 0.23 
M+6      0.12% ± 0.02% 0.60% ± 0.02% 31.50% ± 0.50% 
M+7      0.00% ± 0.00% 0.05% ± 0.01%  
M+8      0.00% ± 0.00% 0.13% ± 0.03%  
M+9      0.00% ± 0.00% 0.00% ± 0.00%  
M+10      0.00% ± 0.00% 0.00% ± 0.00%  
M+11      0.00% ± 0.00% 0.00% ± 0.00%  
M+12      0.00% ± 0.00% 0.02% ± 0.01%  
M+13      0.00% ± 0.00% 0.01% ± 0.00%  
M+14      0.00% ± 0.00% 0.00% ± 0.00%  
M+15      0.00% ± 0.00% 0.01% ± 0.00%  
M+16      0.00% ± 0.00% 0.01% ± 0.00%  
M+17       0.00% ± 0.00%  
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M+18       0.00% ± 0.00%  
iii) 6 mM [U-13C3]serine 
 Lactate 3-HBA Succinic acid Fumaric acid Malic acid Palmitic acid Stearic acid Mannose 
M+1  31.33% ± 0.85% 66.47% ± 2.22% 54.02% ± 2.24% 64.47% ± 3.18% 5.74% ± 0.08% 4.47% ± 0.18% 9.05% ± 0.46% 
M+2  52.67% ± 1.29% 28.62% ± 0.97% 31.04% ± 1.79% 29.39% ± 6.86% 10.50% ± 0.20% 7.48% ± 0.24% 10.68% ± 0.16% 
M+3  4.97% ± 0.23% 4.50% ± 0.34% 10.78% ± 0.27% 5.69% ± 2.66% 4.37% ± 0.24% 3.38% ± 0.09% 28.34% ± 0.29% 
M+4  10.98% ± 0.152 0.35% ± 0.15% 4.22% ± 0.44% 0.40% ± 0.70% 7.79% ± 0.20% 5.41% ± 0.26% 12.11% ± 0.19% 
M+5      5.53% ± 0.14% 4.18% ± 0.14% 10.16% ± 0.30% 
M+6      10.98% ± 0.48% 8.26% ± 0.36% 29.67% ± 1.05% 
M+7      7.80% ± 0.40% 6.95% ± 0.33%  
M+8      13.24% ± 0.62% 11.92% ± 0.69%  
M+9      7.99% ± 0.37% 8.87% ± 0.54%  
M+10      11.12% ± 0.69% 12.29% ± 0.65%  
M+11      5.01% ± 0.41% 7.37% ± 0.39%  
M+12      5.92% ± 0.42% 8.66% ± 0.52%  
M+13      1.80% ± 0.15% 4.03% ± 0.31%  
M+14      1.75% ± 0.17% 4.02% ± 0.235  
M+15      0.25% ± 0.02% 1.28% ± 0.11%  
M+16      0.21% ± 0.03% 1.09% ± 0.09%  
M+17       0.19% ± 0.02%  
M+18       0.14% ± 0.01%  
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Table 5.9: Kinetics of 13C-excess (mol%) in histidine from co-metabolism experiments with glycerol and 
glucose as precursor.  L. pneumophila wild-type was grown in MDM supplemented with either 50 mM 
[U-13C3]glycerol or 50 mM [U-
13C3]glycerol and 11 mM glucose, 11 mM [U-
13C6]glucose or 11 mM [U-
13C6]glucose 
and 50 mM glycerol or 11 mM [U-13C6]glucose or 11 mM [U-
13C6]glucose and 11 mM glucose-6-phosphate. 
13C-excess [mol%] 
in histidine 
12 h 24 h 36 h 48 h 
50mM [U-
13
C3]glycerol 0.37% ± 0.04% 0.92% ± 0.08% 3.47% ± 0.09% 4.29% ± 0.04% 
50mM [U-
13
C3]glycerol + 
11mM glucose 
0.33% ± 0.11% 0.66% ± 0.03% 2.70% ± 0.02% 3.00% ± 0.05% 
     
11mM [U-
13
C6]glucose 9.31% ± 0.04% 18.45% ± 0.03% 18.57% ± 0.02% 18.61% ± 0.04% 
11mM [U-
13
C6]glucose + 
50mM glycerol 
9.16% ± 0.08% 15.15% ± 0.04% 18.74% ± 0.05% 20.72% ± 0.01% 
     
11mM [U-
13
C6]glucose 9.31% ± 0.04% 18.45% ± 0.03% 18.57% ± 0.02% 18.61% ± 0.04% 
11mM [U-
13
C6]glucose + 
11mM glucose-6-
phosphate 
5.24% ± 1.12% 8.04% ± 1.72% 8.28% ± 1.84% 8.41% ± 1.75% 
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Table 5.10: Ratio of 13C-excess in histidine to 13C-excess in alanine calculated from time series experiments with 
L. pneumophila wild-type grown in CE MDM with either 50 mM [U-13C3]glycerol, 11 mM [U-
13C6]glucose or 6 mM 
[U-13C3]serine as precursor. Shown is the ratio of means from samples taken after 12, 24, 36 or 48 h. Standard 
deviation was calculated from the highest possible (+) and the lowest possible (-) value. 
Ratio: 13C-Excess [mol%] His/13C-Excess [mol%] Ala 
             
 12 h + - 24 h + - 36 h + - 48 h + - 
50 mM [U-13C3]glycerol 0.94 1.05 0.48 1.79 0.49 0.34 4.99 0.71 0.56 4.92 0.89 0.67 
11 mM [U-13C6]glucose 6.34 0.21 0.20 6.74 0.07 0.07 5.25 0.17 0.16 4.87 0.08 0.08 
6 mM [U-13C3]serine 0.63 0.02 0.02 0.83 0.05 0.05 0.84 0.04 0.04 0.87 0.06 0.06 
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Table 5.11: 
13
C-Excess (mol%) of alanine, aspartate, glutamate, glycine, serine, DAP, PHB and mannose from 
experiments with uninfected A. castellanii and A. castellanii infected with L. pneumophila wild-type or ∆glpD. 
Infections were supplemented with either (i) 50 mM [U-13C3]glycerol, (ii) 11 mM [U-
13C6]glucose or (iii) 6 mM 
[U-13C3]serine 5 h post infcection. Cells were lysed and fractionated 15 h post infection, resulting in fraction 1 (F1), 
containing eukaryotic cell debris and fraction 2 (F2), containing L. pneumophila bacteria. 
i) 50 mM [U-
13
C3]glycerol 
 uninfected WT-infected (F1) WT-infected (F2) 
∆glpD-infected 
(F1) 
∆glpD-infected 
(F2) 
Ala 17.83% ± 0.28% 0.37% ± 0.19% 0.48% ± 0.14% 0.55% ± 0.22% 0.46% ± 0.11% 
Asp 7.51% ± 0.37% 0.18% ± 0.13% 0.22% ± 0.08% 0.17% ± 0.09% 0.19% ± 0.05% 
Glu 10.65% ± 0.06% 0.32% ± 0.10% 0.61% ± 0.26% 0.58% ± 0.24% 0.51% ± 0.18% 
Gly 7.22% ± 0.18% 0.68% ± 0.89% 0.12% ± 0.10% 0.19% ± 0.14% 0.08% ± 0.10% 
Ser 9.26% ± 0.18% 0.20% ± 0.11% 0.20% ± 0.05% 0.25% ± 0.03% 0.24% ± 0.02% 
DAP 
  
0.52% ± 0.04% 
 
0.24% ± 0.03% 
PHB 
  
0.06% ± 0.03% 
 
0.07% ± 0.10% 
Mannose  0.23% ± 0.19% 0.67% ± 0.07% 0.11% ± 0.04% 0.10% ± 0.04% 
ii) 11 mM [U-
13
C6]glucose 
 uninfected WT-infected (F1) WT-infected (F2)   
Ala 5.98% ± 0.12% 1.22% ± 0.16% 2.06% ± 0.44%   
Asp 2.33% ± 0.04% 0.24% ± 0.00% 0.54% ± 0.17%   
Glu 3.09% ± 0.07% 0.74% ± 0.16% 1.28% ± 0.39%   
Gly 0.57% ± 0.22% 0.27% ± 0.17% 0.27% ± 0.07%   
Ser 0.31% ± 0.06% 0.22% ± 0.01% 0.22% ± 0.02%   
DAP   5.18% ± 1.30%   
PHB   3.91% ± 1.11%   
Mannose  0.60% ± 0.27% 4.47% ± 0.40%   
iii) 6 mM [U-
13
C3]serine 
 uninfected WT-infected (F1) WT-infected (F2)   
Ala 1.32% ± 0.07% 6.85% ± 1.07% 17.90% ± 0.44%   
Asp 0.37% ± 0.09% 1.36% ± 0.50% 3.82% ± 0.05%   
Glu 0.93% ± 0.10% 2.66% ± 1.35% 8.18% ± 0.05%   
Gly 5.43% ± 0.15% 2.11% ± 0.59% 4.64% ± 0.11%   
Ser 12.63% ± 0.08% 12.52% ± 2.21% 31.51% ± 0.16%   
DAP   31.35% ± 0.23%   
PHB   33.64% ± 1.00%   
Mannose  0.10% ± 0.04% 0.22% ± 0.08%   
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Table 5.12: Relative fraction of isotopologues in mannose (%) from fraction 2 of in vivo infection and 
separation experiments. A. castellanii cells were either fed with (i) 50 mM [U-13C3]glycerol or (ii) 11 mM 
[U-13C6]glucose. M+x represents the mass of the unlabeled metabolite plus x labeled 
13C-atoms. Mean and standard 
deviation from two independent experiments are shown. 
Relative fraction of isotopologues in mannose 
 
i) 50 mM [U-
13
C3]glycerol ii) 11 mM [U-
13
C6]glucose 
M+1 19.59% ± 11.87% 6.25% ± 3.84% 
M+2 4.97% ± 3.03% 12.51% ± 0.07% 
M+3 67.67% ± 2.80% 30.37% ± 2.80% 
M+4 4.38% ± 0.51% 9.12% ± 0.97% 
M+5 1.80% ± 1.09% 3.81% ± 0.40% 
M+6 2.35% ± 1.67% 37.86% ± 3.11% 
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